<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000013" GROUP_ID="PREG" ID="251699081020065239" MERGED_FROM="" MODIFIED="2011-12-01 17:15:32 +0100" MODIFIED_BY="Sonja Henderson" NOTES="&lt;p&gt;Exported from Review Manager 4.2.6&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.5&lt;br&gt;Exported from Review Manager 4.2.6&lt;br&gt;Short title (no longer in use): Amnioinfusion for cord compression&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2011-12-01 12:47:34 +0000" NOTES_MODIFIED_BY="Sonja Henderson" REVIEW_NO="0071" REVMAN_SUB_VERSION="5.1.4" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.0">
<COVER_SHEET MODIFIED="2011-12-01 17:15:32 +0100" MODIFIED_BY="Sonja Henderson">
<TITLE>Amnioinfusion for potential or suspected umbilical cord compression in labour</TITLE>
<CONTACT MODIFIED="2011-12-01 17:15:32 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-12-01 17:15:32 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON><PERSON ID="16495233707895187386090810093217" ROLE="AUTHOR"><FIRST_NAME>Theresa</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Lawrie</LAST_NAME><SUFFIX>MBBCH, PhD, DFSRH</SUFFIX><POSITION>Researcher</POSITION><EMAIL_1>tess@lawrie.com</EMAIL_1><MOBILE_PHONE>+447826939464</MOBILE_PHONE><ADDRESS><DEPARTMENT>The Cochrane Gynaecological Cancer Review Group</DEPARTMENT><ORGANISATION>Royal United Hospital</ORGANISATION><ADDRESS_1>Wolfson Centre</ADDRESS_1><CITY>Bath</CITY><ZIP>BA13NG</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-11-29 10:51:54 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="29" MONTH="11" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="10" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="29" MONTH="11" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1996"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1996"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="1998"/>
</DATES>
<WHATS_NEW MODIFIED="2011-11-29 10:52:16 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-11-29 10:52:16 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="29" MONTH="11" YEAR="2011"/>
<DESCRIPTION>
<P>Six newly identified trials included (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>; <LINK REF="STD-Mino-1999" TYPE="STUDY">Mino 1999</LINK>; <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>; <LINK REF="STD-Wang-1997" TYPE="STUDY">Wang 1997</LINK>) and one new trial excluded (<LINK REF="STD-Rinehart-2000" TYPE="STUDY">Rinehart 2000</LINK>). Two trials previously awaiting classification (<LINK REF="STD-McDermot-1998" TYPE="STUDY">McDermot 1998</LINK>; <LINK REF="STD-Washburne-1996" TYPE="STUDY">Washburne 1996</LINK>) now excluded. The comparison of amnioinfusion for suspected amnionitis removed from the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2011-03-30 14:17:44 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="9" MONTH="3" YEAR="2011"/>
<DESCRIPTION>
<P>A new co-author helped to prepare this update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-05-18 14:43:00 +0100" MODIFIED_BY="Denise Atherton">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-05-18 14:43:00 +0100" MODIFIED_BY="Denise Atherton">
<DATE DAY="30" MONTH="9" YEAR="2010"/>
<DESCRIPTION>
<P>New search conducted in September 2010 identified 13 new reports/trials for classification: <LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>, <LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>, <LINK REF="REF-Mino-1997a" TYPE="REFERENCE">Mino 1997a</LINK>, <LINK REF="REF-Mino-1997b" TYPE="REFERENCE">Mino 1997b</LINK>, <LINK REF="REF-Mino-1998" TYPE="REFERENCE">Mino 1998</LINK>, Mi&#328;o 1999, <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>, <LINK REF="REF-Puertas-1997" TYPE="REFERENCE">Puertas 1997</LINK>, <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>, <LINK REF="STD-Wang-1997" TYPE="STUDY">Wang 1997</LINK>, <LINK REF="STD-McDermot-1998" TYPE="STUDY">McDermot 1998</LINK>, <LINK REF="STD-Rinehart-2000" TYPE="STUDY">Rinehart 2000</LINK>, Washburne 1994.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-01-27 09:01:04 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>Contact details edited.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-07-02 10:31:02 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-30 09:40:55 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="11" YEAR="2004"/>
<DESCRIPTION>
<P>Search updated. One new trial identified which has been included (<LINK REF="STD-Amin-2003" TYPE="STUDY">Amin 2003</LINK>). The title has changed from 'Amnioinfusion for umbilical cord compression in labour' to 'Amnioinfusion for potential or suspected umbilical cord compression in labour'.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-30 12:06:40 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="10" YEAR="1997"/>
<DESCRIPTION>
<P>Search updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-10-30 12:05:49 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="10" YEAR="1997"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of the Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>South African Medical Research Council</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>UNDP/UNFPA/WHO/World Bank (HRP)</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-12-01 12:47:34 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-12-01 12:47:34 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-10-30 09:42:34 +0000" MODIFIED_BY="[Empty name]">Amnioinfusion for potential or suspected umbilical cord compression in labour</TITLE>
<SUMMARY_BODY MODIFIED="2011-12-01 12:47:34 +0000" MODIFIED_BY="[Empty name]">
<P>Infusing fluid into the uterus during labour may reduce fetal heart rate abnormalities and reduce caesarean sections.</P>
<P>Most women have adequate amniotic fluid to protect their baby during pregnancy and labour. Occasionally the volume of amniotic fluid is reduced, and this may cause compression of the umbilical cord. This in turn might lead to intermittent slowing of the baby's heart rate during labour. Infusing fluid into the uterus through a catheter placed through the cervix, or a needle through the abdomen may reduce this problem and the incidence of caesarean section. In addition, it may improve the newborn baby's condition at birth and prevent infection of the womb. The 19 studies reviewed were of average quality, and too small to measure the risk of rare complications for the mother; all but two studies had fewer than 200 participants.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-12-01 12:44:47 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-01-27 09:36:16 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion aims to prevent or relieve umbilical cord compression during labour by infusing a solution into the uterine cavity.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-09-25 12:56:02 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of amnioinfusion for potential or suspected umbilical cord compression on maternal and perinatal outcome .</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-11-29 10:56:24 +0000" MODIFIED_BY="Lynn Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 October 2011).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-01-27 09:36:16 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trials of amnioinfusion compared with no amnioinfusion in women with babies at risk of umbilical cord compression in labour.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-11-28 16:54:29 +0000" MODIFIED_BY="Denise Atherton">
<P>The original review had one author only (Justus Hofmeyr (GJH)). For this update, two authors (GJH and T Lawrie) assessed 13 additional trial reports for eligibility and quality. We extracted data and checked for accuracy.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-12-01 12:44:47 +0000" MODIFIED_BY="[Empty name]">
<P>We have included 19 studies, with all but two studies having fewer than 200 participants. Transcervical amnioinfusion for potential or suspected umbilical cord compression was associated with the following reductions: caesarean section overall (13 trials, 1493 participants; average risk ratio (RR) 0.62, 95% confidence interval (CI) 0.46 to 0.83); fetal heart rate (FHR) decelerations (seven trials, 1006 participants; average RR 0.53, 95% CI 0.38 to 0.74); Apgar score less than seven at five minutes (12 trials, 1804 participants; average RR 0.47, 95% CI 0.30 to 0.72); meconium below the vocal cords (three trials, 674 participants, RR 0.53, 95% CI 0.31 to 0.92); postpartum endometritis (six trials, 767 participants; RR 0.45, 95% CI 0.25 to 0.81) and maternal hospital stay greater than three days (four trials, 1051 participants; average RR 0.45, 95% CI 0.25 to 0.78). Transabdominal amnioinfusion showed similar trends, though numbers studied were small.</P>
<P>Mean cord umbilical artery pH was higher in the amnioinfusion group (seven trials, 855 participants; average mean difference 0.03, 95% CI 0.00 to 0.06) and there was a trend toward fewer neonates with a low cord arterial pH (less than 7.2 or as defined by trial authors) in the amnioinfusion group (eight trials, 972 participants, average RR 0.58, 95% CI 0.29 to 1.14).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-11-29 02:05:32 +0000" MODIFIED_BY="[Empty name]">
<P>The use of amnioinfusion for potential or suspected umbilical cord compression may be of considerable benefit to mother and baby by reducing the occurrence of variable FHR decelerations, improving short-term measures of neonatal outcome, reducing maternal postpartum endometritis and lowering the use of caesarean section, although there were methodological limitations to the trials reviewed here. In addition, the trials are too small to address the possibility of rare but serious maternal adverse effects of amnioinfusion. More research is needed to confirm the findings, assess longer-term measures of fetal outcome, and to assess the impact on caesarean section rates when the diagnosis of fetal distress is more stringent. Trials should assess amnioinfusion in specific clinical situations, such as FHR decelerations, oligohydramnios or prelabour rupture of membranes.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-11-29 11:03:32 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2011-11-29 10:52:44 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion has been described as a method of preventing or relieving umbilical cord compression during labour (<LINK REF="REF-Miyazaki-1983" TYPE="REFERENCE">Miyazaki 1983</LINK>). Saline or Ringers lactate is infused transcervically through a catheter into the uterine cavity, or transabdominally through a 'spinal' needle when membranes are intact. The technique has been used prophylactically in various conditions which are commonly associated with oligohydramnios (reduced volume of amniotic fluid) (<LINK REF="REF-Macri-1992" TYPE="REFERENCE">Macri 1992</LINK>), and therapeutically for repetitive variable fetal heart rate (FHR) decelerations during labour. This heart rate abnormality is considered to be due often to umbilical cord compression, particularly when there is oligohydramnios (<LINK REF="REF-Gabbe-1976" TYPE="REFERENCE">Gabbe 1976</LINK>).</P>
<P>There is considerable variability in the diagnosis of oligohydramnios (clinically or with ultrasound), and in the assessment of the severity of variable FHR decelerations on cardiotocography. The use of amnioinfusion for these conditions might therefore vary.</P>
<P>Amnioinfusion with antibiotics has been used to treat established amnionitis (<LINK REF="REF-Goodlin-1981" TYPE="REFERENCE">Goodlin 1981</LINK>), and to prevent infection following premature rupture of membranes (<LINK REF="REF-Ogita-1988" TYPE="REFERENCE">Ogita 1988</LINK>). Saline amnioinfusion has been used to reduce infection in prolonged rupture of membranes, presumably through dilution or irrigation (<LINK REF="STD-Monahan-1995" TYPE="STUDY">Monahan 1995</LINK>).</P>
<P>Transabdominal amnioinfusion has also been used to facilitate external cephalic version at term (<LINK REF="REF-Benifla-1995" TYPE="REFERENCE">Benifla 1995</LINK>), and antepartum amnioinfusion has been used for various fetal indications such as to reduce the risk of pulmonary hypoplasia and to improve ultrasound visualisation of fetal anomalies (<LINK REF="REF-Gramellini-2003" TYPE="REFERENCE">Gramellini 2003</LINK>). Reassuring FHR acceleration in response to small-volume amnioinfusion has been described (<LINK REF="REF-Wax-2004" TYPE="REFERENCE">Wax 2004</LINK>).</P>
<P>This review deals with amnioinfusion for potential or suspected cord compression in labour. 'Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour' (<LINK REF="REF-Novikova-1996" TYPE="REFERENCE">Novikova 1996</LINK>), 'Amnioinfusion for meconium-stained liquor in labour' (<LINK REF="REF-Hofmeyr-2010" TYPE="REFERENCE">Hofmeyr 2010</LINK>), and 'Amnioinfusion for preterm rupture of membranes' (<LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>) are separate Cochrane reviews in the current edition of <I>The Cochrane Library</I>.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2011-11-29 02:06:16 +0000" MODIFIED_BY="Denise Atherton">
<P>To determine, from the best available evidence, the effects of amnioinfusion for potential or suspected umbilical cord compression in labour on FHR characteristics and perinatal and maternal mortality and morbidity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2011-11-29 11:03:32 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-11-29 08:36:33 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2011-11-29 02:06:23 +0000" MODIFIED_BY="[Empty name]">
<P>Clinical trials comparing the effect of amnioinfusion (treatment group) versus no amnioinfusion (control group) for potential or suspected umbilical cord compression in labour, on FHR characteristics, mode of delivery and perinatal and maternal mortality and morbidity; with random allocation to study groups and adequate allocation concealment; where violations of allocated management and exclusions after allocation were insufficient to materially affect outcomes.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-11-29 02:06:30 +0000" MODIFIED_BY="[Empty name]">
<P>Women whose babies were considered to be at increased risk of, or had FHR patterns suggestive of, umbilical cord compression in labour.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-01-12 10:45:40 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion compared with no amnioinfusion. We considered transcervical and transabdominal amnioinfusion separately because there are fundamental differences between the techniques, which may result in different outcomes.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-11-29 08:36:33 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Mother</HEADING>
<UL>
<LI>Caesarean section</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Baby</HEADING>
<UL>
<LI>Abnormal FHR pattern on cardiotocography, e.g. persistent variable decelerations</LI>
<LI>Low Apgar score at 5 minutes (&lt; 7 or as defined by trial authors)</LI>
<LI>Meconium aspiration syndrome</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<UL>
<LI>Caesarean section for suspected fetal distress</LI>
<LI>Instrumental vaginal delivery</LI>
<LI>Instrumental vaginal delivery for suspected fetal distress</LI>
<LI>Intrapartum maternal T &gt; 38ºC</LI>
<LI>Postpartum endometritis/puerperal infection</LI>
<LI>Rupture of membranes to delivery interval (hours)</LI>
<LI>Neonatal admission to intensive/high care</LI>
<LI>Meconium below vocal cords</LI>
<LI>Maternal hospital stay greater than three days</LI>
<LI>Low 1 minute Apgar scores</LI>
<LI>Low umbilical cord arterial pH</LI>
<LI>Meconium-stained liquor</LI>
<LI>Neonatal hospital stay greater than three days</LI>
<LI>Umbilical cord prolapse</LI>
<LI>Mild or severe birth asphyxia</LI>
<LI>Perinatal death</LI>
<LI>Neonatal infection</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-11-29 10:55:03 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2011-11-29 10:55:03 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (31 October 2011). </P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of EMBASE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. </P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-11-29 11:03:32 +0000" MODIFIED_BY="[Empty name]">
<P>For the methods used when assessing the trials identified in the previous version of this review,<I> see</I> <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For this update, we used the following methods when assessing the trials identified by the updated search (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>; <LINK REF="STD-McDermot-1998" TYPE="STUDY">McDermot 1998</LINK>; <LINK REF="STD-Mino-1999" TYPE="STUDY">Mino 1999</LINK>; <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>; <LINK REF="STD-Wang-1997" TYPE="STUDY">Wang 1997</LINK>; <LINK REF="STD-Rinehart-2000" TYPE="STUDY">Rinehart 2000</LINK>):</P>
<STUDY_SELECTION MODIFIED="2011-01-27 12:34:08 +0000" MODIFIED_BY="[Empty name]">
<P>Both authors independently assessed for inclusion all the potential studies identified as a result of the updated search strategy. We resolved any disagreement through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-11-29 10:54:13 +0000" MODIFIED_BY="[Empty name]">
<P>We designed a new form to extract data and, for eligible studies, independently extracted the data using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager software (<LINK REF="REF-Revman-2011" TYPE="REFERENCE">Revman 2011</LINK>) and checked for accuracy. Where information provided was unclear, we attempted to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-11-29 11:03:32 +0000" MODIFIED_BY="[Empty name]">
<P>For the original review, GJH assessed trials for eligibility. For the 2011 update, both authors independently assessed the risk of bias of the newly identified eligible studies using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved any disagreement by discussion.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We describe for each included study the method used to conceal allocation to interventions prior to assignment and assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We consider studies to be at low risk of bias if they were blinded, or if we judge that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel;</LI>
<LI>low, high or unclear risk of bias for outcome assessors.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information is reported, or was supplied by the trial authors, we re-include missing data in the analyses which we undertook.</P>
<P>We assessed methods as:</P>
<UL>
<LI>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; &#8216;as treated&#8217; analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting (checking for reporting bias)</HEADING>
<P>We describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above</HEADING>
<P>We describe for each included study any important concerns we have about other possible sources of bias.</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Handbook </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings. When we had concerns about the impact of the level of bias, we undertook sensitivity analyses.</P>
<P>Note: The risk of bias assessment performed for the original review only included points 1) to 3) above, therefore the risk of bias tables for the originally included trials in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> may be incomplete. Where details are incomplete we have entered "Unclear: Details not available for the 2011 review update".</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-07-08 10:21:22 +0100" MODIFIED_BY="[Empty name]">
<P>For dichotomous data, we present results as summary risk ratio with 95% confidence intervals. For continuous data we planned to use the mean difference if outcomes were measured in the same way between trials and the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2011-11-28 17:10:29 +0000" MODIFIED_BY="[Empty name]">
<P>We noted levels of attrition for included studies. We explored the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>We carried out analyses for all outcomes, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and analysed all participants in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-05-18 14:47:19 +0100" MODIFIED_BY="Denise Atherton">
<P>We assessed statistical heterogeneity in each meta-analysis using the T², I² and Chi² statistics. We regarded heterogeneity as substantial if T² was greater than zero and either I² was greater than 30% or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2011-11-28 17:11:00 +0000" MODIFIED_BY="[Empty name]">
<P>If there were 10 or more studies in the meta-analysis we investigated reporting biases (such as publication bias) using funnel plots (<I>see </I>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). We assessed funnel plot asymmetry visually, and used formal tests for funnel plot asymmetry. For dichotomous outcomes we used the test proposed by <LINK REF="REF-Harbord-2006" TYPE="REFERENCE">Harbord 2006</LINK> and for continuous outcomes we would have used the test proposed by <LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>. If we detected asymmetry in any of these tests or by a visual assessment, we performed exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-11-29 10:54:13 +0000" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-Revman-2011" TYPE="REFERENCE">Revman 2011</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and we judged the trials&#8217; populations and methods to be sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if we detected substantial statistical heterogeneity, we used random-effects meta-analysis to produce an overall summary. We treated the random-effects summary as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful we did not combine trials. Where we used random-effects analyses, we have presented the results as the average treatment effect with its' 95% confidence interval, and the estimates of  T² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-11-29 08:36:34 +0000" MODIFIED_BY="[Empty name]">
<P>Where we identified substantial heterogeneity we investigated it using sensitivity analyses. We considered whether an overall effect was clinically meaningful and, if it was, used random-effects analysis to produce it.</P>
<P>We carried out the following subgroup analysis.</P>
<OL>
<LI>Amnioinfusion for FHR decelerations (suspected cord compression - therapeutic amnioinfusion)</LI>
<LI>Oligohydramnios without FHR decelerations (prophylactic amnioinfusion)</LI>
<LI>Mixed or other indications, e.g. prelabour rupture of the membranes at term or preterm</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-05-18 14:48:01 +0100" MODIFIED_BY="Denise Atherton">
<P>We performed sensitivity analyses where there was a risk of bias associated with the quality of some of the included trials, e.g. <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK> and where there was substantial heterogeneity.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-11-29 10:57:45 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2011-11-29 10:57:45 +0000" MODIFIED_BY="Denise Atherton">
<P>
<I>See</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>We have included 19 studies: 13 from the original review and six from the updated search. One newly identified report contributed no data (<LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>). All except two (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Schrimmer-1991" TYPE="STUDY">Schrimmer 1991</LINK>) had 200 or fewer participants. The primary author of the <LINK REF="STD-Owen-1990" TYPE="STUDY">Owen 1990</LINK> trial provided additional unpublished data for inclusion in this review.</P>
<P>Two trials were stopped before reaching their planned sample size because preliminary results produced significant differences between the groups (<LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>; <LINK REF="STD-Vergani-1996" TYPE="STUDY">Vergani 1996</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-11-29 02:07:02 +0000" MODIFIED_BY="[Empty name]">
<P>
<I>See </I>'Risk of Bias' tables in<I> </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK> and <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>.</P>
<P>Participants of 10 studies were 'randomised' or 'randomly allocated' to groups with no further details provided (<LINK REF="STD-Busowski-1995" TYPE="STUDY">Busowski 1995</LINK>; <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK>; <LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>; <LINK REF="STD-MacGregor-1991" TYPE="STUDY">MacGregor 1991</LINK>; <LINK REF="STD-Miyazaki-1985" TYPE="STUDY">Miyazaki 1985</LINK>; <LINK REF="STD-Nageotte-1985" TYPE="STUDY">Nageotte 1985</LINK>; <LINK REF="STD-Owen-1990" TYPE="STUDY">Owen 1990</LINK>; <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>; <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>; <LINK REF="STD-Wu-1989" TYPE="STUDY">Wu 1989</LINK>) and nine studies used random number tables or computer-generated randomisation (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Amin-2003" TYPE="STUDY">Amin 2003</LINK>; <LINK REF="STD-Mino-1999" TYPE="STUDY">Mino 1999</LINK>; Monahan 1995a; <LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>; <LINK REF="STD-Schrimmer-1991" TYPE="STUDY">Schrimmer 1991</LINK>; <LINK REF="STD-Strong-1990" TYPE="STUDY">Strong 1990</LINK>; <LINK REF="STD-Vergani-1996" TYPE="STUDY">Vergani 1996</LINK>). <LINK REF="STD-Wang-1997" TYPE="STUDY">Wang 1997</LINK> used coin-tossing for the first of each pair of women to randomise participants.</P>
<P>Ten studies performed group allocation by sealed envelopes (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Amin-2003" TYPE="STUDY">Amin 2003</LINK>; <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK>; <LINK REF="STD-Miyazaki-1985" TYPE="STUDY">Miyazaki 1985</LINK>; Monahan 1995a; <LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK>; <LINK REF="STD-Owen-1990" TYPE="STUDY">Owen 1990</LINK>; <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>; <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK>; <LINK REF="STD-Strong-1990" TYPE="STUDY">Strong 1990</LINK>). One group (<LINK REF="STD-Schrimmer-1991" TYPE="STUDY">Schrimmer 1991</LINK>) used 'computer' randomisation and sealed envelopes in a ratio of 3:2.</P>
<P>
<LINK REF="STD-Nageotte-1985" TYPE="STUDY">Nageotte 1985</LINK> recorded five withdrawals after randomisation and <LINK REF="STD-Regi-2009" TYPE="STUDY">Regi 2009</LINK> recorded two. We have excluded results from women who declined participation in <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK> and were used as a comparison group from this review.</P>
<P>The interpretation of FHR response to amnioinfusion in some studies may have been subject to bias as tracings were often not stated to have been assessed 'blind' (<LINK REF="STD-Abdel_x002d_Aleem-2005" TYPE="STUDY">Abdel-Aleem 2005</LINK>; <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK>; <LINK REF="STD-Mino-1999" TYPE="STUDY">Mino 1999</LINK>; <LINK REF="STD-Miyazaki-1985" TYPE="STUDY">Miyazaki 1985</LINK>; <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK>; <LINK REF="STD-Wang-1997" TYPE="STUDY">Wang 1997</LINK>). Apgar score assessments may also have been subject to bias.</P>
<P>In one study (<LINK REF="STD-Owen-1990" TYPE="STUDY">Owen 1990</LINK>) the allocations were imbalanced (43 experimental versus 57 control women, of whom 22 and 36 respectively were multiparous), and the estimated gestational age of women with oligohydramnios/suspected impaired fetal growth in the amnioinfusion group was significantly less than that of the control group. Personal communication with the primary author has established that the enrolment discrepancy was in part a chance imbalance in the randomisation, and in part the result of exclusion of a few women allocated to the experimental group who, for technical reasons, did not actually receive amnioinfusion.</P>
<P>The study by <LINK REF="STD-Persson_x002d_Kjerstadius-1999" TYPE="STUDY">Persson-Kjerstadius 1999</LINK> also had imbalanced group sizes (52 controls versus 60 in the study group). Missing mode of delivery data could have altered results for this outcome (4/60 in the amnioinfusion group); however on sensitivity analysis, review results were not significantly affected by these missing data and so we have retained these data in the meta-analysis. In this study, data on neonatal outcome were tabled without denominators, and for "ominous fetal heart rate patterns", as percentages, and so the latter were unusable. Attempts to contact the authors for additional information were unsuccessful.</P>
<P>In one study (<LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK>), three women in each group received the non-allocated management, but analysis was according to 'intention to treat'.</P>
<P>After unsuccessful attempts to contact authors of a trial conducted in Spain (<LINK REF="STD-Mino-1999" TYPE="STUDY">Mino 1999</LINK>), we considered five reports to pertain to the same trial at different stages of enrolment (<LINK REF="REF-Mino-1997a" TYPE="REFERENCE">Mino 1997a</LINK>; <LINK REF="REF-Mino-1997b" TYPE="REFERENCE">Mino 1997b</LINK>; <LINK REF="REF-Mino-1998" TYPE="REFERENCE">Mino 1998</LINK>; <LINK REF="REF-Puertas-1997" TYPE="REFERENCE">Puertas 1997</LINK>). Two reports published as abstracts (<LINK REF="STD-Gonzalez-2001" TYPE="STUDY">Gonzalez 2001</LINK>; <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>) had no usable data as results were presented as percentages only.</P>
<P>The overall methodological quality of the trials reviewed was thus not ideal.</P>
<P>For data analysis, we have applied a random-effects model where substantial heterogeneity existed on meta-analysis (20 out of 31 outcomes in the comparison 'Transcervical amnioinfusion'). We have expressed results for these outcomes as the 'average' effect.</P>
<P>We performed funnel plots on four outcomes:<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>, <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK> and <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>. We were satisfied that the first three outcomes were free from reporting bias. The asymmetry in <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK> (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>) is discussed below in <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK>.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-11-29 02:07:33 +0000" MODIFIED_BY="[Empty name]">
<P>There was significant heterogeneity for several outcomes, for which we have used a random-effects model.</P>
<SUBSECTION>
<HEADING LEVEL="3">Mode of delivery</HEADING>
<P>The incidence of caesarean section (primary outcome) was significantly reduced (13 trials, 1493 women; average risk ratio (RR) 0.62, 95% confidence interval (CI) 0.46 to 0.83; (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>)). This reduction was due to a reduction in the sub-groups oligohydramnios (average RR 0.60 95%CI 0.42 to 0.85) and mixed group (average RR 0.48, 95%CI 0.27 to 0.86). There was no difference in the one trial in the FHR deceleration group which reported this outcome.</P>
<P>The effect was most marked for caesarean section performed for suspected fetal distress (12 trials, 1588 women; average RR 0.46; 95% CI 0.31 to 0.68 (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>)), which was reduced in all three groups. The magnitude of the reduction was less for FHR decelerations than for the other two sub-groups (test for subgroup differences: P = 0.02). Since the diagnosis of fetal distress may be subject to reporting bias, the latter result should be interpreted with caution: the use of scalp blood pH measurement was not used to confirm all diagnoses of fetal distress, therefore it is possible that the difference in caesarean sections for fetal distress is due to the difference in the rate of variable FHR decelerations, which do not necessarily denote fetal distress. Another possible explanation is that attending staff may have been reassured that problems relating to oligohydramnios had been attended to by means of amnioinfusion, and therefore less likely to opt for caesarean section for fetal distress.</P>
<P>Likewise, the results for the outcome 'forceps or vacuum for fetal distress' may be subject to bias (four trials, 665 women; RR 0.58, 95% CI 0.39 to 0.85 (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>)). The incidence of forceps or vacuum assisted delivery overall was not significantly different between groups (five trials, 705 women; RR 0.85, 95% CI 0.64 to 1.12 (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>)).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Fetal/neonatal outcome</HEADING>
<P>Persistant variable FHR decelerations (primary outcome) were significantly less frequent in the amnioinfusion group (seven trials, 1006 participants; average RR 0.53, 95% CI 0.38 to 0.74 (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>)). This effect was slightly greater in the FHR deceleration subgroup (three trials, 682 participants; 0.44, 95% CI 0.24 to 0.80) than in the oligohydramnios (3 trials, 131 participants, average RR 0.54 95% CI 0.30 to 0.99) or mixed indication group (one trial, 193 participants; RR 0.81, 95% CI 0.71 to 0.93). The test for subgroup differences was not significant: (P = 0.07).</P>
<P>Mean cord umbilical artery pH was higher in the amnioinfusion group compared with the control group (seven trials, 855 participants; average mean difference (MD) 0.03, 95% CI 0.00 to 0.06 (random-effects) or MD 0.03, 95% CI 0.02-0.04,(fixed-effect) (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>)) and there was a trend toward fewer neonates with a lower cord arterial pH (less than 7.2 or as defined by trial authors) in the amnioinfusion group (eight trials, 972 participants, average RR 0.58, 95% CI 0.29 to 1.14 (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>)).</P>
<P>Neonates with Apgar scores less than seven at one minute were significantly fewer in the amnioinfusion group versus the controls (10 trials, 1628 participants; average RR 0.47, 95% CI 0.29 to 0.77 (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>)): this effect was significant overall and for the oligohydramnios subgroup only (six trials, 746 participants; 0.27, 95% CI 0.18 to 0.39) (test for subgroup differences: P = 0.03). The results for neonatal Apgar scores less than seven at five minutes (primary outcome) were similar to the one-minute assessment (12 trials, 1804 participants; average RR 0.47, 95% CI 0.30 to 0.72 (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>)). Since the Apgar assessment was rarely stated by investigators as blind, this result may be subject to some observer bias. In addition asymmetry in the funnel plot suggests the possibility of publication bias (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
<P>The frequency of meconium below the vocal cords was halved in the amnioinfusion group (three trials, 674 participants, average RR 0.53, 95% CI 0.31 to 0.92 (<LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>)) but there was no significant difference in the occurrence of meconium aspiration syndrome (primary outcome) (two trials, 514 participants; RR 0.14, 95% CI 0.01 to 2.75 (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>)).</P>
<P>The outcome 'mild' or 'severe' birth asphyxia was reported in one study only (118 participants, RR 0.32, 95% CI 0.15 to 0.70 (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>).</P>
<P>Umbilical cord prolapse occurred in two out of 677 women (seven trials), both of whom were receiving amnioinfusion. In both cases the babies were born in poor condition. Very large studies will be required to determine whether there is an increase in this rare outcome with amnioinfusion.</P>
<P>Perinatal death was also a rare event occurring in two amnioinfusion cases and five control cases (nine trials, 1022 participants; RR 0.47, 95% CI 0.12 to 1.79 (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>)).</P>
<P>There was no significant difference between groups in the rates of neonatal sepsis.</P>
<P>There was a trend towards fewer neonatal admissions to an intensive care or high risk nursery in the average amnioinfusion group (five trials, 958 participants; average RR 0.74, 95% CI 0.49 to 1.10 (<LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>)).</P>
<P>Neonatal hospital stay more than three days was significantly reduced in one but not the other trial which reported this outcome (<LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Maternal outcome</HEADING>
<P>Postpartum endometritis/puerperal infection was reduced only in the mixed indication sub-group (two trials, 161 participants; average RR 0.20, 95% CI 0.05 to 0.88; <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). This outcome may be subject to bias as few studies reported assessor blinding. In addition, it may be secondary to the reduced rate of caesarean section with amnioinfusion, as may the shorter maternal hospital stay (four trials, 1051 participants; average RR 0.45, 95% CI 0.25 to 0.78 (<LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>)).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other outcomes</HEADING>
<P>There was no significant difference between groups with regard to the time from rupture of membranes to delivery (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
<P>The results of the two trials of transabdominal amnioinfusion are very similar to those of the trials of transcervical amnioinfusion but numbers of participants are small. There was a reduction in suspicious/ominous FHR patterns (one trial, 70 participants; RR 0.13, 95% CI 0.03 to 0.52 (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>)) and caesarean section for fetal distress (two trials, 110 participants; RR 0.20, 95% CI 0.05 to 0.74 (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>)). The trends to reduced caesarean sections overall and improved fetal outcomes did not reach statistical significance.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-11-29 02:08:21 +0000" MODIFIED_BY="[Empty name]">
<P>The results of the trials reviewed are generally consistent, except for the results of the study of <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK>. The lack of positive outcomes in the latter trial may be the result of the small numbers studied or the fact that amnioinfusion was administered on one occasion only.</P>
<P>The evidence available from these trials suggests that amnioinfusion for potential (oligohydramnios) or suspected umbilical cord compression (FHR decelerations) reduces the occurrence of variable FHR decelerations and improves short-term neonatal outcomes, namely Apgar scores and umbilical artery pH.</P>
<P>In addition, of considerable importance is the large reduction in caesarean sections, which is accounted for by a reduction in operations performed for 'fetal distress'. As no mention is made of fetal scalp blood sampling in any of the studies, this diagnosis may have been based on FHR patterns alone. Extrapolation of the results as a guide to clinical practice should therefore be limited to clinical situations in which caesarean sections are commonly performed for abnormal FHR patterns alone.</P>
<P>The decrease in puerperal infection appears to be a maternal benefit of amnioinfusion. This effect may be secondary to the lower rate of caesarean section following amnioinfusion as may the significantly shorter length of hospital stay.</P>
<P>The trials reviewed are too small to address the possibility of rare but serious maternal side effects of amnioinfusion. Several case reports have been published of cardiac failure or amniotic fluid embolism following amnioinfusion, though a causal relationship has not been established (<LINK REF="REF-Dibble-1992" TYPE="REFERENCE">Dibble 1992</LINK>; <LINK REF="REF-Dragich-1991" TYPE="REFERENCE">Dragich 1991</LINK>; <LINK REF="REF-Hofmeyr-1996" TYPE="REFERENCE">Hofmeyr 1996</LINK>; <LINK REF="REF-Maher-1994" TYPE="REFERENCE">Maher 1994</LINK>; <LINK REF="REF-Wegnelius-1996" TYPE="REFERENCE">Wegnelius 1996</LINK>; <LINK REF="REF-Wenstrom-1994" TYPE="REFERENCE">Wenstrom 1994</LINK>). The benefits shown in the trials reviewed need to be weighed against the theoretical small risk of serious maternal complications. Extrapolation from the Cochrane review of amnioinfusion for meconium-stained liquor, which included one large trial, is reassuring in that no increase in maternal death or severe morbidity was found (<LINK REF="REF-Hofmeyr-2010" TYPE="REFERENCE">Hofmeyr 2010</LINK>). Larger trials are needed to address the risk-benefit ratio of amnioinfusion for oligohydramnios or FHR decelerations conclusively.</P>
<P>The trials reviewed are also too small to assess the possibility of rare fetal complications, such as umbilical cord prolapse.</P>
<P>Trials in this review include the use of amnioinfusion both prophylactically for situations such as oligohydramnios, or therapeutically for FHR decelerations. The limited evidence available suggests that there is no advantage to using amnioinfusion prophylactically as opposed to therapeutically (<I>see</I> Cochrane review by <LINK REF="REF-Novikova-1996" TYPE="REFERENCE">Novikova 1996</LINK>).</P>
<P>The trials of transabdominal amnioinfusion, though small, suggest that similar results are achieved as with transcervical amnioinfusion. The risk of transabdominal insertion of a needle into the amniotic cavity needs to be weighed against several theoretical advantages of the transabdominal route in women with intact membranes: the membranes do not need to be ruptured to perform amnioinfusion; there is no ongoing leakage of amniotic fluid, so that a single infusion is likely to be effective for several hours; and the discomfort, inconvenience and possible risks of an indwelling intrauterine catheter are avoided.</P>
<P>The results should be interpreted with caution because of the methodological shortcomings mentioned, and the small numbers in the individual studies. The latter limitation raises the possibility of publication bias. It is worth noting that in the review of amnioinfusion for meconium stained liquor, positive results form a number of small trials were not borne out by a large, multicentre trial (<LINK REF="REF-Hofmeyr-2010" TYPE="REFERENCE">Hofmeyr 2010</LINK>).</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-09-30 14:11:22 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-07-17 20:11:50 +0100" MODIFIED_BY="[Empty name]">
<P>In settings in which fetal scalp blood sampling is not used to confirm fetal distress, the use of amnioinfusion for potential or suspected umbilical cord compression may be of considerable benefit to the mother and baby, though the methodological limitations of the trials reviewed here need to be kept in mind. Amnioinfusion may also be useful both for oligohydramnios and for repeated variable decelerations in settings where fetal blood sampling reveals no imminent indication for caesarean section, by decreasing the risk of meconium below the cords and fetal acidosis.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-09-30 14:11:22 +0100" MODIFIED_BY="[Empty name]">
<P>Larger randomised studies are needed to assess the effect of amnioinfusion for oligohydramnios or FHR decelerations on neonatal well-being, and on the rate of caesarean sections, where fetal scalp blood sampling is used to confirm the diagnosis of fetal distress. Trials should assess amnioinfusion in specific clinical situations, such as FHR decelerations, oligohydramnios or prelabour rupture of membranes.</P>
<P>The use of transabdominal amnioinfusion deserves further research. In particular, a large trial in women with intact membranes comparing transabdominal amnioinfusion with artificial rupture of membranes and transcervical amnioinfusion may help to define possible risks associated with the presence of an indwelling intrauterine catheter.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-09-25 14:42:14 +0100" MODIFIED_BY="[Empty name]">
<P>Sonja Henderson, Denise Atherton and the Cochrane Pregnancy and Childbirth Group team for administrative and technical support, and Lynn Hampson for literature search.</P>
<P>John Owen for providing additional information in his trial.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2011-01-28 10:05:12 +0000" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-01-28 10:04:47 +0000" MODIFIED_BY="[Empty name]">
<P>GJ Hofmeyr prepared the original review. For the update, Tess Lawrie and GJ Hofmeyr assessed trials, performed data extraction and contributed to the text. GJ Hofmeyr maintains the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-07-17 20:04:50 +0100" MODIFIED_BY="[Empty name]">
<P>The original review included a comparison of amnioinfusion for suspected versus potential chorioamnionitis. During the update process, we decided that this topic requires a separate review and removed this comparison from the review. In response to reviewer recommendations, the sub-groups were redefined to be more clinically relevant, and all outcomes were analysed in these sub-groups. In keeping with current systematic review methodology, the number of primary outcomes was reduced.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-11-29 11:03:47 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2011-11-29 02:10:43 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2011-11-29 02:10:43 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdel_x002d_Aleem-2005" MODIFIED="2011-01-21 11:10:29 +0000" MODIFIED_BY="[Empty name]" NAME="Abdel-Aleem 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-21 11:10:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Aleem H, Amin AF, Shokry M, Radwan RA</AU>
<TI>Therapeutic amnioinfusion for intrapartum fetal distress using a pediatric feeding tube</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2005</YR>
<VL>90</VL>
<NO>2</NO>
<PG>94-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amin-2003" MODIFIED="2011-03-11 09:50:34 +0000" MODIFIED_BY="Lynn Hampson" NAME="Amin 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-03-11 09:50:34 +0000" MODIFIED_BY="Lynn Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amin AF, Mohammed MS, Sayed GH, Abdel-Razik S</AU>
<TI>Prophylactic transcervical amnioinfusion in laboring women with oligohydramnios</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2003</YR>
<VL>81</VL>
<PG>183-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Busowski-1995" NAME="Busowski 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;[8765]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Busowski J, Pendergraft JS, Parsons M, O'Brien W</AU>
<TI>Transabdominal amnioinfusion prior to induction of labor</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>172</VL>
<PG>287</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chauhan-1992" NAME="Chauhan 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;[7439]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chauhan SP, Rutherford SE, Hess LW, Morrison JC</AU>
<TI>Prophylactic intrapartum amnioinfusion for patients with oligohydramnios. A prospective randomized study</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1992</YR>
<VL>37</VL>
<NO>9</NO>
<PG>817-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-2001" MODIFIED="2011-03-10 15:27:07 +0000" MODIFIED_BY="Jill Hampson" NAME="Gonzalez 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-03-10 15:27:07 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez R, Malde J, Carrillo MP, Sancho-Minano J, Garrote A, Munoz A, et al</AU>
<TI>The use of amnioinfusion in preterm deliveries. Preliminary results</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2001</YR>
<VL>29 Suppl 1</VL>
<NO>Pt 2</NO>
<PG>629</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacGregor-1991" NAME="MacGregor 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;[6177]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacGregor SN, Banzhaf WC, Silver RK, Depp R</AU>
<TI>A prospective, randomized evaluation of intrapartum amnioinfusion</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1991</YR>
<VL>36</VL>
<PG>69-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mino-1999" MODIFIED="2011-11-29 02:10:43 +0000" MODIFIED_BY="Lynn Hampson" NAME="Mino 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-03-10 14:50:32 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Carrillo MP, Santiago JC, Herruzo AJ, Miranda JA</AU>
<TI>Influence of amnioinfusion on variable or prolonged decelerations: a randomised study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<NO>167</NO>
<PG>95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-24 13:36:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Herruzo AJ, Miranda JA</AU>
<TI>Amnioinfusion in labor induction of term pregnancies with premature rupture of the membranes and low amniotic fluid</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1998</YR>
<VL>61</VL>
<PG>135-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-03-11 09:50:59 +0000" MODIFIED_BY="Lynn Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Miranda JA, Herruzo AJ</AU>
<TI>Amnioinfusion in term labor with low amniotic fluid due to rupture of membranes: a new indication</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1999</YR>
<VL>82</VL>
<PG>29-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-11-29 02:10:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Mozas J, Carrillo Badillo MP, Rodríguez Oliver A, Miranda JA</AU>
<TI>A modification of the amniotic fluid index after amnioinfusion for infants with early rupture of membranes</TI>
<TO>Modificación del índice de líquido amniótico tras amnioinfusión en gestantes con rotura prematura de membranas a término</TO>
<SO>Acta Ginecológica</SO>
<YR>1997</YR>
<VL>54</VL>
<NO>1</NO>
<PG>11-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-24 13:36:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Mino M, Carrillo MP, Mozas J, Herruzo AJ, Miranda JA</AU>
<TI>Influence of amnioinfusion on neonatal acid-base state: a randomized study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76 Suppl</VL>
<NO>167:1</NO>
<PG>94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miyazaki-1985" NAME="Miyazaki 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;[1105]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyazaki FS, Nevarez F</AU>
<TI>Saline amnioinfusion for relief of repetitive variable decelerations: a prospective randomized study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1985</YR>
<VL>153</VL>
<PG>301-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nageotte-1985" NAME="Nageotte 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;[1433]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nageotte MP, Freeman RK, Garite TJ, Dorchester W</AU>
<TI>Prophylactic intrapartum amnioinfusion in patients with preterm premature rupture of membranes</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1985</YR>
<VL>153</VL>
<PG>557-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nageotte-1991" NAME="Nageotte 1991" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;[5358]&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Nageotte MP, Bertucci L, Towers CV, Lagrew DC, Mondanlau H</AU>
<TI>Prophylactic amnioinfusion in pregnancies complicated by oligohydramnios or thick meconium: a prospective study</TI>
<SO>Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 February 1-4; New Orleans, Louisiana</SO>
<YR>1989</YR>
<PG>78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[6455]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nageotte MP, Bertucci L, Towers CV, Lagrew DL, Modanlou H</AU>
<TI>Prophylactic amnioinfusion in pregnancies complicated by oligohydramnios: a prospective study</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1991</YR>
<VL>77</VL>
<PG>677-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Owen-1990" NAME="Owen 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Owen J, Henson BV, Hauth JC</AU>
<TI>A prospective randomized study of saline amnioinfusion</TI>
<SO>Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians;1989 February 1-4; New Orleans, Louisiana, USA</SO>
<YR>1989</YR>
<PG>440</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[5586]&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Owen J, Henson BV, Hauth JC</AU>
<TI>A prospective randomized study of saline solution amnioinfusion</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<PG>1146-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Persson_x002d_Kjerstadius-1999" MODIFIED="2011-01-19 12:07:32 +0000" MODIFIED_BY="[Empty name]" NAME="Persson-Kjerstadius 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-01-19 12:07:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson-Kjerstadius N, Forsgren H, Westgren M</AU>
<TI>Intrapartum amnioinfusion in women with oligohydramniosis A prospective randomized trial</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1999</YR>
<VL>78</VL>
<NO>2</NO>
<PG>116-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Puertas-2001" MODIFIED="2011-03-11 09:51:56 +0000" MODIFIED_BY="Lynn Hampson" NAME="Puertas 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Munoz A, Mozas J, Carrillo MP, Perez B, Gozalez R, Fernandez M, Miranda JA</AU>
<TI>Value of intrapartum transcervical amnioinfusion in pregnancies with oligohydramnios and integral ovular membranes</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>2001</YR>
<VL>29 Suppl 1</VL>
<PG>632</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-03-10 14:57:45 +0000" MODIFIED_BY="Jill Hampson"/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Regi-2009" MODIFIED="2011-03-09 10:59:30 +0000" MODIFIED_BY="[Empty name]" NAME="Regi 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-01-21 13:48:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Regi A, Alexander N, Jose R, Lionel J, Varghese L, Peedicayil A</AU>
<TI>Amnioinfusion for relief of recurrent severe and moderate variable decelerations in labor</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>2009</YR>
<VL>54</VL>
<NO>5</NO>
<PG>295-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schrimmer-1991" MODIFIED="2011-01-27 09:54:34 +0000" MODIFIED_BY="[Empty name]" NAME="Schrimmer 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;[6337].&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schrimmer DB, Macri CJ, Paul RH</AU>
<TI>Prophylactic amnioinfusion as a treatment for oligohydramnios in laboring patients: a prospective, randomized trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>164</VL>
<PG>305</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-27 09:54:34 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[6917]&lt;/p&gt;" NOTES_MODIFIED="2011-01-27 09:54:34 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schrimmer DB, Macri CJ, Paul RH</AU>
<TI>Prophylactic amnioinfusion as a treatment for oligohydramnios in labouring patients: a prospective, randomized trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>165</VL>
<PG>972-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strong-1990" NAME="Strong 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;[5638]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strong TH, Hetzler G, Sarno AP, Paul RH</AU>
<TI>Prophylactic intrapartum amnioinfusion: a randomized clinical trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1990</YR>
<VL>162</VL>
<PG>1370-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vergani-1996" MODIFIED="2011-01-27 09:54:15 +0000" MODIFIED_BY="[Empty name]" NAME="Vergani 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-01-27 09:54:15 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9272]&lt;/p&gt;" NOTES_MODIFIED="2011-01-27 09:54:15 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vergani P, Ceruti P, Strobelt N, Locatelli A, D'Oria P, Mariani S</AU>
<TI>Transabdominal amnioinfusion in oligohydramnios at term before induction of labor with intact membranes: a randomized clinical trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1996</YR>
<VL>175</VL>
<PG>465-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-1997" MODIFIED="2011-01-20 13:37:02 +0000" MODIFIED_BY="[Empty name]" NAME="Wang 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-01-20 13:37:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang CC, Rogers MS</AU>
<TI>Lipid peroxidation in cord blood: a randomised sequential pairs study of prophylactic saline amnioinfusion for intrapartum oligohydramnios</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<NO>10</NO>
<PG>1145-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-1989" MODIFIED="2011-01-27 09:54:53 +0000" MODIFIED_BY="[Empty name]" NAME="Wu 1989" YEAR="1989">
<REFERENCE MODIFIED="2011-01-27 09:54:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[5101]&lt;/p&gt;" NOTES_MODIFIED="2011-01-27 09:54:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu BT</AU>
<TI>Intrapartum amnioinfusion in patients with oligohydramnios</TI>
<SO>Chung Hua Fu Chan Ko Tsa Chih</SO>
<YR>1989</YR>
<VL>24</VL>
<PG>2-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-07-08 10:36:06 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-McDermot-1998" MODIFIED="2011-01-20 14:20:00 +0000" MODIFIED_BY="[Empty name]" NAME="McDermot 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-01-20 14:20:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McDermott TM, Parilla BV</AU>
<TI>Amnioinfusion as a therapy to reduce post partum endometriosis after chorioamnionitis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>178</VL>
<NO>1</NO>
<PG>S212</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McEvoy-1991" NAME="McEvoy 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;[8965]&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McEvoy C, Sardesai S, Macri C, Paul R, Durand M</AU>
<TI>Neonatal pulmonary mechanics and oxygenation after prophylactic amnioinfusion in labor: a randomized clinical trial</TI>
<SO>Pediatrics</SO>
<YR>1995</YR>
<VL>95</VL>
<PG>688-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[6781]&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McEvoy C, Sardesai S, Macri C, Paul R, Durand M</AU>
<TI>Neonatal pulmonary mechanics and oxygenation following prophylactic amnioinfusion in labour: a randomized clinical trial</TI>
<SO>Pediatric Research</SO>
<YR>1991</YR>
<VL>29</VL>
<PG>226A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monahan-1995" MODIFIED="2011-07-08 10:36:06 +0100" MODIFIED_BY="[Empty name]" NAME="Monahan 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-07-08 10:36:06 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9080]&lt;/p&gt;" NOTES_MODIFIED="2011-07-08 10:36:06 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monahan E, Katz VL, Cox RL</AU>
<TI>Amnioinfusion for preventing puerperal infection. A prospective study</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1995</YR>
<VL>40</VL>
<PG>721-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muse-1997" MODIFIED="2011-03-10 15:42:35 +0000" MODIFIED_BY="Jill Hampson" NAME="Muse 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-03-10 15:42:35 +0000" MODIFIED_BY="Jill Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muse K, Cooke R, Milligan D</AU>
<TI>Cold amnioinfusion does not induce the neonatal thyrotropin surge in utero</TI>
<SO>Fertility and Sterility</SO>
<YR>1997</YR>
<VL>Suppl</VL>
<PG>S77-S78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pressman-1996" NAME="Pressman 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pressman EK, Blakemore KJ</AU>
<TI>A prospective randomised trial of two solutions for intrapartum amnioinfusion: effects on fetal electrolytes, osmolality, and acid base status</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1996</YR>
<VL>175</VL>
<PG>945-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rinehart-2000" MODIFIED="2011-01-21 09:40:06 +0000" MODIFIED_BY="[Empty name]" NAME="Rinehart 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-01-21 09:40:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rinehart BK, Terrone DA, Barrow JH, Isler CM, Barrilleaux PS, Roberts WE</AU>
<TI>Randomized trial of intermittent or continuous amnioinfusion for variable decelerations</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2000</YR>
<VL>96</VL>
<NO>4</NO>
<PG>571-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Washburne-1996" MODIFIED="2011-05-18 14:41:57 +0100" MODIFIED_BY="Denise Atherton" NAME="Washburne 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-05-18 14:41:57 +0100" MODIFIED_BY="Denise Atherton" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Washburne JF, Chauhan SP, Magann EF, Rhodes PG, Naef RW, Morrison JC</AU>
<TI>Neonatal electrolyte response to amnioinfusion with lactated Ringer's solution vs. normal saline</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1996</YR>
<VL>41</VL>
<PG>741-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-05-18 14:41:26 +0100" MODIFIED_BY="Denise Atherton" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Washburne JF, Chauhan SP, Magann EF, Rhodes PH, Wilkins PW, Morrison JC</AU>
<TI>Newborn electrolyte responses to amnioinfusion with lactated ringer's vs normal saline: a randomized prospective study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>376</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2011-01-24 14:08:40 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-11-29 11:03:47 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2011-11-29 11:03:47 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alderson-2004" NAME="Alderson 2004" TYPE="OTHER">
<AU>Alderson P, Green S, Higgins JPT, editors</AU>
<TI>Cochrane Reviewers&#8217; Handbook 4.2.2 [updated March 2004]</TI>
<SO>In: Review Manager (RevMan) [Computer program]. Oxford, England: The Cochrane Collaboration, 2004</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Benifla-1995" MODIFIED="2011-01-18 13:52:52 +0000" MODIFIED_BY="[Empty name]" NAME="Benifla 1995" TYPE="JOURNAL_ARTICLE">
<AU>Benifla JL, Goffinet F, Bascou V, Darai E, Proust A, Madelenat P</AU>
<TI>Transabdominal amnioinfusion facilitates external version manoeuvre after initial failure</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)</SO>
<YR>1995</YR>
<VL>24</VL>
<PG>319-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dibble-1992" NAME="Dibble 1992" TYPE="JOURNAL_ARTICLE">
<AU>Dibble LA, Elliot JP</AU>
<TI>Possible amniotic fluid embolism associated with amnioinfusion</TI>
<SO>Journal of Maternal-Fetal Medicine</SO>
<YR>1992</YR>
<VL>1</VL>
<PG>263-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dragich-1991" NAME="Dragich 1991" TYPE="JOURNAL_ARTICLE">
<AU>Dragich DA, Ross AF, Chestnut DH, Wenstrom KD</AU>
<TI>Respiratory failure associated with amnioinfusion during labor</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>1991</YR>
<VL>72</VL>
<PG>549-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2011-01-25 12:46:48 +0000" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Smith GD, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gabbe-1976" MODIFIED="2010-09-10 11:17:52 +0100" MODIFIED_BY="Lynn Hampson" NAME="Gabbe 1976" TYPE="JOURNAL_ARTICLE">
<AU>Gabbe SG, Ettinger BB, Freeman RK, Martin CB</AU>
<TI>Umbilical cord compression associated with amniotomy: laboratory observations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1976</YR>
<VL>126</VL>
<PG>353-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goodlin-1981" MODIFIED="2011-03-10 15:53:14 +0000" MODIFIED_BY="Jill Hampson" NAME="Goodlin 1981" TYPE="JOURNAL_ARTICLE">
<AU>Goodlin RC</AU>
<TI>Intra-amniotic antibiotic infusions</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1981</YR>
<VL>139</VL>
<PG>975</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gramellini-2003" NAME="Gramellini 2003" TYPE="JOURNAL_ARTICLE">
<AU>Gramellini D, Fieni S, Kaihura C, Piantelli G, Verrotti C</AU>
<TI>Antepartum amnioinfusion: a review</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2003</YR>
<VL>14</VL>
<PG>291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harbord-2006" MODIFIED="2011-01-25 12:47:18 +0000" MODIFIED_BY="[Empty name]" NAME="Harbord 2006" TYPE="JOURNAL_ARTICLE">
<AU>Harbord RM, Egger M, Sterne JA</AU>
<TI>A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints</TI>
<SO>Statistics in Medicine</SO>
<YR>2006</YR>
<VL>25</VL>
<PG>3443-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-11-29 11:03:47 +0000" MODIFIED_BY="Jill Hampson" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1998" MODIFIED="2011-03-10 15:01:20 +0000" MODIFIED_BY="Jill Hampson" NAME="Hofmeyr 1998" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for preterm rupture of membranes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-03-10 15:01:20 +0000" MODIFIED_BY="Jill Hampson">
<IDENTIFIER MODIFIED="2011-03-10 15:01:20 +0000" MODIFIED_BY="Jill Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD000942"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2010" MODIFIED="2011-11-10 16:32:48 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2010" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ, Xu H</AU>
<TI>Amnioinfusion for meconium-stained liquor in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-03-10 15:04:55 +0000" MODIFIED_BY="Jill Hampson">
<IDENTIFIER MODIFIED="2011-03-10 15:04:55 +0000" MODIFIED_BY="Jill Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD000014.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Macri-1992" MODIFIED="2011-03-09 14:03:17 +0000" MODIFIED_BY="[Empty name]" NAME="Macri 1992" TYPE="JOURNAL_ARTICLE">
<AU>Macri CJ, Schrimmer DB, Leung A, Greenspoon JS, Paul RH</AU>
<TI>Prophylactic amnioinfusion improves outcome of pregnancy complicated by thick meconium and oligohydramnios</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<NO>1</NO>
<PG>117-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maher-1994" MODIFIED="2010-09-10 11:19:38 +0100" MODIFIED_BY="Lynn Hampson" NAME="Maher 1994" TYPE="JOURNAL_ARTICLE">
<AU>Maher JE, Wenstrom KD, Hauth JC, Meis BJ</AU>
<TI>Amniotic fluid embolism after saline amnioinfusion: two cases and review of the literature</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1994</YR>
<VL>83</VL>
<PG>851-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mino-1997a" MODIFIED="2011-01-25 14:40:32 +0000" MODIFIED_BY="[Empty name]" NAME="Mino 1997a" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Mozas J, Carrillo Badillo MP, Rodríguez Oliver A, Miranda JA</AU>
<TI>A modification of the amniotic fluid index after aminoinfusion for infants with early rupture of membranes</TI>
<TO>Modificación del índice de líquido amniótico tras amnioinfusión en gestantes con rotura prematura de membranas a término</TO>
<SO>Acta Ginecológica</SO>
<YR>1997</YR>
<VL>54</VL>
<NO>1</NO>
<PG>11-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mino-1997b" MODIFIED="2011-11-29 01:46:03 +0000" MODIFIED_BY="Jill Hampson" NAME="Mino 1997b" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Carrillo MP, Santiago JC, Herruzo AJ, Miranda JA</AU>
<TI>Influence of amnioinfusion on variable or prolonged decelerations: a randomised study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<NO>167</NO>
<PG>95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mino-1998" MODIFIED="2011-01-25 14:40:07 +0000" MODIFIED_BY="[Empty name]" NAME="Mino 1998" TYPE="JOURNAL_ARTICLE">
<AU>Mino M, Puertas A, Herruzo AJ, Miranda JA</AU>
<TI>Amnioinfusion in labor induction of term pregnancies with premature rupture of the membranes and low amniotic fluid</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1998</YR>
<VL>61</VL>
<PG>135-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyazaki-1983" NAME="Miyazaki 1983" TYPE="JOURNAL_ARTICLE">
<AU>Miyazaki FS, Taylor NA</AU>
<TI>Saline amnioinfusion for relief of prolonged variable decelerations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1983</YR>
<VL>146</VL>
<PG>670-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Novikova-1996" MODIFIED="2011-03-10 15:28:14 +0000" MODIFIED_BY="Jill Hampson" NAME="Novikova 1996" TYPE="COCHRANE_REVIEW">
<AU>Novikova N, Hofmeyr GJ, Essilfie-Appiah G</AU>
<TI>Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1996</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-03-10 10:53:58 +0000" MODIFIED_BY="Denise Atherton">
<IDENTIFIER MODIFIED="2011-03-10 10:53:58 +0000" MODIFIED_BY="Denise Atherton" TYPE="DOI" VALUE="10.1002/14651858.CD000176"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ogita-1988" NAME="Ogita 1988" TYPE="JOURNAL_ARTICLE">
<AU>Ogita S, Imanaka M, Matsumoto M, Oka T, Sugawa T</AU>
<TI>Transcervical amnioinfusion of antibiotics: a basic study for managing premature rupture of membranes</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1988</YR>
<VL>158</VL>
<PG>23-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Puertas-1997" MODIFIED="2011-01-25 14:40:37 +0000" MODIFIED_BY="[Empty name]" NAME="Puertas 1997" TYPE="JOURNAL_ARTICLE">
<AU>Puertas A, Mino M, Carrillo MP, Mozas J, Herruzo AJ, Miranda JA</AU>
<TI>Influence of amnioinfusion on neonatal acid-base state: a randomized study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76 Suppl</VL>
<NO>167:1</NO>
<PG>94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2003" NAME="RevMan 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2003</YR>
<EN>4.2 for Windows</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Revman-2011" MODIFIED="2011-11-29 10:54:18 +0000" MODIFIED_BY="[Empty name]" NAME="Revman 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wax-2004" NAME="Wax 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wax JR, Flaherty N, Pinette MG, Blackstone J, Cartin A</AU>
<TI>Small-volume amnioinfusion: a potential stimulus of intrapartum fetal heart rate accelerations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<PG>380-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wegnelius-1996" MODIFIED="2011-03-10 15:51:59 +0000" MODIFIED_BY="Jill Hampson" NAME="Wegnelius 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wegnelius G, Bergstrom M, Ahlbom L, Thomassen P</AU>
<TI>A case report of life-threatening pulmonary edema</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>65</VL>
<NO>2</NO>
<PG>237-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wenstrom-1994" NAME="Wenstrom 1994" TYPE="JOURNAL_ARTICLE">
<AU>Wenstrom KD, Andrews WW, Maher JE</AU>
<TI>Prevalence, protocols and complications associated with amnioinfusion</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<PG>341</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Hofmeyr-1995" NAME="Hofmeyr 1995" TYPE="OTHER">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion in intrapartum umbilical cord compression (potential, or diagnosed by electronic fetal monitoring). [revised 24 March 1993]</TI>
<SO>In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1996" NAME="Hofmeyr 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Gulmezoglu AM, Nidodem VC, de Jager M</AU>
<TI>Amnioinfusion</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>64</VL>
<PG>159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-11-29 11:00:02 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-11-29 11:00:02 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-11-28 23:00:12 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<CHAR_METHODS MODIFIED="2011-01-21 11:12:06 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trial conducted in Egypt. Randomisation by a random number table; allocation concealment by sealed opaque envelopes. Intention-to-treat analysis.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:11:16 +0100" MODIFIED_BY="Denise Atherton">
<P>438 women in labour with fetal distress diagnosed on a FHR tracing. Inclusion criteria: single fetus, vertex presentation, gestational age &gt; 37 weeks, cervical dilatation &lt; 5 cm. Exclusion criteria: vaginal bleeding, fetal anomalies, uterine scars, uterine anomalies, malpresentation, intrauterine growth retardation, maternal temperature higher than 38C, grand multiparity (&gt; 5) and severe pre-eclampsia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-11-28 23:00:12 +0000" MODIFIED_BY="Denise Atherton">
<P>Amnioinfusion with a 1000 ml warmed NS solution via a paediatric feeding tube vs no amnioinfusion. (A bolus of 500 ml was infused over 30 minutes followed by another 500 ml over 15-20 min.) If the FHR pattern did not become reassuring after the first 200 ml, a CS was performed; if the FHR pattern was corrected the infusion was completed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 15:00:30 +0100" MODIFIED_BY="Denise Atherton">
<P>Neonatal Apgars, meconium, admission to NICU, mode of delivery, maternal fever, hospital stay longer than 3 days, maternal complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:00:35 +0100" MODIFIED_BY="Denise Atherton">
<P>Fetal blood gas monitoring not available in this hospital setting, otherwise a high-quality trial.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-29 02:10:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amin-2003">
<CHAR_METHODS>
<P>Computer-generated random sequence in sequentially numbered opaque sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-29 02:10:12 +0000" MODIFIED_BY="[Empty name]">
<P>Women in early labour (cervix &lt; 4 cm); 37 or more weeks' gestation; 4-quadrant AFI &lt; 5 cm; membranes intact or ruptured; singleton term gestation; vertex presentation; normal FHR pattern. Exclusion criteria: vaginal bleeding; fetal congenital anomalies; fever; symmetrical fetal growth impairment; grand multiparity; uterine anomalies or scars; severe pre-eclampsia; estimated fetal weight &lt; 1500 g; meconium-stained amniotic fluid.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-11-28 23:00:52 +0000" MODIFIED_BY="Denise Atherton">
<P>Transcervical amnioinfusion of 500 ml normal saline at 37 degrees centigrade over 30 minutes then 500 ml by gravity infusion, then re-evaluation of AFI vs routine care. Continuous FHR monitoring in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 15:11:24 +0100" MODIFIED_BY="Denise Atherton">
<P>160/182 women gave consent. There were no exclusions after enrolment. Baseline data were similar between groups. Mean AFI in the amnioinfusion group increased from 3.2 (SD 1.3) to 11.8 (1.5) after amnioinfusion. Outcomes: abnormal FHR patterns; caesarean section; Apgar scores; meconium below cords; umbilical artery pH; need for intensive care admission; maternal hypertonus; pyrexia and hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>February 2000 to September 2001, Assuit University Hospital.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 09:34:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Busowski-1995">
<CHAR_METHODS MODIFIED="2011-01-24 12:33:56 +0000" MODIFIED_BY="[Empty name]">
<P>'Prospectively randomised', method not specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-24 12:32:24 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: decreased amniotic fluid prior to induction of labour.<BR/>Exclusion criteria: chorioamnionitis; fetal distress; non-vertex presentation; vaginal bleeding.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 09:34:57 +0100" MODIFIED_BY="[Empty name]">
<P>Transabdominal amnioinfusion prior to induction of labour with 250 ml normal saline over 20 minutes under ultrasound guidance using a 22 gauge needle (n = 16), compared with no amnioinfusion (n = 15).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 15:01:31 +0100" MODIFIED_BY="Denise Atherton">
<P>Caesarean section for fetal distress; cord pH &lt; 7.20; 5-minute Apgar scores &lt; 7. Data on caesarean section rates overall have been requested from the authors.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Considered separately from transcervical amnioinfusion as is a fundamentally different procedure.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-29 02:10:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chauhan-1992">
<CHAR_METHODS MODIFIED="2011-01-24 12:36:08 +0000" MODIFIED_BY="[Empty name]">
<P>Randomisation using sealed envelopes drawn from a box.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-29 02:10:19 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women in labour; gestational age 37 or more weeks; AFI 5 cm or less; no FHR tracing abnormalities. Exclusion criteria: multiple pregnancy; ruptured membranes; late FHR decelerations; variable decelerations; non-reactive FHR patterns; chorioamnionitis; thick meconium; inability to place fetal scalp lead and the intrauterine pressure catheter at the time of artificial amniotomy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 15:10:22 +0100" MODIFIED_BY="Denise Atherton">
<P>Amnioinfusion with 250 ml normal saline at room temperature, followed if necessary by repeat infusions of 100 ml until an AFI of 5 cm or more achieved (n = 21), compared with control group (n = 17).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Recurrent (5 or more) moderate or severe variable decelerations or bradycardia; caesarean section for fetal distress; caesarean section overall; intrauterine resuscitation with terbutaline; Apgar score &lt; 7 at 1 minute; Apgar score &lt; 7 at 5 minutes; umbilical arterial pH &lt; 7.2; perinatal death.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:11:28 +0100" MODIFIED_BY="Denise Atherton">
<P>An additional 15 women who refused participation were included as a comparison group. As they were not subject to random allocation, their results have not been included in this review. The interpretation of FHR response to the amnioinfusion may have been subject to bias as tracings were not stated to have been assessed 'blind'.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-18 15:12:34 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Gonzalez-2001">
<CHAR_METHODS MODIFIED="2011-01-24 15:05:48 +0000" MODIFIED_BY="[Empty name]">
<P>&#8220;Randomly assigned&#8221;, no other details.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-24 15:07:00 +0000" MODIFIED_BY="[Empty name]">
<P>44 women in preterm labour (spontaneous or induced) with premature rupture of membranes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-05-18 15:12:34 +0100" MODIFIED_BY="Denise Atherton">
<P>Amnioinfusion (24) vs no amnioinfusion (20).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-24 15:07:43 +0000" MODIFIED_BY="[Empty name]">
<P>Mode of delivery, FHR patterns.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-24 15:09:52 +0000" MODIFIED_BY="[Empty name]">
<P>Abstract only, results presented as percentages only and so no usable data from this report. More fetal distress reported in control group (15% vs 4%).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-28 23:02:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MacGregor-1991">
<CHAR_METHODS>
<P>'Randomized', method not given.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-11-28 23:02:22 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: oligohydramnios (no amniotic fluid pocket measuring &gt; 1 x 1 cm on ultrasound examination); singleton pregnancy; &gt; 26 weeks' gestation (11/35 were &lt; 35 weeks); cephalic presentation; cervical dilatation &lt; 8 cm; no suspicion of intra-amniotic infection; no vaginal bleeding; no FHR pattern necessitating urgent delivery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 09:49:02 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour with Ringer's solution warmed to 37 degrees centigrade at 10 ml per minute for 1 hour and continued if variable decelerations persisted until decelerations ceased or 800 ml had been infused, followed by infusion at 3 ml per minute till delivery (n = 19), compared with control group (n = 16).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Persistent variable decelerations; umbilical cord prolapse; caesarean section for suspected fetal distress; caesarean section overall; perinatal death; postpartum endometritis; umbilical arterial pH &lt; 7.20.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>All but 1 case of postpartum endometritis followed caesarean section. Maternal age higher in the amnioinfusion group (26.4 vs 23.1 years).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 09:52:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mino-1999">
<CHAR_METHODS MODIFIED="2011-01-24 14:10:40 +0000" MODIFIED_BY="[Empty name]">
<P>Randomisation by random number table. Allocation concealment not described.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:02:32 +0100" MODIFIED_BY="Denise Atherton">
<P>200 women with prelabour rupture of membranes at term for induction of labour with oxytocin. Included if AFI &lt; 10 cm and &#8216;normal fluid volume had been observed the week before&#8217; PROM. Excluded if multiple pregnancy, vaginal bleeding, fetal or uterine anomalies, non-vertex presentation, fetal distress, and MSL, maternal viral infection.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 09:52:14 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion in early labour (600 ml warm normal saline over 1 hour; AFI repeated, if &lt; 15 cm, amnioinfusion was continued at 180 ml/hour until full dilatation achieved or uterine baseline activity reached 20 mmHg) vs no amnioinfusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-24 14:13:26 +0000" MODIFIED_BY="[Empty name]">
<P>Not clearly pre-specified. Fetal umbilical artery pH at delivery, neonatal acidosis, Apgar scores, mode of delivery, pathological FHR patterns, maternal and neonatal infection-related data.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-24 14:19:35 +0000" MODIFIED_BY="[Empty name]">
<P>We have grouped the 1997 and 1998 Minô reports together with this trial as they seem to be earlier reports of the same trial. We were unfortunately unsuccessful in our attempts to contact the authors for clarity. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 09:54:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyazaki-1985">
<CHAR_METHODS>
<P>Allocation by sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:11:30 +0100" MODIFIED_BY="Denise Atherton">
<P>Women with variable FHR decelerations during labour. Exclusions included severely abnormal FHR tracings, advanced labour, labour ward too busy and non-participation in the study of some attending staff.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 09:54:57 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour with normal saline until decelerations resolved plus 250 ml (maximum 800 ml) and repeated if necessary (n = 49), compared with control group (n = 47).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Persistent variable decelerations; umbilical cord prolapse; caesarean section for suspected fetal distress; Apgar score &lt; 7 at 1 minute; Apgar score &lt; 7 at 5 minutes; perinatal death.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:11:32 +0100" MODIFIED_BY="Denise Atherton">
<P>FHR tracings not stated to have been assessed 'blind'.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-18 15:04:32 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Nageotte-1985">
<CHAR_METHODS>
<P>'Random' allocation (method not specified).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:04:32 +0100" MODIFIED_BY="Denise Atherton">
<P>Women with clinically confirmed spontaneous prelabour rupture of the membranes at 26 to 35 weeks' gestation, ultrasound-diagnosed oligohydramnios, vertex presentation and no fetal anomaly or distress.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intrapartum amnioinfusion with normal saline warmed to 37 degrees centigrade at 10 ml per minute for 1 hour (repeated if large fluid loss occurred subsequently), followed by infusion at 3 ml per minute (n = 29), compared with control group (n = 32). All participants had intrauterine pressure catheter inserted as early in labour as possible.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Caesarean section for suspected fetal distress; caesarean section, overall; perinatal death; postpartum endometritis; Apgar score &lt; 7 at 1 minute; incidence of variable decelerations in first and second stage labour; umbilical arterial pH.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-24 13:02:33 +0000" MODIFIED_BY="[Empty name]">
<P>There were 5 withdrawals after randomisation, for apparently legitimate reasons.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-18 15:10:27 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Nageotte-1991">
<CHAR_METHODS>
<P>Allocation by random number table using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:10:27 +0100" MODIFIED_BY="Denise Atherton">
<P>Inclusion criteria: postdates pregnancy (42 or more weeks), or suspected impaired fetal growth (clinical impression confirmed by poor growth on ultrasound measurements and estimated fetal weight below the 10th percentile for gestational age), plus oligohydramnios (AFI &lt; 8 cm). Exclusion criteria: previous classical caesarean section; non-vertex presentation; placenta praevia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Comparison between warmed saline (93-96 degrees Fahrenheit) group, room temperature saline (68-72 degrees Fahrenheit) group (together n = 50), and control group (n = 26). Amnioinfusion rate was 10 ml per minute for 1 hour, then 3 ml per minute until delivery, briefly stopped every 30 minutes to evaluate resting tone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Meconium-stained amniotic fluid; umbilical cord prolapse; ruptured membranes to delivery interval; maximum maternal temperature intrapartum; variable FHR decelerations per hour in first and second stage of labour; caesarean section for suspected fetal distress; caesarean section overall; Apgar score &lt; 7 at 5 minutes; umbilical arteria pH; perinatal death; meconium below the cords; meconium aspiration syndrome.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:05:12 +0100" MODIFIED_BY="Denise Atherton">
<P>3 women in the control group received amnioinfusion and 3 in the amnioinfusion groups did not, but analysis was in the original groups according to intention to treat. The maternal and neonatal temperatures given are for the control and the warmed saline group. The room temperature saline group temperatures were identical to the control group. For all other analyses, the 2 amnioinfusion groups are grouped together.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-28 23:04:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Owen-1990">
<CHAR_METHODS>
<P>Randomly allocated using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:05:31 +0100" MODIFIED_BY="Denise Atherton">
<P>Women in spontaneous labour or due for induction of labour with no previous positive contraction stress test, with 1 of the following: postdates (at least 42 weeks) (5 amnioinfusion and 6 control); recurrent mild to moderate variable decelerations in labour unresponsive to maternal position change, hydration and oxygen therapy (13 and 20); preterm labour (before 37 weeks) (11 and 18); or oligohydramnios and/or suspected impaired fetal growth (14 and 13).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-11-28 23:04:51 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour with saline warmed to 37 degrees Centigrade at 10 ml per minute for 1 hour, then 3 ml per minute (n = 43), was compared with a control group (n = 57). All women had intrauterine pressure transducers. Amnioinfusion was performed through a second intrauterine catheter.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 15:10:30 +0100" MODIFIED_BY="Denise Atherton">
<P>Umbilical cord prolapse; caesarean section for suspected fetal distress; caesarean section overall; forceps or vacuum for suspected fetal distress; Apgar score &lt; 7 at 5 minutes; cord arterial pH &lt; 7.2; perinatal death; postpartum endometritis; admission to high-risk nursery.</P>
<P>The 4-quadrant AFI in 31 cases increased from mean 9.8 cm (SD 3.8) to 14.7 (3.7) after amnioinfusion.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The treatments were not blinded. There was an unexplained imbalance between the treatment and control group, and within the various enrolment categories which might have influenced results. For example, in the amnioinfusion group there were relatively fewer women enrolled for variable decelerations and preterm labour. Personal communication with the first author revealed that the discrepancies were partly due to chance and partly due to withdrawal of a few women from the amnioinfusion group who for technical reasons did not receive amnioinfusion. These withdrawals may have affected the results.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-28 23:05:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<CHAR_METHODS MODIFIED="2011-01-19 14:08:15 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trial conducted in Sweden between Sept 1994 and March 1996. Sealed envelopes were used for allocation; envelopes were used in sequential &#8216;random order&#8217;; randomisation code not disclosed to participants or study coordinator; no post-randomisation exclusions. Sample size not pre-specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:06:01 +0100" MODIFIED_BY="Denise Atherton">
<P>112 women at term in labour or who were to be induced, with an AFI of &lt; 5 cm on ultrasound. Excluded if placenta praevia, maternal fever or multiple pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-11-28 23:05:21 +0000" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour (500 ml normal saline at 37°C infused over 30 min, ultrasound repeated 1 hour after infusion - if repeat AFI &lt; 8 another 250 ml infused) vs no amnioinfusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-19 12:09:04 +0000" MODIFIED_BY="[Empty name]">
<P>FHR abnormalities, mode of delivery, Apgar score, pH in umbilical artery blood and NICU admission.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-08 10:54:35 +0100" MODIFIED_BY="[Empty name]">
<P>Imbalance in group size with 60 in study group vs 52 in the control group. Missing data: 4/60 in study group not reported on for mode of delivery. Some outcomes reported as percentages (abnormal FHR patterns) and total number of subjects for each outcome not always stated. Umbilical artery pH data presented as means without SD. Authors were contacted but were unable to clarify these issues.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 12:44:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Puertas-2001">
<CHAR_METHODS MODIFIED="2011-05-18 15:06:41 +0100" MODIFIED_BY="Denise Atherton">
<P>'Randomised clinical assay.'</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:10:32 +0100" MODIFIED_BY="Denise Atherton">
<P>Women in labour, intact membranes and oligohydramnios (AFI &lt; 8).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 12:44:31 +0100" MODIFIED_BY="[Empty name]">
<P>Intrapartum transcervical amnioinfusion during labour vs no amnioinfusion; continuous monitoring of FHR, fetal oxygen saturation and intrauterine pressure.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Interventions for fetal distress; neonatal acid-base status.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>University Hospital, Granada. Data not included yet as only percentages given in the abstract.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 12:46:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Regi-2009">
<CHAR_METHODS MODIFIED="2011-05-18 15:07:00 +0100" MODIFIED_BY="Denise Atherton">
<P>Randomised controlled trial conducted in India between October 2003 and September 2004; computer-generated random number table used and allocation concealed via sequential sealed opaque envelopes. Diagnosis of fetal distress made by 2 clinicians.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:07:03 +0100" MODIFIED_BY="Denise Atherton">
<P>150 pregnant women &gt; 34 weeks' gestation with the presence of severe repetitive variable decelerations in active labour. Exclusion criteria: variable decelerations with poor variability or delayed recovery, baseline bradycardia or tachycardia, repetitive late decelerations, Grade II and III MSL, previous caesarean section, and the presence of a contraindication to vaginal delivery.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 12:46:23 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour (500 ml warmed normal saline over 30 minutes then a continuous infusion of 3 ml/minutes until delivery) vs no amnioinfusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-21 14:31:19 +0000" MODIFIED_BY="[Empty name]">
<P>FHR patterns, neonatal Apgars, mode of delivery, fetal distress, duration of labour, ROM to delivery interval, umbilical artery pH, length of hospital stay.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-26 14:48:10 +0000" MODIFIED_BY="[Empty name]">
<P>Sample size estimated to be 400 but study was discontinued after 150 participants due to a significant relief of variable decelerations in the amnioinfusion group.</P>
<P>Baseline characteristics were similar between groups. Attempts to contact authors for unpublished data were unsuccessful.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-05-18 15:12:13 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Schrimmer-1991">
<CHAR_METHODS MODIFIED="2011-01-21 14:33:35 +0000" MODIFIED_BY="[Empty name]">
<P>Computer randomisation with treatment: non-treatment ratio of 3:2, using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:10:35 +0100" MODIFIED_BY="Denise Atherton">
<P>Inclusion criteria: women in labour or admitted for induction of labour, with oligohydramnios (4-quadrant AFI &lt; 5 cm); singleton vertex presentation; normal FHR baseline and variability. Exclusion criteria: moderate or severe variable decelerations; late decelerations; vaginal bleeding; fetal anomalies; chorioamnionitis.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Amnioinfusion of 500 ml saline warmed to 37 degrees centigrade infused by gravity over 20-30 minutes (15 to 25 ml per minute), followed by repeat ultrasound examination after initial infusion and hourly, and reinfusion of 500 ml if AFI &lt; 5 cm, 250 ml if AFI &gt; 5 and &lt; 10 cm (n = 175), compared with control group (n = 130). Women in both groups had intrauterine pressure transducers inserted.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-18 15:12:13 +0100" MODIFIED_BY="Denise Atherton">
<P>Increase in AFI after 500 ml infusion (mean 8.4, SD 1.4 cm); amnionitis (amnioinfusion 18/175 vs control 9/130); caesarean section for suspected fetal distress; caesarean section overall; forceps or vacuum for suspected fetal distress; forceps or vacuum delivery overall; Apgar score &lt; 7 at 1 minute; Apgar score &lt; 7 at 5 minutes; cord arterial pH &lt; 7.2; perinatal death; postpartum endometritis; maternal hospital stay &gt; 3 days; neonatal hospital stay &gt; 3 days.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:07:47 +0100" MODIFIED_BY="Denise Atherton">
<P>Los Angeles, California, USA. August 1989 to September 1990. 85 subjects from this study are included in the report of <LINK REF="REF-Macri-1992" TYPE="REFERENCE">Macri 1992</LINK> (Paul RH, personal communication). (<I>See</I> Cochrane review '<LINK REF="REF-Hofmeyr-2010" TYPE="REFERENCE">Hofmeyr 2010</LINK>'.)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 12:48:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Strong-1990">
<CHAR_METHODS MODIFIED="2011-01-27 11:38:41 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised permuted block technique (n = 6) allocation using sealed envelopes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:10:40 +0100" MODIFIED_BY="Denise Atherton">
<P>Inclusion criteria: labouring women with oligohydramnios (AFI &lt; 5 cm); singleton vertex presentation; 4 cm or less cervical dilatation; 37 or more weeks gestation; normal baseline FHR variability; estimated fetal weight &gt; 2500 g. Exclusion criteria: late FHR decelerations; moderate or severe variable decelerations; vaginal bleeding; chorioamnionitis; meconium-stained amniotic fluid; fetal anomalies; uterine anomalies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 12:48:27 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour of 250 ml saline warmed to 37 degrees centigrade at 10 to 20 ml per minute, repeated until an AFI of 8 cm was reached and if the AFI fell below 8 cm on subsequent hourly ultrasound examinations (n = 30), compared with control group (n = 30).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Persistent variable decelerations; meconium-stained amniotic fluid; umbilical cord prolapse; caesarean section for suspected fetal distress; caesarean section overall; forceps or vacuum for suspected fetal distress; forceps or vacuum delivery overall; Apgar score &lt; 7 at 1 minute; Apgar score &lt; 7 at 5 minutes; umbilical cord arterial pH &lt; 7.20; neonatal sepsis; perinatal death; rupture of membranes to delivery interval; intrapartum maternal temperature &gt; 38 degrees centigrade.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>The rupture of membranes to delivery interval was longer in the amnioinfusion group (mean 16.8, SD 12.1 hours) than the control group (10.1, 6.5), and this difference persisted for vaginal deliveries (data not given). This result is difficult to interpret as the incidence of ruptured membranes at admission in the amnioinfusion group was 15/30 compared with 8/30 in the control group. The longer duration of ruptured membranes may thus have been related to a chance difference in the groups rather than an effect of amnioinfusion. The same may apply to the excess of maternal pyrexia in the amnioinfusion group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-11-28 23:07:38 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vergani-1996">
<CHAR_METHODS MODIFIED="2011-01-24 13:44:39 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation by a 'computer generated randomisation table'. Not specified whether next allocation concealed prior to enrolment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Non-labouring primiparous women at term with ultrasonographic diagnosis of oligohydramnios (largest amniotic fluid pocket &lt; 2 x 2 cm on perpendicular planes); singleton gestation; vertex presentation; gestational age 37+ weeks; ultrasound estimated fetal weight 2500 g+; reactive non-stress test; cervical Bishop score 6 or less; intact membranes. Exclusion criteria: maternal indications leading to an elective caesarean section.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-11-28 23:07:38 +0000" MODIFIED_BY="[Empty name]">
<P>Transabdominal amnioinfusion before labour under ultrasonographic guidance: normal saline 500 ml at 37 degrees centigrade infused through a 20-gauge spinal needle at 30 ml per minute. Sulbactam-ampicillin 3 gm given intravenously (n = 39). Compared with no amnioinfusion (n = 40). Labour induction within 1-4 hours of randomisation: for Bishop score 4 or less, intracervical prostaglandin E2 0.5 mg, repeated 3 times 6-hourly; for Bishop score 5-6 intravaginal prostaglandin E2 1.5 mg, repeated twice at 8 hour intervals. Membranes were ruptured when Bishop score was &gt; 6 or all the doses of prostaglandins had been given, and oxytocin infusion started after 2 hours if not in labour.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Apgar score at 5 minutes; umbilical artery pH; meconium-stained amniotic fluid; maternal infectious morbidity; neonatal complications.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Power calculation required 114 participants in each group to show a 75% reduction in caesarean section for fetal distress. The study was suspended when an interim analysis showed that significance had been reached (total 79 participants). Spontaneous onset of labour occurred in 5 women after amnioinfusion.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 12:52:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-1997">
<CHAR_METHODS MODIFIED="2011-01-20 13:40:47 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trial; randomisation performed sequentially in pairs by tossing a coin for the first woman in the pair. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-05-18 15:14:12 +0100" MODIFIED_BY="Denise Atherton">
<P>92 women with singleton term pregnancy, cephalic presentation, no MSL, with oligohydramnios (AFI &#8804; 5 cm), normal FHR pattern 30 minutes after amniotomy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 12:52:41 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour (1 litre normal saline at room temp infused over 30 min, repeated if AFI remained &#8804; 5 cm on ultrasound 30 minutes later) vs no amnioinfusion.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-20 14:07:14 +0000" MODIFIED_BY="[Empty name]">
<P>Fetal arterial lipid peroxidase levels, neonatal arterial pH and base excess, mode of delivery.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-18 15:12:14 +0100" MODIFIED_BY="Denise Atherton">
<P>Investigators excluded 7 participants in each group after randomisation where the blood specimens were considered questionable i.e. the specimens could not be definitely identified as arterial (primary outcomes were biochemical), leaving 39 participants in each group. Continuous data presented as mean [range] without SDs so not usable for this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-09-25 12:53:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-1989">
<CHAR_METHODS>
<P>'Randomized'. Method not specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Hospitalised women in labour, full-term or post-term, vertex presentation, amniotic area =/&lt; 2 cm on ultrasound or &lt; 100 ml obtained at rupture of membranes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-09-25 12:53:03 +0100" MODIFIED_BY="[Empty name]">
<P>Amnioinfusion during labour with normal saline warmed to 37 degrees centigrade, 500 ml at 15-20 ml per minute followed by slow or intermittent infusion (n = 60), compared with controls (n = 58).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>'Mild or severe birth asphyxia'; caesarean section for suspected fetal distress; caesarean section overall; perinatal death; postpartum endometritis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>'Postpartum morbidity' interpreted as postpartum endometritis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AFI: amniotic fluid index<BR/>CS: caesarean section<BR/>FHR: fetal heart rate<BR/>icu: intensive care unit<BR/>MSL: meconium-stained liquor<BR/>NICU: neonatal intensive care unit<BR/>NS: normal saline<BR/>ROM: rupture of membranes<BR/>SD: standard deviation<BR/>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-11-28 23:09:57 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-05-18 15:12:52 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-McDermot-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 15:12:52 +0100" MODIFIED_BY="Denise Atherton">
<P>This randomised trial compares amnioinfusion with no amnioinfusion for 34 women with chorioamnionitis in labour, on subsequent postpartum endometritis.</P>
<P>Results found 3/16 women in the study group and 2/16 women in the control group had postpartum endometritis; 1 neonatal infection occurred in the study group and none in the control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 15:12:58 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-McEvoy-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 15:12:58 +0100" MODIFIED_BY="Denise Atherton">
<P>No difference was found in pulmonary mechanics or oxygen saturation in a subset of 18 neonates born to mothers who had been enrolled in a randomised trial of amnioinfusion for oligohydramnios at their institution. They do not state how the subset of 18 infants studied was derived from the larger trial.</P>
<P>In a subsequent publication by the same authors in 1995, results of 42 infants, presumably from the same study, are given. No significant differences in pulmonary mechanics or oxygenation were found between infants whose mothers had received amnioinfusion (n = 22) or the controls (n = 20). The study is excluded because, without information on how the subset of infants studied was derived from the larger trial, it is not possible to be sure that selection bias was excluded. It is also not stated whether the subset was derived from the larger study from the same unit included in this review (<LINK REF="STD-Schrimmer-1991" TYPE="STUDY">Schrimmer 1991</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-08 11:12:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Monahan-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-08 11:12:13 +0100" MODIFIED_BY="[Empty name]">
<P>This RCT studies amnioinfusion for preventing puerperal infection not cord compression.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 15:13:11 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Muse-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 15:13:11 +0100" MODIFIED_BY="Denise Atherton">
<P>Randomised comparison of the effect of cold versus body temperature amnioinfusion on fetal TSH levels. The difference (13.12 SD 5.02 versus 7.67 SD 0.75 respectively) was not statistically significant, but the numbers studied were small (total n = 13).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-11-28 23:09:57 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Pressman-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-11-28 23:09:57 +0000" MODIFIED_BY="Denise Atherton">
<P>No randomised comparison with a control group.</P>
<P>39 women receiving amnioinfusion were randomised by sequential sealed envelopes to receive lactated Ringer's solution plus 5 ml/L physiologic glucose (n = 18) or normal saline (n = 21). Infusates were warmed to 39 degrees centigrade and 500 ml infused over 30 minutes, followed by a continuous infusion at 200 ml/hour.</P>
<P>The groups were not well matched for nulliparity (Ringer's 22% vs saline 52%). There were no differences in neonatal electrolyte or acid-base status. There were no statistically significant differences in length of labour (10.9 (SD 8.9) vs 12.1 (5.4) hours); length of ruptured membranes (7.7 (9.4) vs 9.8 (5.1) hours); caesarean sections (39% vs 33%); operative deliveries (55% vs 36%); chorioamnionitis (5.6 vs 19%); postpartum endometritis (17% vs 19%); or Apgar scores &lt; 7 at 5 minutes (5.5 vs 4.8%).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-21 09:42:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rinehart-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-21 09:42:53 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised trial comparing continuous amnioinfusion with bolus amnioinfusion for repeated variable decelerations in labour. There were 35 in bolus group and 30 in continuous group. No significant difference in any of the neonatal outcome variables between groups (except for increased cost with continuous infusion).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-05-18 15:14:47 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Washburne-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 15:14:47 +0100" MODIFIED_BY="Denise Atherton">
<P>No randomised comparison of amnioinfusion with control group.</P>
<P>67 women receiving amnioinfusion were randomised by computer-generated cards in sealed envelopes to receive lactated Ringer's solution (n = 30) or normal saline (n = 37). Warmed solution was infused in 500 ml increments to a volume of 500-1500 ml.</P>
<P>There were no statistically significant differences with respect to amnioinfusion to delivery time (Ringer's lactate 3.9 hours (SD 2.5) vs saline 5.9 hours (3.6)); or maternal or neonatal electrolyte levels.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>SD: standard deviation<BR/>TSH: thyroid stimulating hormone<BR/>vs: versus</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2011-01-24 14:08:40 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-11-28 23:08:35 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-07-08 10:55:33 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-21 11:19:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>Random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:29:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>Computer-generated random sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-31 11:51:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:36:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 15:06:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>&#8220;Randomly assigned&#8221;, no other details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:38:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 14:10:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>Randomisation by random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:03:30 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>"Randomised."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:04:46 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>"Random allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 12:11:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>Random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:05:50 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>"randomly allocated."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-08 10:55:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>Sealed envelopes drawn at random out of a mixed box.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:06:51 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>'Randomised.'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-21 14:33:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>Computer-generated random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:34:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>Computer randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 12:14:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>Block randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:44:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>Computer-generated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-20 13:48:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>Randomisation in pairs by coin-tossing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:09:24 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>'Randomised.'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-07-08 10:36:06 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-21 11:19:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>Sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:29:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>Sequentially numbered opaque sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:36:03 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Inadequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:37:07 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>Sealed envelopes drawn from a box.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 15:06:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:39:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 14:11:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:21:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 12:13:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:27:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:28:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 13:49:29 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:58:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-21 14:33:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>Sequential sealed opaque envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:34:32 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:39:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:44:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-20 13:48:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>Once first participant's group was allocated, was second patient's allocation revealed?</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:45:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-07-21 10:55:13 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-24 14:20:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 11:59:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:00:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 11:15:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>Assessor blinding not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-24 15:08:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 11:15:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-24 14:20:04 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:05:14 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:13:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:11:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-21 10:46:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>The treatments were not blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-19 13:50:59 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>Participant and investigator blinding not possible due to intervention. Blinding of assessor of FHR patterns not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 11:59:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-21 14:36:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>Not possible. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 11:35:04 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>Study not blinded, but research procedures carried out by researchers not involved in clinical care and clinical decisions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:14:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-27 12:15:26 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-20 13:42:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>Partial blinding as investigators were not involved in the clinical decision making or interpreting of FHR tracings.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-21 10:55:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>Details not available for the 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-11-28 23:08:31 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-21 11:18:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>No missing data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-24 12:31:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>No post-randomisation exclusions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-24 12:35:51 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Authors contacted for clarity.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-28 23:02:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>Details not available for 2011 review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-27 11:15:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-28 23:02:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-24 14:20:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>Adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-07-21 10:45:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>Details not available for 2011 review update</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-27 11:26:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>There were 5 withdrawals after randomisation, for apparently legitimate reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-28 23:04:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-27 11:30:40 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>Unpublished data provided by author.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-26 09:46:51 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>Missing data: 4/60 in study group not reported on for mode of delivery. This could affect the findings related to caesarean section rate and/or vacuum extraction. It is not clear whether missing data is due to bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-27 11:59:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Data presented as percentages.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-07-21 10:48:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>Two post-randomisation exclusions after not receiving the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-28 23:06:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>Low attrition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-07-21 10:52:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>Low attrition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-07-21 10:53:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>Low attrition.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-18 15:09:03 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>7 post-randomisation exclusions in each group due to "questionable blood samples" - samples that could not be definitely identified as arterial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-11-28 23:08:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>Details not available for the 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-11-28 23:08:33 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:00:41 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>Intention-to-treat analysis. All outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:31:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>Baseline data similar. Outcomes pre-specified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 12:01:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Overall caesarean section rates not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:02:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>Details not available for 2011 review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 15:08:41 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>Results reported as percentages only.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:02:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:26:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>See below.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:21:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>All pre-specified outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:03:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:05:23 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>3 women in the control group received amnioinfusion and 3 in the amnioinfusion groups did not, but analysis was in the original groups according to intention to treat.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:30:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>Withdrawals due to technical reasons may have affected results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:12:11 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>All outcomes reported but denominators and SDs missing.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:32:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Data presented as percentages.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:06:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>All expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:51:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>All expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:52:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>All expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:53:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>All expected outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:09:09 +0100" MODIFIED_BY="Denise Atherton" RESULT="YES" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>6 patients in the study group did not receive amnioinfusion due to rapid delivery but were analysed by intention-to-treat.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:08:33 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>Details not available for the 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-11-28 23:08:35 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:00:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Aleem-2005">
<DESCRIPTION>
<P>A good quality trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:01:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Amin-2003">
<DESCRIPTION>
<P>A good quality trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:01:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Busowski-1995">
<DESCRIPTION>
<P>Details not available for 2011 review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-24 12:37:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chauhan-1992">
<DESCRIPTION>
<P>An additional 15 women who refused participation were included as a comparison group. As they were not subject to random allocation, their results have not been included in this review.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 12:03:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gonzalez-2001">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:02:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1991">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 15:03:10 +0100" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Mino-1999">
<DESCRIPTION>
<P>Four other reports (<LINK REF="REF-Mino-1997a" TYPE="REFERENCE">Mino 1997a</LINK>; <LINK REF="REF-Mino-1997b" TYPE="REFERENCE">Mino 1997b</LINK>; <LINK REF="REF-Mino-1998" TYPE="REFERENCE">Mino 1998</LINK>; <LINK REF="REF-Puertas-1997" TYPE="REFERENCE">Puertas 1997</LINK>) seem to be of the same trial and yet there are no references in the 1999 article to the other reports.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:03:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miyazaki-1985">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:03:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nageotte-1985">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:04:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nageotte-1991">
<DESCRIPTION>
<P>Details not available for 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:47:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Owen-1990">
<DESCRIPTION>
<P>No other bias noted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 13:56:41 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999">
<DESCRIPTION>
<P>Imbalance in group size, some outcomes reported as percentages (denominators absent) and four cases missing. Moderate risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:32:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Puertas-2001">
<DESCRIPTION>
<P>Onyl brief information provided (abstract).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:06:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Regi-2009">
<DESCRIPTION>
<P>A good quality trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:38:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schrimmer-1991">
<DESCRIPTION>
<P>Discrepancy between the number of caesarean sections in the amnioinfusion group ascribed to fetal distress, between the preliminary report and the final report (24/171 vs 14/175).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-27 11:44:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Strong-1990">
<DESCRIPTION>
<P>Baseline imbalance in groups with regard to the incidence of ruptured membranes at enrolment might have affected some outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 10:54:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vergani-1996">
<DESCRIPTION>
<P>No other bias noted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-21 11:00:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-1997">
<DESCRIPTION>
<P>No other potential bias noted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-28 23:08:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wu-1989">
<DESCRIPTION>
<P>Details not available for the 2011 review update.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-11-29 01:48:01 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2011-11-29 01:48:01 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM)*</NAME>
<DICH_OUTCOME CHI2="20.287833092023586" CI_END="0.8331818844779316" CI_START="0.46111182054393673" CI_STUDY="95" CI_TOTAL="95" DF="12" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6198306346058148" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="175" I2="40.85124840307391" I2_Q="66.18577508738895" ID="CMP-001.01" LOG_CI_END="-0.07926018130326441" LOG_CI_START="-0.33619374455308276" LOG_EFFECT_SIZE="-0.20772696292817358" METHOD="MH" MODIFIED="2011-07-08 14:05:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.06183333143944392" P_Q="0.051957287341212854" P_Z="0.0015285736228712813" Q="5.914670542260745" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10797619490309641" TOTALS="YES" TOTAL_1="781" TOTAL_2="712" WEIGHT="99.99999999999999" Z="3.1692034377092626">
<NAME>Caesarean section, overall</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5589568758580952" CI_START="0.688090926852743" DF="0" EFFECT_SIZE="1.0357142857142858" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="28" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.19283410182392807" LOG_CI_START="-0.16235416871045427" LOG_EFFECT_SIZE="0.015239966556736905" MODIFIED="2011-07-08 14:05:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8664327979827532" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="15.034376096328172" Z="0.16819128363591518">
<NAME>Fetal heart rate (FHR) decelerations</NAME>
<DICH_DATA CI_END="1.5589568758580952" CI_START="0.688090926852743" EFFECT_SIZE="1.0357142857142858" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="28" LOG_CI_END="0.19283410182392807" LOG_CI_START="-0.16235416871045427" LOG_EFFECT_SIZE="0.015239966556736905" MODIFIED="2011-07-08 11:24:38 +0100" MODIFIED_BY="[Empty name]" ORDER="302" O_E="0.0" SE="0.20863934832219136" STUDY_ID="STD-Regi-2009" TOTAL_1="75" TOTAL_2="75" VAR="0.043530377668308695" WEIGHT="15.034376096328172"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.15396697660873" CI_END="0.8469782021643507" CI_START="0.423494719721954" DF="8" EFFECT_SIZE="0.5989080032327136" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="113" I2="34.17786953513505" ID="CMP-001.01.02" LOG_CI_END="-0.07212776653063445" LOG_CI_START="-0.373152000232718" LOG_EFFECT_SIZE="-0.22263988338167626" MODIFIED="2011-07-08 11:43:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.14446545815624612" P_Z="0.0037410488315548305" STUDIES="9" TAU2="0.09127672317218032" TOTAL_1="534" TOTAL_2="448" WEIGHT="68.19652693213007" Z="2.8992094595423454">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.7587909899126088" CI_START="0.11400397667002032" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.11987783468172447" LOG_CI_START="-0.9430799994027858" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.48355302647358617" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.2338235294117647" WEIGHT="6.664156320400829"/>
<DICH_DATA CI_END="4.178159107760945" CI_START="0.2788378672293112" EFFECT_SIZE="1.0793650793650793" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6209849742529313" LOG_CI_START="-0.5546482477476222" LOG_EFFECT_SIZE="0.03316836325265459" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.6905727740814294" STUDY_ID="STD-Chauhan-1992" TOTAL_1="21" TOTAL_2="17" VAR="0.47689075630252087" WEIGHT="3.8945725834034195"/>
<DICH_DATA CI_END="2.423688611080884" CI_START="0.5971175850171121" EFFECT_SIZE="1.2030075187969924" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.38447682210472484" LOG_CI_START="-0.22394013872704693" LOG_EFFECT_SIZE="0.08026834168883897" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.35738713450511117" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.12772556390977444" WEIGHT="9.663936343014505"/>
<DICH_DATA CI_END="1.323670590673784" CI_START="0.20428043193311346" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.12177991980741268" LOG_CI_START="-0.6897732325378143" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.47671033894047987" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.22725274725274722" WEIGHT="6.794779646577231"/>
<DICH_DATA CI_END="1.0018431520445878" CI_START="0.21325631889585522" EFFECT_SIZE="0.4622222222222222" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="7.997339728165488E-4" LOG_CI_START="-0.6710980915979807" LOG_EFFECT_SIZE="-0.33514917881258216" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="297" O_E="0.0" SE="0.39467610868816316" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.15576923076923077" WEIGHT="8.636384071108216"/>
<DICH_DATA CI_END="0.8147471188094777" CI_START="0.3266350532110961" EFFECT_SIZE="0.5158730158730159" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="36" LOG_CI_END="-0.08897716665583152" LOG_CI_START="-0.485937210293583" LOG_EFFECT_SIZE="-0.2874571884747073" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="295" O_E="0.0" SE="0.23317629461672207" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.054371184371184364" WEIGHT="14.030450034280255"/>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="4.973635788179133"/>
<DICH_DATA CI_END="2.6127566687335975" CI_START="0.484402169993675" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.41709896489491244" LOG_CI_START="-0.31479392000014983" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="298" O_E="0.0" SE="0.4299175035155696" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" VAR="0.18482905982905984" WEIGHT="7.779255174869615"/>
<DICH_DATA CI_END="0.7900070581287125" CI_START="0.09655759192710124" EFFECT_SIZE="0.2761904761904762" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.10236902859226839" LOG_CI_START="-1.0152135737496957" LOG_EFFECT_SIZE="-0.558791301170982" MODIFIED="2011-01-26 11:55:16 +0000" MODIFIED_BY="[Empty name]" ORDER="299" O_E="0.0" SE="0.5362094044788471" STUDY_ID="STD-Wu-1989" TOTAL_1="60" TOTAL_2="58" VAR="0.2875205254515599" WEIGHT="5.759356970296872"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.3500282340899556" CI_END="0.8608533323942531" CI_START="0.266048427715823" DF="2" EFFECT_SIZE="0.47856940518321667" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="34" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="-0.06507083502452607" LOG_CI_START="-0.5750393033108046" LOG_EFFECT_SIZE="-0.3200550691676653" MODIFIED="2011-07-08 11:48:52 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5091492766312113" P_Z="0.013888359419312069" STUDIES="3" TAU2="0.0" TOTAL_1="172" TOTAL_2="189" WEIGHT="16.769096971541742" Z="2.460138018909662">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="1.0577116358824425" CI_START="0.08508935417441399" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.02436728205181728" LOG_CI_START="-1.0701247726124925" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2011-07-08 11:43:58 +0100" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.6429100507328637" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.41333333333333333" WEIGHT="4.369394130987546"/>
<DICH_DATA CI_END="1.3974320796263402" CI_START="0.07112743761259913" EFFECT_SIZE="0.31527093596059114" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.14533070875143397" LOG_CI_START="-1.1479628366100854" LOG_EFFECT_SIZE="-0.5013160639293257" MODIFIED="2011-07-08 11:25:04 +0100" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.7596870304516546" STUDY_ID="STD-Nageotte-1985" TOTAL_1="29" TOTAL_2="32" VAR="0.5771243842364532" WEIGHT="3.3247772114934544"/>
<DICH_DATA CI_END="1.3090585696145682" CI_START="0.29725957553645044" EFFECT_SIZE="0.6238030095759234" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" LOG_CI_END="0.11695907809496467" LOG_CI_START="-0.5268641466818157" LOG_EFFECT_SIZE="-0.20495253429342547" MODIFIED="2011-07-08 11:35:55 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.3781849492102423" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.14302385580915356" WEIGHT="9.07492562906074"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="23.362214338102913" CI_END="0.6846210428490292" CI_START="0.31083760461372195" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4613089691598686" ESTIMABLE="YES" EVENTS_1="154" EVENTS_2="263" I2="52.9154221393329" I2_Q="73.42572742920494" ID="CMP-001.02" LOG_CI_END="-0.1645497563042354" LOG_CI_START="-0.507466446472422" LOG_EFFECT_SIZE="-0.3360081013883287" METHOD="MH" MODIFIED="2011-07-08 14:05:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.015707094568618518" P_Q="0.023213212733653954" P_Z="1.225566130022823E-4" Q="7.526076187680809" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.18178835432880341" TOTALS="YES" TOTAL_1="829" TOTAL_2="759" WEIGHT="100.0" Z="3.8409549381326915">
<NAME>Caesarean for suspected fetal distress</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.13664033950805402" CI_END="0.8169342762576365" CI_START="0.5990113746717249" DF="2" EFFECT_SIZE="0.6995376500500438" ESTIMABLE="YES" EVENTS_1="129" EVENTS_2="185" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-0.08781288178679192" LOG_CI_START="-0.2225649306820397" LOG_EFFECT_SIZE="-0.15518890623441584" MODIFIED="2011-07-08 14:05:58 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9339614112290954" P_Z="6.34858600744166E-6" STUDIES="3" TAU2="0.0" TOTAL_1="342" TOTAL_2="341" WEIGHT="49.01989297625601" Z="4.5144347638983495">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.8312672734875561" CI_START="0.5974002202714733" EFFECT_SIZE="0.7046979865771812" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="149" LOG_CI_END="-0.08025931708446495" LOG_CI_START="-0.22373462160020696" LOG_EFFECT_SIZE="-0.15199696934233597" MODIFIED="2011-01-26 11:47:30 +0000" MODIFIED_BY="[Empty name]" ORDER="279" O_E="0.0" SE="0.08427810408675838" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.007102798828458479" WEIGHT="21.480324239584405"/>
<DICH_DATA CI_END="1.5475716612590023" CI_START="0.33440696488958366" EFFECT_SIZE="0.7193877551020408" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.1896507684312677" LOG_CI_START="-0.47572468583346006" LOG_EFFECT_SIZE="-0.14303695870109617" MODIFIED="2011-01-26 11:47:31 +0000" MODIFIED_BY="[Empty name]" ORDER="6375" O_E="0.0" SE="0.39084483549671917" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="0.15275968543445745" WEIGHT="12.128133282975405"/>
<DICH_DATA CI_END="1.1083889162659104" CI_START="0.3620153184020929" EFFECT_SIZE="0.6334459459459459" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" LOG_CI_END="0.04469217424785057" LOG_CI_START="-0.4412730522382525" LOG_EFFECT_SIZE="-0.19829043899520093" MODIFIED="2011-01-26 12:49:43 +0000" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.2854583796046045" STUDY_ID="STD-Regi-2009" TOTAL_1="74" TOTAL_2="75" VAR="0.08148648648648649" WEIGHT="15.411435453696203"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.445811844613846" CI_END="0.6417656565488505" CI_START="0.17455251282910092" DF="6" EFFECT_SIZE="0.3346965909566747" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="62" I2="36.47978491736212" ID="CMP-001.02.02" LOG_CI_END="-0.19262352745616118" LOG_CI_START="-0.7580738947732781" LOG_EFFECT_SIZE="-0.4753487111147196" MODIFIED="2011-07-08 11:44:10 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15001458172601878" P_Z="9.83141147872153E-4" STUDIES="7" TAU2="0.25762740985620103" TOTAL_1="415" TOTAL_2="329" WEIGHT="42.36231258364341" Z="3.2953072726890156">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="16.37173906956138" CI_START="0.16011220198453802" EFFECT_SIZE="1.619047619047619" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2140948143049757" LOG_CI_START="-0.7955755696883039" LOG_EFFECT_SIZE="0.20925962230833586" MODIFIED="2011-01-26 11:49:59 +0000" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="1.1804903315864927" STUDY_ID="STD-Chauhan-1992" TOTAL_1="21" TOTAL_2="17" VAR="1.3935574229691876" WEIGHT="2.575588974990778"/>
<DICH_DATA CI_END="2.1036827601919534" CI_START="0.33709515886013175" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.3229802478933123" LOG_CI_START="-0.4722474844871208" LOG_EFFECT_SIZE="-0.07463361829690421" MODIFIED="2011-01-26 11:50:09 +0000" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="0.4671207064410278" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.2182017543859649" WEIGHT="10.143858879021263"/>
<DICH_DATA CI_END="1.3268513331516507" CI_START="0.05094768216378148" EFFECT_SIZE="0.26" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.12282226513358147" LOG_CI_START="-1.2928755691919454" LOG_EFFECT_SIZE="-0.585026652029182" MODIFIED="2011-01-26 11:50:25 +0000" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.831587915700115" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.6915384615384615" WEIGHT="4.645962017984875"/>
<DICH_DATA CI_END="0.7057072183874005" CI_START="0.08688474645884237" EFFECT_SIZE="0.24761904761904763" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.15137544032442726" LOG_CI_START="-1.0610564618738128" LOG_EFFECT_SIZE="-0.6062159510991201" MODIFIED="2011-01-26 11:50:42 +0000" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.5343511350517892" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.2855311355311355" WEIGHT="8.682375342451577"/>
<DICH_DATA CI_END="0.4660742418828511" CI_START="0.09282641285907944" EFFECT_SIZE="0.208" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="25" LOG_CI_END="-0.33154489817716876" LOG_CI_START="-1.0323284318973083" LOG_EFFECT_SIZE="-0.6819366650372385" MODIFIED="2011-01-26 11:50:50 +0000" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.41164371664164806" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.16945054945054944" WEIGHT="11.551804689482392"/>
<DICH_DATA CI_END="2.1080777784770572" CI_START="0.029647862445166522" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3238866303262053" LOG_CI_START="-1.52800661298213" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2011-01-26 11:50:58 +0000" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="1.0878112581387145" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="1.1833333333333331" WEIGHT="2.9722209034387475"/>
<DICH_DATA CI_END="0.9637473000429718" CI_START="0.0033587937480282167" EFFECT_SIZE="0.05689488910318226" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.016036825623820552" LOG_CI_START="-2.473816663869973" LOG_EFFECT_SIZE="-1.2449267447468968" MODIFIED="2011-01-26 11:51:05 +0000" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="1.4437120431922033" STUDY_ID="STD-Wu-1989" TOTAL_1="60" TOTAL_2="58" VAR="2.084304463658206" WEIGHT="1.7905017762737743"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2390441995423272" CI_END="0.7851794311468495" CI_START="0.07168276810572842" DF="1" EFFECT_SIZE="0.23724214441006758" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="16" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="-0.10503108586320133" LOG_CI_START="-1.1445852322824366" LOG_EFFECT_SIZE="-0.6248081590728191" MODIFIED="2011-07-08 11:49:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6248973244804099" P_Z="0.018472276252175655" STUDIES="2" TAU2="0.0" TOTAL_1="72" TOTAL_2="89" WEIGHT="8.617794440100582" Z="2.3560128988906683">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="1.205230417108226" CI_START="0.020617585162668046" EFFECT_SIZE="0.15763546798029557" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.08107008368466051" LOG_CI_START="-1.6857622028712744" LOG_EFFECT_SIZE="-0.802346059593307" MODIFIED="2011-07-08 11:17:30 +0100" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="1.0378460310838276" STUDY_ID="STD-Nageotte-1985" TOTAL_1="29" TOTAL_2="32" VAR="1.077124384236453" WEIGHT="3.222974151831305"/>
<DICH_DATA CI_END="1.2942330882050783" CI_START="0.06704637069099138" EFFECT_SIZE="0.29457364341085274" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="0.11201249874780889" LOG_CI_START="-1.1736247261126864" LOG_EFFECT_SIZE="-0.5308061136824388" MODIFIED="2011-07-08 11:44:10 +0100" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.7551896698899554" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.5703114375084999" WEIGHT="5.394820288269276"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.885819571809976" CI_END="0.853827999313886" CI_START="0.39396786553987784" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5799834432359909" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="57" I2="0.0" I2_Q="37.3755196196643" ID="CMP-001.03" LOG_CI_END="-0.06862960761577208" LOG_CI_START="-0.404539200478629" LOG_EFFECT_SIZE="-0.23658440404720057" METHOD="MH" MODIFIED="2011-07-08 11:49:26 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.40956675888458394" P_Q="0.20635454812761023" P_Z="0.005765229206063022" Q="1.596819636549038" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="348" TOTAL_2="317" WEIGHT="100.0" Z="2.7608435191411798">
<NAME>Forceps/vacuum-suspected fetal distress</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.2877245070239747" CI_END="0.8636524267822698" CI_START="0.1523689539956986" DF="1" EFFECT_SIZE="0.36275862068965514" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" I2="56.28844308264779" ID="CMP-001.03.01" LOG_CI_END="-0.06366100231376762" LOG_CI_START="-0.8171035138487039" LOG_EFFECT_SIZE="-0.4403822580812359" MODIFIED="2011-07-08 11:47:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1304010986684765" P_Z="0.021953441275010976" STUDIES="2" TAU2="0.0" TOTAL_1="205" TOTAL_2="160" WEIGHT="31.043932516913593" Z="2.2911724572356382">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="1.5109510113632618" CI_START="0.2209384407457593" EFFECT_SIZE="0.5777777777777777" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.17925038370400964" LOG_CI_START="-0.6557287153130611" LOG_EFFECT_SIZE="-0.23823916580452575" ORDER="6392" O_E="0.0" SE="0.4904708559758271" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.24056166056166053" WEIGHT="17.98407125117753"/>
<DICH_DATA CI_END="1.1174408989082671" CI_START="0.003977341843122656" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.048224562715142645" LOG_CI_START="-2.400407080826505" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="6393" O_E="0.0" SE="1.438338348338483" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="2.0688172043010753" WEIGHT="13.059861265736064"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.15235552019033782" CI_END="1.0450995758017656" CI_START="0.4395588006022866" DF="1" EFFECT_SIZE="0.6777777777777777" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="41" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.019157671462380677" LOG_CI_START="-0.35698302031949647" LOG_EFFECT_SIZE="-0.1689126744285579" MODIFIED="2011-07-08 11:49:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.696294592721274" P_Z="0.07835467583840222" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="157" WEIGHT="68.95606748308641" Z="1.7603134446527553">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="1.0520985366814857" CI_START="0.39562177497515927" EFFECT_SIZE="0.6451612903225806" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="31" LOG_CI_END="0.022056416560106158" LOG_CI_START="-0.40271981290068926" LOG_EFFECT_SIZE="-0.1903316981702915" MODIFIED="2011-07-08 11:47:13 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.24951565986151858" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.06225806451612904" WEIGHT="53.98075989837573"/>
<DICH_DATA CI_END="2.018808625292405" CI_START="0.31334310985448965" EFFECT_SIZE="0.7953488372093023" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.3050951515742766" LOG_CI_START="-0.5039798506211796" LOG_EFFECT_SIZE="-0.09944234952345152" MODIFIED="2011-07-08 11:47:05 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.47525466127546345" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.2258669930640555" WEIGHT="14.975307584710686"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.852614933908359" CI_END="1.1225781641330226" CI_START="0.6362483306162786" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8451263118113898" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="76" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.05021659027206739" LOG_CI_START="-0.19637334415237856" LOG_EFFECT_SIZE="-0.0730783769401556" METHOD="MH" MODIFIED="2011-07-08 14:06:10 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5827850495467604" P_Q="0.6239863605996537" P_Z="0.2453599250558387" Q="0.24030441955065757" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="379" TOTAL_2="326" WEIGHT="100.0" Z="1.1616937016156492">
<NAME>Forceps or vacuum delivery, overall</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6305326568909562" CI_START="0.5535001069655704" DF="0" EFFECT_SIZE="0.95" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="20" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.2123295014342231" LOG_CI_START="-0.2568822908565276" LOG_EFFECT_SIZE="-0.022276394711152253" MODIFIED="2011-07-08 14:06:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.8523637546341987" STUDIES="1" TAU2="0.0" TOTAL_1="75" TOTAL_2="75" WEIGHT="24.82630309020611" Z="0.1861032994337113">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="1.6305326568909562" CI_START="0.5535001069655704" EFFECT_SIZE="0.95" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="20" LOG_CI_END="0.2123295014342231" LOG_CI_START="-0.2568822908565276" LOG_EFFECT_SIZE="-0.022276394711152253" MODIFIED="2011-07-08 11:28:31 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.2756173294274178" STUDY_ID="STD-Regi-2009" TOTAL_1="75" TOTAL_2="75" VAR="0.07596491228070175" WEIGHT="24.82630309020611"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.569295143104394" CI_END="1.1316425360690578" CI_START="0.5804805577154674" DF="3" EFFECT_SIZE="0.8104915116593835" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="56" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.05370926331030251" LOG_CI_START="-0.23621232169334946" LOG_EFFECT_SIZE="-0.09125152919152348" MODIFIED="2011-07-08 11:28:31 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4628979900475002" P_Z="0.21728495811671" STUDIES="4" TAU2="0.0" TOTAL_1="304" TOTAL_2="251" WEIGHT="75.17369690979389" Z="1.2337798908441988">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="3.998180806766625" CI_START="0.6314291482170898" EFFECT_SIZE="1.5888888888888888" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6018624300035856" LOG_CI_START="-0.19967537395211188" LOG_EFFECT_SIZE="0.2010935280257369" MODIFIED="2011-01-26 10:31:13 +0000" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.4708272737196962" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.2216783216783217" WEIGHT="7.979883136137679"/>
<DICH_DATA CI_END="1.1910791367851334" CI_START="0.4633082031672149" EFFECT_SIZE="0.7428571428571429" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="28" LOG_CI_END="0.075940617509079" LOG_CI_START="-0.3341300102679944" LOG_EFFECT_SIZE="-0.12909469637945767" ORDER="6394" O_E="0.0" SE="0.2408775166385979" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.05802197802197802" WEIGHT="39.88488037442949"/>
<DICH_DATA CI_END="1.6924505528238085" CI_START="0.23080437968970652" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.22851598905616716" LOG_CI_START="-0.6367559543680167" LOG_EFFECT_SIZE="-0.2041199826559248" ORDER="6395" O_E="0.0" SE="0.5082650227325636" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.25833333333333336" WEIGHT="9.930521236082445"/>
<DICH_DATA CI_END="1.4090188028467763" CI_START="0.36209884538221826" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.14891678865095528" LOG_CI_START="-0.4411728600074313" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2011-01-26 11:07:24 +0000" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="0.3466215806128063" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" VAR="0.12014652014652016" WEIGHT="17.37841216314428"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="49.283985657671394" CI_END="0.7413054678504216" CI_START="0.3840127208132923" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5335454335508936" ESTIMABLE="YES" EVENTS_1="242" EVENTS_2="395" I2="87.8256599584371" I2_Q="62.0489733945728" ID="CMP-001.05" LOG_CI_END="-0.13000279652130653" LOG_CI_START="-0.41565438894623613" LOG_EFFECT_SIZE="-0.2728285927337713" METHOD="MH" MODIFIED="2011-11-29 01:47:15 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="6.541185038066999E-9" P_Q="0.07172090864206104" P_Z="1.8114175730967898E-4" Q="5.269949666431394" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.14304193360502804" TOTALS="YES" TOTAL_1="507" TOTAL_2="499" WEIGHT="99.99999999999999" Z="3.743961034290179">
<NAME>Persistent variable decelerations</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="26.75882921330866" CI_END="0.800856503065311" CI_START="0.23972748529517254" DF="2" EFFECT_SIZE="0.4381635716968409" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="267" I2="92.52583144031844" ID="CMP-001.05.01" LOG_CI_END="-0.09644529354097274" LOG_CI_START="-0.6202821702729155" LOG_EFFECT_SIZE="-0.35836373190694415" MODIFIED="2011-11-29 01:47:15 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.5466660835405932E-6" P_Z="0.007325468917514163" STUDIES="3" TAU2="0.25776598788053556" TOTAL_1="341" TOTAL_2="341" WEIGHT="50.12666794645489" Z="2.6816745406887383">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.8312672734875561" CI_START="0.5974002202714733" EFFECT_SIZE="0.7046979865771812" ESTIMABLE="YES" EVENTS_1="105" EVENTS_2="149" LOG_CI_END="-0.08025931708446495" LOG_CI_START="-0.22373462160020696" LOG_EFFECT_SIZE="-0.15199696934233597" MODIFIED="2011-01-26 12:00:46 +0000" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.08427810408675838" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.007102798828458479" WEIGHT="18.75160312405725"/>
<DICH_DATA CI_END="0.6850755619075027" CI_START="0.38199927274114676" EFFECT_SIZE="0.5115646258503401" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.16426152440590852" LOG_CI_START="-0.41793746390715913" LOG_EFFECT_SIZE="-0.29109949415653386" MODIFIED="2011-01-26 12:00:52 +0000" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.14901050257918708" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="0.022204129878901916" WEIGHT="17.037951612289433"/>
<DICH_DATA CI_END="0.33195818259836607" CI_START="0.13425492495820388" EFFECT_SIZE="0.211109026083693" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="73" LOG_CI_END="-0.4789166217496418" LOG_CI_START="-0.8720697738374192" LOG_EFFECT_SIZE="-0.6754931977935306" MODIFIED="2011-01-26 12:46:47 +0000" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.2309401076758503" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.05333333333333333" WEIGHT="14.337113210108207"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.193983621501075" CI_END="0.9947730281391417" CI_START="0.2984170226875876" DF="2" EFFECT_SIZE="0.5448460381678465" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="41" I2="52.31264161961183" ID="CMP-001.05.02" LOG_CI_END="-0.0022759985218609525" LOG_CI_START="-0.5251764069083972" LOG_EFFECT_SIZE="-0.26372620271512903" MODIFIED="2011-07-08 12:32:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.12282540697957611" P_Z="0.04803868802579606" STUDIES="3" TAU2="0.15087428750704984" TOTAL_1="68" TOTAL_2="63" WEIGHT="30.78607725022927" Z="1.9770260294731548">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="1.3833223141345323" CI_START="0.22606185814188323" EFFECT_SIZE="0.5592105263157895" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.14092338252522937" LOG_CI_START="-0.6457727069861889" LOG_EFFECT_SIZE="-0.2524246622304798" ORDER="6352" O_E="0.0" SE="0.4621091771874552" STUDY_ID="STD-Chauhan-1992" TOTAL_1="19" TOTAL_2="17" VAR="0.21354489164086687" WEIGHT="7.895564935185217"/>
<DICH_DATA CI_END="0.7012275867306513" CI_START="0.11236505295337727" EFFECT_SIZE="0.2807017543859649" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="-0.15414100682634999" LOG_CI_START="-0.9493687392067831" LOG_EFFECT_SIZE="-0.5517548730165667" ORDER="6353" O_E="0.0" SE="0.4671207064410278" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.2182017543859649" WEIGHT="7.793781669704095"/>
<DICH_DATA CI_END="1.1463986008373643" CI_START="0.5063673889597718" EFFECT_SIZE="0.7619047619047619" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="21" LOG_CI_END="0.05933564733958223" LOG_CI_START="-0.2955342714955712" LOG_EFFECT_SIZE="-0.11809931207799451" ORDER="6355" O_E="0.0" SE="0.208452346958198" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.04345238095238096" WEIGHT="15.096730645339957"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.927177672714068" CI_START="0.71357447936921" DF="0" EFFECT_SIZE="0.81339432324654" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="87" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="-0.03283703512667234" LOG_CI_START="-0.14656069067694702" LOG_EFFECT_SIZE="-0.08969886290180969" MODIFIED="2011-07-08 12:32:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.0019893338568436783" STUDIES="1" TAU2="0.0" TOTAL_1="98" TOTAL_2="95" WEIGHT="19.087254803315833" Z="3.0918200772050066">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="0.927177672714068" CI_START="0.71357447936921" EFFECT_SIZE="0.81339432324654" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="87" LOG_CI_END="-0.03283703512667234" LOG_CI_START="-0.14656069067694702" LOG_EFFECT_SIZE="-0.08969886290180969" MODIFIED="2011-07-08 12:32:17 +0100" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.06680183821140534" STUDY_ID="STD-Mino-1999" TOTAL_1="98" TOTAL_2="95" VAR="0.0044624855884227745" WEIGHT="19.087254803315833"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2263056901466511" CI_START="0.49330136561022975" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.08859874342507054" LOG_CI_START="-0.30688768227520663" LOG_EFFECT_SIZE="-0.10914446942506803" METHOD="MH" MODIFIED="2011-11-29 01:47:26 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.27934002627833154" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="1.081803143084294">
<NAME>Variable FHR decelerations during second stage of labour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.226305690146651" CI_START="0.49330136561022986" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.08859874342507046" LOG_CI_START="-0.3068876822752065" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="6358" O_E="0.0" SE="0.23231068414572315" STUDY_ID="STD-MacGregor-1991" TOTAL_1="10" TOTAL_2="10" VAR="0.05396825396825394" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.757297113861355" CI_END="1.3307141812344985" CI_START="0.3362001848045959" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6688694593514752" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="41" I2="55.60355051066128" I2_Q="33.40893519900533" ID="CMP-001.07" LOG_CI_END="0.1240847851197783" LOG_CI_START="-0.47340205217080666" LOG_EFFECT_SIZE="-0.17465863352551425" METHOD="MH" MODIFIED="2011-07-08 14:06:47 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.08004937512865973" P_Q="0.22040989331928518" P_Z="0.25184410287409087" Q="1.501702973196883" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.25496028691631545" TOTALS="YES" TOTAL_1="192" TOTAL_2="170" WEIGHT="100.0" Z="1.1458817498016276">
<NAME>Meconium-stained amniotic fluid</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.8320721076713715" CI_START="0.47171267358171654" DF="0" EFFECT_SIZE="1.1558219178082192" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.4521043067737719" LOG_CI_START="-0.3263224553365211" LOG_EFFECT_SIZE="0.06289092571862544" MODIFIED="2011-07-08 14:06:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7514711097111042" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="75" WEIGHT="26.544649757799668" Z="0.3167001839164023">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="2.8320721076713715" CI_START="0.47171267358171654" EFFECT_SIZE="1.1558219178082192" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.4521043067737719" LOG_CI_START="-0.3263224553365211" LOG_EFFECT_SIZE="0.06289092571862544" MODIFIED="2011-07-08 11:30:44 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.4572517333382034" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.20907914764079147" WEIGHT="26.544649757799668"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.724162163399677" CI_END="1.4185794299387018" CI_START="0.1621472727738536" DF="2" EFFECT_SIZE="0.47960273745845994" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" I2="70.25651744560518" ID="CMP-001.07.02" LOG_CI_END="0.15185365808625834" LOG_CI_START="-0.7900903515190804" LOG_EFFECT_SIZE="-0.319118346716411" MODIFIED="2011-07-08 11:30:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.03466315429675981" P_Z="0.18417134237707827" STUDIES="3" TAU2="0.6045545914722656" TOTAL_1="119" TOTAL_2="95" WEIGHT="73.45535024220034" Z="1.3280204767843697">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="1.4201302170107664" CI_START="0.6169124419055709" EFFECT_SIZE="0.936" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="15" LOG_CI_END="0.15232816828192328" LOG_CI_START="-0.2097764708057127" LOG_EFFECT_SIZE="-0.028724151261894745" ORDER="6362" O_E="0.0" SE="0.2127020574469491" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.04524216524216523" WEIGHT="41.0315244780982"/>
<DICH_DATA CI_END="1.0149061803159989" CI_START="0.1302892893188476" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.00642589717111953" LOG_CI_START="-0.8850912848316449" LOG_EFFECT_SIZE="-0.43933269383026263" ORDER="6363" O_E="0.0" SE="0.523681605789648" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.2742424242424243" WEIGHT="23.276079287566166"/>
<DICH_DATA CI_END="1.1071955153006299" CI_START="0.018432303042489127" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.04422431800490262" LOG_CI_START="-1.7344203980334163" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2011-01-26 11:03:55 +0000" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="1.0447847106342492" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" VAR="1.0915750915750917" WEIGHT="9.147746476535973"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.1875918537641415E-4" CI_END="27.626996610661976" CI_START="0.31273890726187037" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="2.9393939393939394" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="1.4413336744093248" LOG_CI_START="-0.5048180856326101" LOG_EFFECT_SIZE="0.4682577943883574" METHOD="MH" MODIFIED="2011-07-08 14:07:04 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.985755462902381" P_Q="0.9857556024013115" P_Z="0.34559794307212444" Q="3.1875294142850514E-4" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="346" TOTAL_2="331" WEIGHT="100.00000000000001" Z="0.9431622253976398">
<NAME>Umbilical cord prolapse</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="68.97877806426546" CI_START="0.12024567892855917" DF="0" EFFECT_SIZE="2.88" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.08.01" LOG_CI_END="1.838715496719584" LOG_CI_START="-0.9199305212011221" LOG_EFFECT_SIZE="0.45939248775923086" MODIFIED="2011-07-08 14:07:04 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5138989378855852" STUDIES="2" TAU2="0.0" TOTAL_1="124" TOTAL_2="122" WEIGHT="50.50505050505051" Z="0.6527787363273303">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="68.97877806426546" CI_START="0.12024567892855917" EFFECT_SIZE="2.88" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.838715496719584" LOG_CI_START="-0.9199305212011221" LOG_EFFECT_SIZE="0.45939248775923086" MODIFIED="2011-07-08 11:32:33 +0100" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="1.6204423264446448" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="2.625833333333333" WEIGHT="50.50505050505051"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 11:32:00 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.0" STUDY_ID="STD-Regi-2009" TOTAL_1="75" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="70.82882080128432" CI_START="0.12706691849706483" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-001.08.02" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-07-08 11:32:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.49584060533880536" STUDIES="5" TAU2="0.0" TOTAL_1="222" TOTAL_2="209" WEIGHT="49.4949494949495" Z="0.6810488185180525">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6364" O_E="0.0" SE="0.0" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6365" O_E="0.0" SE="0.0" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6367" O_E="0.0" SE="0.0" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6368" O_E="0.0" SE="0.0" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="6369" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="49.4949494949495"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.2032246910161986" CI_END="3.9050894192619303" CI_START="-0.12639708116124093" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="1.8893461690503448" ESTIMABLE="YES" I2="42.3434470323807" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2011-07-08 14:07:12 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.15750698244808625" P_Q="0.42150697850641383" P_Z="0.06620036827263676" Q="1.7278395065730352" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="1.7544707737666432" TOTALS="YES" TOTAL_1="253" TOTAL_2="231" UNITS="" WEIGHT="100.0" Z="1.8370645394837386">
<NAME>Rupture of membranes to delivery interval (hours)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.3427504510201675" CI_START="-1.102750451020166" DF="0" EFFECT_SIZE="1.620000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" MODIFIED="2011-07-08 14:07:12 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.24355290133223617" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="75" WEIGHT="28.709057668127535" Z="1.1661522831683748">
<NAME>FHR decelerations</NAME>
<CONT_DATA CI_END="4.3427504510201675" CI_START="-1.102750451020166" EFFECT_SIZE="1.620000000000001" ESTIMABLE="YES" MEAN_1="11.14" MEAN_2="9.52" MODIFIED="2011-07-08 11:50:45 +0100" MODIFIED_BY="[Empty name]" ORDER="314" SD_1="8.3" SD_2="8.6" SE="1.38918391995816" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" WEIGHT="28.709057668127535"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6164538865497557" CI_END="8.511650738636325" CI_START="-1.2675733127941928" DF="1" EFFECT_SIZE="3.622038712921066" ESTIMABLE="YES" I2="72.34860359427836" ID="CMP-001.09.02" MODIFIED="2011-07-08 11:51:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.057210877077313316" P_Z="0.14653864190914068" STUDIES="2" TAU2="9.408935897435905" TOTAL_1="80" TOTAL_2="56" WEIGHT="52.94586336094423" Z="1.4518668128677636">
<NAME>Oligohydramnios</NAME>
<CONT_DATA CI_END="3.46295740586868" CI_START="-0.26295740586868055" EFFECT_SIZE="1.5999999999999996" ESTIMABLE="YES" MEAN_1="8.6" MEAN_2="7.0" ORDER="6370" SD_1="4.5" SD_2="3.6" SE="0.9505059381516449" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" WEIGHT="39.79516681578141"/>
<CONT_DATA CI_END="11.615043645490019" CI_START="1.7849563545099842" EFFECT_SIZE="6.700000000000001" ESTIMABLE="YES" MEAN_1="16.8" MEAN_2="10.1" ORDER="6371" SD_1="12.1" SD_2="6.5" SE="2.5077214093010145" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" WEIGHT="13.150696545162825"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.415443347563791" CI_START="-4.435443347563787" DF="0" EFFECT_SIZE="-0.509999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.03" MODIFIED="2011-07-08 11:51:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.7989998361305242" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="18.34507897092823" Z="0.2546417165173928">
<NAME>Mixed or other indications</NAME>
<CONT_DATA CI_END="3.415443347563791" CI_START="-4.435443347563787" EFFECT_SIZE="-0.509999999999998" ESTIMABLE="YES" MEAN_1="17.82" MEAN_2="18.33" MODIFIED="2011-07-08 11:51:17 +0100" MODIFIED_BY="[Empty name]" ORDER="315" SD_1="13.92" SD_2="14.4" SE="2.0028140203224063" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="18.34507897092823"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.8356220096671358" CI_END="2.8161168809302564" CI_START="0.8510351175856418" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5481002425222312" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="0.44965067592804375" LOG_CI_START="-0.07005251857700193" LOG_EFFECT_SIZE="0.1897990786755209" METHOD="MH" MODIFIED="2011-07-08 14:08:01 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.6072142072949838" P_Q="0.6238139614417735" P_Z="0.1522629449559378" Q="0.9438063162641654" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="422" TOTAL_2="424" WEIGHT="99.99999999999999" Z="1.4315838826320455">
<NAME>Intrapartum maternal temperature &gt; 38ºC</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.825171571671548" CI_END="2.710073688964113" CI_START="0.69612539233989" DF="1" EFFECT_SIZE="1.3735177865612647" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="13" I2="0.0" ID="CMP-001.10.01" LOG_CI_END="0.4329810998321173" LOG_CI_START="-0.15731252433148782" LOG_EFFECT_SIZE="0.13783428775031473" MODIFIED="2011-07-08 14:08:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3636725104941819" P_Z="0.36002996823478606" STUDIES="2" TAU2="0.0" TOTAL_1="292" TOTAL_2="294" WEIGHT="81.81083265966046" Z="0.9153080052596763">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="2.497034899769803" CI_START="0.6066366551576552" EFFECT_SIZE="1.2307692307692308" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.39742461230390097" LOG_CI_START="-0.21707135160572494" LOG_EFFECT_SIZE="0.09017663034908803" MODIFIED="2011-01-26 12:03:28 +0000" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.36095797100459315" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.13029065683175273" WEIGHT="78.8197251414713"/>
<DICH_DATA CI_END="105.1670972985515" CI_START="0.2507401414839899" EFFECT_SIZE="5.135135135135135" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.021879887186973" LOG_CI_START="-0.6007761334153054" LOG_EFFECT_SIZE="0.710551876885834" MODIFIED="2011-01-26 12:48:46 +0000" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.5405611288584573" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="2.3733285917496443" WEIGHT="2.9911075181891675"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.691755493981939" CI_START="0.6573298803032126" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="1.1364591349471005" LOG_CI_START="-0.18221662550777554" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-07-08 14:07:32 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.15610250623813543" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="12.126111560226354" Z="1.4183023659834681">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="13.691755493981939" CI_START="0.6573298803032126" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.1364591349471005" LOG_CI_START="-0.18221662550777554" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-07-08 14:07:32 +0100" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.7745966692414834" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.6" WEIGHT="12.126111560226354"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.766915493466893" CI_START="0.0634239462001528" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.10.03" LOG_CI_END="1.1977467399242954" LOG_CI_START="-1.1977467399242954" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 14:08:01 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="6.063055780113177" Z="0.0">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="15.766915493466893" CI_START="0.0634239462001528" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1977467399242954" LOG_CI_START="-1.1977467399242954" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 14:08:01 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.407124727947029" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="1.98" WEIGHT="6.063055780113177"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="23.976043076589416" CI_END="0.770123407763688" CI_START="0.29004507414013353" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4726208849615844" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="190" I2="62.46252990432879" I2_Q="70.47946100476031" ID="CMP-001.11" LOG_CI_END="-0.11343967610492452" LOG_CI_START="-0.5375345057934339" LOG_EFFECT_SIZE="-0.3254870909491792" METHOD="MH" MODIFIED="2011-11-29 01:47:46 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.004339356914844217" P_Q="0.03379411826420098" P_Z="0.0026254761438169716" Q="6.774944049370197" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.30918865340473833" TOTALS="YES" TOTAL_1="844" TOTAL_2="784" WEIGHT="99.99999999999999" Z="3.0084921156037807">
<NAME>Apgar score &lt; 7 at 1 minute</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.930998854033156" CI_END="1.9179871061349383" CI_START="0.31525583276444746" DF="2" EFFECT_SIZE="0.7775966964796357" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="94" I2="81.70341039545467" ID="CMP-001.11.01" LOG_CI_END="0.2828456832552553" LOG_CI_START="-0.5013368695003845" LOG_EFFECT_SIZE="-0.10924559312256456" MODIFIED="2011-11-29 01:47:46 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.004230247334510162" P_Z="0.5850035448301181" STUDIES="3" TAU2="0.5120013477980517" TOTAL_1="341" TOTAL_2="341" WEIGHT="43.311086473986144" Z="0.5460907724547773">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.5528049304268116" CI_START="0.25659171981276924" EFFECT_SIZE="0.37662337662337664" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="77" LOG_CI_END="-0.25742809217581025" LOG_CI_START="-0.5907573623712412" LOG_EFFECT_SIZE="-0.42409272727352576" MODIFIED="2011-01-26 12:07:24 +0000" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.19579926331929456" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.038337351516378446" WEIGHT="17.857220111741317"/>
<DICH_DATA CI_END="2.569740658849399" CI_START="0.5348285852975607" EFFECT_SIZE="1.1723356009070294" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4098892960496444" LOG_CI_START="-0.2717853887974365" LOG_EFFECT_SIZE="0.06905195362610393" MODIFIED="2011-01-26 12:06:36 +0000" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.40041908422328604" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="0.16033544301021505" WEIGHT="13.217316026621791"/>
<DICH_DATA CI_END="3.0716987350609988" CI_START="0.5369306720914802" EFFECT_SIZE="1.2842465753424657" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.48737861887362954" LOG_CI_START="-0.27008178631502844" LOG_EFFECT_SIZE="0.10864841627930052" MODIFIED="2011-01-26 12:57:13 +0000" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.44493599149729435" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.19796803652968037" WEIGHT="12.236550335623035"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.925788516280621" CI_END="0.3944131959756497" CI_START="0.18172669207812833" DF="5" EFFECT_SIZE="0.26772262776354444" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="95" I2="0.0" ID="CMP-001.11.02" LOG_CI_END="-0.4040485631944769" LOG_CI_START="-0.7405812786861032" LOG_EFFECT_SIZE="-0.5723149209402901" MODIFIED="2011-07-08 11:52:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5601494574265586" P_Z="2.6230502568918952E-11" STUDIES="6" TAU2="0.0" TOTAL_1="403" TOTAL_2="343" WEIGHT="53.220386966435534" Z="6.666315524297179">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.50853056944563" CI_START="0.12290313258479978" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="32" LOG_CI_END="-0.29368293508635424" LOG_CI_START="-0.9104370475695706" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="6396" O_E="0.0" SE="0.36228441865473593" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.13124999999999998" WEIGHT="14.090153796578006"/>
<DICH_DATA CI_END="0.9538711362450213" CI_START="0.016727289530083407" EFFECT_SIZE="0.12631578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="-0.020510292589231455" LOG_CI_START="-1.7765744258932146" LOG_EFFECT_SIZE="-0.8985423592412229" ORDER="6397" O_E="0.0" SE="1.0315207645604128" STUDY_ID="STD-Chauhan-1992" TOTAL_1="19" TOTAL_2="12" VAR="1.0640350877192983" WEIGHT="4.5191822560180555"/>
<DICH_DATA CI_END="3.2940771789354084" CI_START="0.22801867421754152" EFFECT_SIZE="0.8666666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5177337703021941" LOG_CI_START="-0.6420295837998831" LOG_EFFECT_SIZE="-0.06214790674884446" MODIFIED="2011-01-26 10:32:55 +0000" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.6812507351207514" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.4641025641025641" WEIGHT="8.025240975107641"/>
<DICH_DATA CI_END="0.4026652515816417" CI_START="0.13264701999790712" EFFECT_SIZE="0.2311111111111111" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="45" LOG_CI_END="-0.3950558466713813" LOG_CI_START="-0.8773025022817454" LOG_EFFECT_SIZE="-0.6361791744765634" ORDER="6399" O_E="0.0" SE="0.28327407266497273" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.08024420024420024" WEIGHT="15.935605602563912"/>
<DICH_DATA CI_END="3.0260386806300987" CI_START="0.036718338011454264" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.48087447513357967" LOG_CI_START="-1.4351169845729046" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="6400" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="3.9380825672177067"/>
<DICH_DATA CI_END="1.551015624495367" CI_START="0.07163764784591502" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.19061617279615944" LOG_CI_START="-1.1448586822354845" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2011-01-26 11:08:19 +0000" MODIFIED_BY="[Empty name]" ORDER="274" O_E="0.0" SE="0.7844645405527361" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" VAR="0.6153846153846153" WEIGHT="6.712121768950214"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="21.705078767310894" CI_START="0.18428866547235168" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2011-07-08 11:52:47 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.568838135954588" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="3.4685265595783057" Z="0.5697634726880932">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="21.705078767310894" CI_START="0.18428866547235168" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3365613662238505" LOG_CI_START="-0.7345013748958881" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2011-07-08 11:52:47 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="1.2165525060596438" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="1.48" WEIGHT="3.4685265595783057"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.999377925808243" CI_END="0.724781431653674" CI_START="0.30036255628470804" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.46658032916014364" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="-0.13979294148141577" LOG_CI_START="-0.5223542081941364" LOG_EFFECT_SIZE="-0.33107357483777605" METHOD="MH" MODIFIED="2011-11-29 01:48:01 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.5342090221209095" P_Q="0.786742681525891" P_Z="6.929397590519526E-4" Q="0.47970810916222784" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="937" TOTAL_2="867" WEIGHT="99.99999999999999" Z="3.392357456837075">
<NAME>Apgar score &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.1489573841579652" CI_END="1.3830284406686262" CI_START="0.16199915389295577" DF="1" EFFECT_SIZE="0.47333860733962047" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="33" I2="53.46580591258053" ID="CMP-001.12.01" LOG_CI_END="0.1408311110554027" LOG_CI_START="-0.7904872537325544" LOG_EFFECT_SIZE="-0.32482807133857583" MODIFIED="2011-11-29 01:48:01 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1426668101327886" P_Z="0.17156122107709074" STUDIES="3" TAU2="0.34168653531246923" TOTAL_1="341" TOTAL_2="341" WEIGHT="48.023837137609064" Z="1.3672044814367408">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.6401536491984058" CI_START="0.15045436690100236" EFFECT_SIZE="0.3103448275862069" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="29" LOG_CI_END="-0.1937157744688416" LOG_CI_START="-0.8225952024504207" LOG_EFFECT_SIZE="-0.5081554884596312" MODIFIED="2011-01-26 12:10:28 +0000" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.369406888999754" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.13646144964047657" WEIGHT="37.00558014076981"/>
<DICH_DATA CI_END="3.615401824910598" CI_START="0.25447608979756486" EFFECT_SIZE="0.9591836734693877" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5581565729011566" LOG_CI_START="-0.5943530170867489" LOG_EFFECT_SIZE="-0.01809822209279622" MODIFIED="2011-01-26 12:10:34 +0000" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="0.6769898381733754" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="0.45831524099001303" WEIGHT="11.018256996839254"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-01-26 12:58:51 +0000" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.0" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.003628876127588" CI_END="0.955576625739904" CI_START="0.2728721291347503" DF="6" EFFECT_SIZE="0.510637080926413" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="27" I2="0.0" ID="CMP-001.12.02" LOG_CI_END="-0.019734482024223718" LOG_CI_START="-0.5640408204353283" LOG_EFFECT_SIZE="-0.29188765122977595" MODIFIED="2011-07-08 11:53:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5433478384905721" P_Z="0.03554576970802005" STUDIES="7" TAU2="0.0" TOTAL_1="453" TOTAL_2="369" WEIGHT="49.398664766480536" Z="2.102085695391116">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.7942735393676985" CI_START="0.04162023484502071" EFFECT_SIZE="0.18181818181818182" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.10002990540731668" LOG_CI_START="-1.3806954735811712" LOG_EFFECT_SIZE="-0.7403626894942439" ORDER="6401" O_E="0.0" SE="0.7522692941421251" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.565909090909091" WEIGHT="8.923403408635993"/>
<DICH_DATA CI_END="44.31575619864576" CI_START="0.08580469625645698" EFFECT_SIZE="1.95" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.6465581644515126" LOG_CI_START="-1.0664889417264767" LOG_EFFECT_SIZE="0.290034611362518" ORDER="6402" O_E="0.0" SE="1.5936572999687195" STUDY_ID="STD-Chauhan-1992" TOTAL_1="19" TOTAL_2="12" VAR="2.5397435897435896" WEIGHT="1.9883247786073186"/>
<DICH_DATA CI_END="3.482963528269354" CI_START="0.0776350363147095" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5419489267825842" LOG_CI_START="-1.1099422395129859" LOG_EFFECT_SIZE="-0.28399665636520083" ORDER="6404" O_E="0.0" SE="0.970329048075168" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.9415384615384615" WEIGHT="5.363386964081016"/>
<DICH_DATA CI_END="2.0718028904433576" CI_START="0.13051434634408465" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.31634843463266576" LOG_CI_START="-0.8843417473630674" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2011-01-26 10:33:55 +0000" MODIFIED_BY="[Empty name]" ORDER="268" O_E="0.0" SE="0.7052913564165503" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.4974358974358974" WEIGHT="10.151730377373966"/>
<DICH_DATA CI_END="1.3566776466434725" CI_START="0.18078043194848178" EFFECT_SIZE="0.49523809523809526" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1324766693881435" LOG_CI_START="-0.7428485802584214" LOG_EFFECT_SIZE="-0.3051859554351389" ORDER="6406" O_E="0.0" SE="0.5141703845722586" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.26437118437118434" WEIGHT="19.1013068342054"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="6407" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="1.9406391128266693"/>
<DICH_DATA CI_END="71.45532212106615" CI_START="0.12595282944426972" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.854034581366758" LOG_CI_START="-0.8997920719274333" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2011-01-26 11:08:51 +0000" MODIFIED_BY="[Empty name]" ORDER="275" O_E="0.0" SE="1.6176114078067905" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" VAR="2.6166666666666667" WEIGHT="1.9298732907501703"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="20.598966654909542" CI_START="0.08530360115303004" DF="0" EFFECT_SIZE="1.3255813953488371" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-001.12.03" LOG_CI_END="1.3138454345765853" LOG_CI_START="-1.069032634390776" LOG_EFFECT_SIZE="0.12240640009290485" MODIFIED="2011-07-08 11:53:59 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8404144837040293" STUDIES="2" TAU2="0.0" TOTAL_1="143" TOTAL_2="157" WEIGHT="2.5774980959103875" Z="0.20136333351144706">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 11:53:45 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.0" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="20.598966654909542" CI_START="0.08530360115303004" EFFECT_SIZE="1.3255813953488371" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.3138454345765853" LOG_CI_START="-1.069032634390776" LOG_EFFECT_SIZE="0.12240640009290485" MODIFIED="2011-07-08 11:53:59 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="1.3997143731481037" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="1.9592003263973887" WEIGHT="2.5774980959103875"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.6997852942229981" CI_START="0.14837002342141384" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.32222222222222224" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="-0.15503518832483315" LOG_CI_START="-0.8286538347559043" LOG_EFFECT_SIZE="-0.49184451154036873" METHOD="MH" MODIFIED="2011-03-09 11:50:14 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.00420782742525935" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="58" WEIGHT="100.0" Z="2.862146212015406">
<NAME>'Mild' or 'severe' birth asphyxia</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6997852942229981" CI_START="0.14837002342141384" EFFECT_SIZE="0.32222222222222224" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="21" LOG_CI_END="-0.15503518832483315" LOG_CI_START="-0.8286538347559043" LOG_EFFECT_SIZE="-0.49184451154036873" ORDER="6408" O_E="0.0" SE="0.39568692737968864" STUDY_ID="STD-Wu-1989" TOTAL_1="60" TOTAL_2="58" VAR="0.15656814449917897" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="23.948574149810685" CI_END="1.1449491799508804" CI_START="0.29407016877464254" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5802545980744521" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="109" I2="70.77070243843583" I2_Q="52.54436375808682" ID="CMP-001.14" LOG_CI_END="0.058786210381830455" LOG_CI_START="-0.5315490291945975" LOG_EFFECT_SIZE="-0.23638140940638352" METHOD="MH" MODIFIED="2011-07-08 12:38:03 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0011633105050469217" P_Q="0.14660441497516086" P_Z="0.11650508089595377" Q="2.107231256793882" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.5347840499434371" TOTALS="YES" TOTAL_1="509" TOTAL_2="463" WEIGHT="100.0" Z="1.5696133924979696">
<NAME>Low cord arterial pH (&lt; 7.2 or as defined by trial authors)</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="7.666946589449169" CI_END="0.810666257425185" CI_START="0.18723333120678715" DF="5" EFFECT_SIZE="0.38959433244678526" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="63" I2="34.78498980440629" ID="CMP-001.14.01" LOG_CI_END="-0.09115790335995454" LOG_CI_START="-0.7276168357761209" LOG_EFFECT_SIZE="-0.40938736956803773" MODIFIED="2011-07-08 11:55:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1755713508122282" P_Z="0.011688813820715833" STUDIES="6" TAU2="0.2767453264044749" TOTAL_1="370" TOTAL_2="308" WEIGHT="61.54637679750423" Z="2.5214022750309413">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.6598682847320492" CI_START="0.0358687325954232" EFFECT_SIZE="0.15384615384615385" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="13" LOG_CI_END="-0.18054274464418482" LOG_CI_START="-1.4452839686415262" LOG_EFFECT_SIZE="-0.8129133566428556" ORDER="6409" O_E="0.0" SE="0.7429152555460663" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.551923076923077" WEIGHT="11.065221360860628"/>
<DICH_DATA CI_END="12.462127901405344" CI_START="0.12803334066697228" EFFECT_SIZE="1.263157894736842" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0955922041960275" LOG_CI_START="-0.8926769226784735" LOG_EFFECT_SIZE="0.10145764075877704" ORDER="6410" O_E="0.0" SE="1.167919127216991" STUDY_ID="STD-Chauhan-1992" TOTAL_1="19" TOTAL_2="12" VAR="1.3640350877192984" WEIGHT="6.332701558929952"/>
<DICH_DATA CI_END="3.610062191210922" CI_START="0.1964346420304632" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.5575146836416905" LOG_CI_START="-0.706781920235499" LOG_EFFECT_SIZE="-0.07463361829690421" ORDER="6411" O_E="0.0" SE="0.742654083486584" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.5515350877192982" WEIGHT="11.069173409827265"/>
<DICH_DATA CI_END="7.482730188050956" CI_START="0.22585339274944488" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.874060085734435" LOG_CI_START="-0.6461733811207614" LOG_EFFECT_SIZE="0.11394335230683679" MODIFIED="2011-01-26 10:34:41 +0000" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="0.8929926637077694" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.7974358974358973" WEIGHT="9.026028274728233"/>
<DICH_DATA CI_END="0.4700835063915126" CI_START="0.15127335918883672" EFFECT_SIZE="0.26666666666666666" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="39" LOG_CI_END="-0.3278249864395186" LOG_CI_START="-0.8202375490159192" LOG_EFFECT_SIZE="-0.5740312677277188" ORDER="6413" O_E="0.0" SE="0.28924557673887363" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.08366300366300365" WEIGHT="19.44330536152077"/>
<DICH_DATA CI_END="1.613718616073239" CI_START="0.005706226578172529" EFFECT_SIZE="0.09595959595959595" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.2078278091094883" LOG_CI_START="-2.2436509877268924" LOG_EFFECT_SIZE="-1.017911589308702" ORDER="6414" O_E="0.0" SE="1.4400107802774456" STUDY_ID="STD-Strong-1990" TOTAL_1="17" TOTAL_2="18" VAR="2.0736310473152577" WEIGHT="4.609946831637382"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.47788599632344" CI_END="2.988539430237171" CI_START="0.3486039474142747" DF="1" EFFECT_SIZE="1.020694196311454" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="46" I2="84.56286509877519" ID="CMP-001.14.02" LOG_CI_END="0.4754589902086683" LOG_CI_START="-0.45766769946776087" LOG_EFFECT_SIZE="0.008895645370453616" MODIFIED="2011-07-08 11:55:26 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.010922508547643206" P_Z="0.9701905524207336" STUDIES="2" TAU2="0.5103542504966295" TOTAL_1="139" TOTAL_2="155" WEIGHT="38.45362320249576" Z="0.03736929773464185">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="0.960529075931178" CI_START="0.38880321218950276" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="36" LOG_CI_END="-0.0174894841855851" LOG_CI_START="-0.410270155704577" LOG_EFFECT_SIZE="-0.21387981994508098" MODIFIED="2011-07-08 11:55:26 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.23072131074593702" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" VAR="0.053232323232323235" WEIGHT="20.449523961824475"/>
<DICH_DATA CI_END="3.7478696867812387" CI_START="0.896805756871903" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="10" LOG_CI_END="0.5737844820834818" LOG_CI_START="-0.04730161253431901" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2011-07-08 11:55:20 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="0.36482904640424824" STUDY_ID="STD-Owen-1990" TOTAL_1="39" TOTAL_2="55" VAR="0.1331002331002331" WEIGHT="18.00409924067129"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.1600019598610881" CI_END="42.62660968395569" CI_START="0.6055338558052791" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="5.080536912751677" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="1.629680792321023" LOG_CI_START="-0.21786157014542568" LOG_EFFECT_SIZE="0.7059096110877987" METHOD="MH" MODIFIED="2011-07-08 10:36:06 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.6891549197271376" P_Q="1.0" P_Z="0.13420408862741218" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="105" WEIGHT="100.0" Z="1.4977274049897595">
<NAME>Neonatal sepsis</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="136.78718905037783" CI_START="0.37784562689507206" EFFECT_SIZE="7.1891891891891895" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1360454249772336" LOG_CI_START="-0.42268559984908916" LOG_EFFECT_SIZE="0.856679912564072" MODIFIED="2011-01-26 12:52:04 +0000" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="1.503011269905828" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="2.25904287746393" WEIGHT="49.66442953020134"/>
<DICH_DATA CI_END="70.82882080128432" CI_START="0.12706691849706483" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850210011475669" LOG_CI_START="-0.8959675020363438" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="6415" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="50.335570469798654"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9645197840590484" CI_END="1.7937738626376958" CI_START="0.12145788569389429" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.466763302723066" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.2537676915514848" LOG_CI_START="-0.9155742832288257" LOG_EFFECT_SIZE="-0.3309032958386704" METHOD="MH" MODIFIED="2011-07-08 14:08:52 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.8098362246791737" P_Q="0.9691372053924731" P_Z="0.26731333044475036" Q="0.06269816507267695" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="520" TOTAL_2="502" WEIGHT="100.00000000000001" Z="1.1092709510085694">
<NAME>Perinatal death</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.137925187328408" CI_START="0.013653493802587735" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-001.16.01" LOG_CI_END="0.9105136930277367" LOG_CI_START="-1.8647562024670619" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2011-07-08 14:08:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.500368809820642" STUDIES="2" TAU2="0.0" TOTAL_1="268" TOTAL_2="266" WEIGHT="22.73708355567591" Z="0.6739095732830519">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="8.137925187328408" CI_START="0.013653493802587735" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9105136930277367" LOG_CI_START="-1.8647562024670619" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2011-07-08 11:57:02 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.6302072744211877" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="2.6575757575757577" WEIGHT="22.73708355567591"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 11:57:09 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.0" STUDY_ID="STD-Miyazaki-1985" TOTAL_1="49" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8979415238694317" CI_END="3.2912351798119652" CI_START="0.06966515315098777" DF="1" EFFECT_SIZE="0.47883650952858575" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.16.02" LOG_CI_END="0.5173589165226699" LOG_CI_START="-1.1569844038045098" LOG_EFFECT_SIZE="-0.31981274364092" MODIFIED="2011-07-08 11:58:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3433343827880796" P_Z="0.4540156994128792" STUDIES="5" TAU2="0.0" TOTAL_1="180" TOTAL_2="147" WEIGHT="48.437761335489064" Z="0.748737074079477">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6416" O_E="0.0" SE="0.0" STUDY_ID="STD-Chauhan-1992" TOTAL_1="21" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6417" O_E="0.0" SE="0.0" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="37.67721214481451" CI_START="0.06695005298655404" EFFECT_SIZE="1.588235294117647" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5760787604978064" LOG_CI_START="-1.1742490749363796" LOG_EFFECT_SIZE="0.20091484278071337" ORDER="6420" O_E="0.0" SE="1.6155561848763955" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="2.6100217864923745" WEIGHT="9.911036421704884"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6422" O_E="0.0" SE="0.0" STUDY_ID="STD-Strong-1990" TOTAL_1="30" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.944898925347026" CI_START="0.009485679882356225" EFFECT_SIZE="0.19344262295081968" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5960358803651128" LOG_CI_START="-2.022931535774396" LOG_EFFECT_SIZE="-0.7134478277046417" ORDER="6423" O_E="0.0" SE="1.5383944243381398" STUDY_ID="STD-Wu-1989" TOTAL_1="60" TOTAL_2="58" VAR="2.3666574048346765" WEIGHT="38.52672491378418"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.7693725899616615" CI_START="0.052761287233447" DF="0" EFFECT_SIZE="0.5517241379310345" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-001.16.03" LOG_CI_END="0.761128586893526" LOG_CI_START="-1.2776846173795884" LOG_EFFECT_SIZE="-0.2582780152430313" MODIFIED="2011-07-08 11:58:08 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6194861766594633" STUDIES="2" TAU2="0.0" TOTAL_1="72" TOTAL_2="89" WEIGHT="28.82515510883503" Z="0.49657870256466813">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="5.7693725899616615" CI_START="0.052761287233447" EFFECT_SIZE="0.5517241379310345" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.761128586893526" LOG_CI_START="-1.2776846173795884" LOG_EFFECT_SIZE="-0.2582780152430313" MODIFIED="2011-07-08 11:58:08 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.197608968478155" STUDY_ID="STD-Nageotte-1985" TOTAL_1="29" TOTAL_2="32" VAR="1.4342672413793103" WEIGHT="28.82515510883503"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-07-08 11:57:58 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.0" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.4631369738971065" CI_END="1.0590274127456605" CI_START="0.21137147456289984" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.47312597247940535" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="33" I2="26.781993219060436" I2_Q="38.48540381387066" ID="CMP-001.17" LOG_CI_END="0.02490720189227323" LOG_CI_START="-0.6749536228744959" LOG_EFFECT_SIZE="-0.32502321049111127" METHOD="MH" MODIFIED="2011-07-17 14:27:51 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.24298903291048057" P_Q="0.20230854624762984" P_Z="0.06868921365156865" Q="1.6256304389517975" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.22646304130733122" TOTALS="YES" TOTAL_1="399" TOTAL_2="368" WEIGHT="100.0" Z="1.8204584801969819">
<NAME>Postpartum endometritis</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.17.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2011-07-08 14:10:27 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="73" TOTAL_2="75" WEIGHT="0.0" Z="0.0">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-01-26 12:52:58 +0000" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.0" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.3187461683383757" CI_END="1.7198757763247225" CI_START="0.23693553500386652" DF="2" EFFECT_SIZE="0.6383570217391585" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="19" I2="39.73627693854765" ID="CMP-001.17.02" LOG_CI_END="0.23549707969534348" LOG_CI_START="-0.6253697999831866" LOG_EFFECT_SIZE="-0.19493636014392152" MODIFIED="2011-07-08 14:10:27 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.1902584167648841" P_Z="0.374736556533235" STUDIES="3" TAU2="0.30944009245381643" TOTAL_1="254" TOTAL_2="204" WEIGHT="75.44932163047285" Z="0.8876360658737148">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="27.17772546575128" CI_START="0.41748381048700767" EFFECT_SIZE="3.3684210526315788" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.434213107326286" LOG_CI_START="-0.37936036126416983" LOG_EFFECT_SIZE="0.5274263730310582" MODIFIED="2011-07-08 14:10:05 +0100" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="1.065302032783488" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" VAR="1.1348684210526316" WEIGHT="12.414656016460006"/>
<DICH_DATA CI_END="1.3296500909705549" CI_START="0.20336177302302616" EFFECT_SIZE="0.52" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.12373736761808488" LOG_CI_START="-0.6917306803484865" LOG_EFFECT_SIZE="-0.28399665636520083" MODIFIED="2011-07-08 14:10:22 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.4790099680075034" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.22945054945054943" WEIGHT="37.06944072776861"/>
<DICH_DATA CI_END="1.2997152130263105" CI_START="0.10110387928293023" EFFECT_SIZE="0.3625" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.11384820233728143" LOG_CI_START="-0.9952321805232562" LOG_EFFECT_SIZE="-0.4406919890929875" MODIFIED="2011-07-08 14:10:27 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.6514793069287173" STUDY_ID="STD-Wu-1989" TOTAL_1="60" TOTAL_2="58" VAR="0.42442528735632185" WEIGHT="25.965224886244247"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5609220120182644" CI_END="0.8823907837675087" CI_START="0.04523843700463586" DF="1" EFFECT_SIZE="0.19979484449038643" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" I2="0.0" ID="CMP-001.17.03" LOG_CI_END="-0.05433903658307144" LOG_CI_START="-1.3444924084324372" LOG_EFFECT_SIZE="-0.6994157225077544" MODIFIED="2011-07-08 14:10:17 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.4538890963832829" P_Z="0.033581223331148526" STUDIES="2" TAU2="0.0" TOTAL_1="72" TOTAL_2="89" WEIGHT="24.55067836952714" Z="2.1250645950275637">
<NAME>Mixed or other indications</NAME>
<DICH_DATA CI_END="3.3417930664224986" CI_START="0.04048385845900427" EFFECT_SIZE="0.367816091954023" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5239795536084553" LOG_CI_START="-1.3927181022058803" LOG_EFFECT_SIZE="-0.4343692742987126" MODIFIED="2011-07-08 14:10:11 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="1.1258776908317545" STUDY_ID="STD-Nageotte-1985" TOTAL_1="29" TOTAL_2="32" VAR="1.2676005747126435" WEIGHT="11.311741781520942"/>
<DICH_DATA CI_END="0.8980100355540668" CI_START="0.016171348624061853" EFFECT_SIZE="0.12050739957716702" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="11" LOG_CI_END="-0.04671880992356338" LOG_CI_START="-1.791253760207077" LOG_EFFECT_SIZE="-0.9189862850653201" MODIFIED="2011-07-08 14:10:17 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="1.0247484653838128" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="1.0501094173064796" WEIGHT="13.2389365880062"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="35.059745806261446" CI_END="0.04297548363874408" CI_START="0.02198967074404697" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.03248257719139552" ESTIMABLE="YES" I2="85.738630201058" I2_Q="0.0" ID="CMP-001.18" MODIFIED="2011-07-08 14:19:42 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="1.4639129449767196E-6" P_Q="0.9231023625616562" P_Z="1.2999590054149778E-9" Q="0.009317381309818535" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="455" TOTAL_2="400" UNITS="" WEIGHT="100.0" Z="6.067401986249943">
<NAME>Umbilical cord arterial pH</NAME>
<GROUP_LABEL_1>Amnioinfusion</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Amnioinfusion</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.8152460776299857" CI_END="0.04702580146491833" CI_START="0.01687303768351288" DF="2" EFFECT_SIZE="0.031949419574215605" ESTIMABLE="YES" I2="47.578741729749936" ID="CMP-001.18.01" MODIFIED="2011-07-08 14:11:56 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.148432908642533" P_Z="3.274320576053628E-5" STUDIES="4" TAU2="0.0" TOTAL_1="283" TOTAL_2="211" WEIGHT="48.43924239920523" Z="4.15349731430177">
<NAME>Oligohydramnios</NAME>
<CONT_DATA CI_END="0.05655253779860183" CI_START="-0.03655253779860226" EFFECT_SIZE="0.009999999999999787" ESTIMABLE="YES" MEAN_1="7.25" MEAN_2="7.24" ORDER="6429" SD_1="0.07" SD_2="0.07" SE="0.023751731238840366" STUDY_ID="STD-MacGregor-1991" TOTAL_1="19" TOTAL_2="16" WEIGHT="5.080481552820756"/>
<CONT_DATA CI_END="0.043057486297198744" CI_START="-0.043057486297198744" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="7.28" MEAN_2="7.28" ORDER="6431" SD_1="0.07" SD_2="0.1" SE="0.021968508930179688" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" WEIGHT="5.938739252855285"/>
<CONT_DATA CI_END="0.0571531459903198" CI_START="0.022846854009678494" EFFECT_SIZE="0.03999999999999915" ESTIMABLE="YES" MEAN_1="7.27" MEAN_2="7.23" ORDER="6433" SD_1="0.05" SD_2="0.09" SE="0.008751765912854766" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" WEIGHT="37.420021593529185"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="7.24" MEAN_2="7.19" MODIFIED="2011-01-26 11:10:17 +0000" MODIFIED_BY="[Empty name]" ORDER="276" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wang-1997" TOTAL_1="39" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="31.235182347321636" CI_END="0.04759634853741921" CI_START="0.018370565798377765" DF="2" EFFECT_SIZE="0.03298345716789849" ESTIMABLE="YES" I2="93.5969639051219" ID="CMP-001.18.02" MODIFIED="2011-07-08 14:12:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.649564561612138E-7" P_Z="9.692206161077348E-6" STUDIES="3" TAU2="0.0" TOTAL_1="172" TOTAL_2="189" WEIGHT="51.56075760079477" Z="4.423928605227209">
<NAME>Mixed or other indications</NAME>
<CONT_DATA CI_END="0.05083470294336943" CI_START="0.00916529705663107" EFFECT_SIZE="0.03000000000000025" ESTIMABLE="YES" MEAN_1="7.24" MEAN_2="7.21" MODIFIED="2011-07-08 14:11:36 +0100" MODIFIED_BY="[Empty name]" ORDER="336" SD_1="0.07" SD_2="0.08" SE="0.01063014581273465" STUDY_ID="STD-Mino-1999" TOTAL_1="100" TOTAL_2="100" WEIGHT="25.36395512077199"/>
<CONT_DATA CI_END="0.14315798557364537" CI_START="0.0768420144263535" EFFECT_SIZE="0.10999999999999943" ESTIMABLE="YES" MEAN_1="7.34" MEAN_2="7.23" MODIFIED="2011-07-08 14:11:45 +0100" MODIFIED_BY="[Empty name]" ORDER="337" SD_1="0.05" SD_2="0.08" SE="0.016917650444187696" STUDY_ID="STD-Nageotte-1985" TOTAL_1="29" TOTAL_2="32" WEIGHT="10.014178425393956"/>
<CONT_DATA CI_END="0.016083828033652704" CI_START="-0.036083828033652274" EFFECT_SIZE="-0.009999999999999787" ESTIMABLE="YES" MEAN_1="7.24" MEAN_2="7.25" MODIFIED="2011-07-08 14:11:56 +0100" MODIFIED_BY="[Empty name]" ORDER="338" SD_1="0.07" SD_2="0.06" SE="0.013308320070878035" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" WEIGHT="16.18262405462883"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.749387877006223" CI_START="0.0074228025212391404" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.43923601338309765" LOG_CI_START="-2.1294320934116113" LOG_EFFECT_SIZE="-0.8450980400142568" METHOD="MH" MODIFIED="2011-03-09 11:50:15 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="1.0" P_Q="1.0" P_Z="0.19716671414869322" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="269" TOTAL_2="245" WEIGHT="100.0" Z="1.2896658135411743">
<NAME>Meconium aspiration syndrome</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.749387877006223" CI_START="0.0074228025212391404" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43923601338309765" LOG_CI_START="-2.1294320934116113" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2011-01-26 12:35:31 +0000" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="1.5088483610434074" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="2.2766233766233768" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6438" O_E="0.0" SE="0.0" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.2427319112174775" CI_END="1.101145189639872" CI_START="0.49156448500663996" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7357199657905599" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="85" I2="35.925488121435166" I2_Q="4.079477448204431" ID="CMP-001.20" LOG_CI_END="0.041844585912927106" LOG_CI_START="-0.3084195019507787" LOG_EFFECT_SIZE="-0.1332874580189258" METHOD="MH" MODIFIED="2011-07-08 14:12:26 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.18173964204598703" P_Q="0.35256181675406606" P_Z="0.13578657401642588" Q="2.0850595334486752" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.07443618645242679" TOTALS="YES" TOTAL_1="475" TOTAL_2="483" WEIGHT="99.99999999999997" Z="1.491666581643059">
<NAME>Admission to ICU/high-care nursery</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.869934436115129" CI_END="1.3095169274020109" CI_START="0.32149703215355374" DF="1" EFFECT_SIZE="0.6488496017680732" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="50" I2="65.15599842923086" ID="CMP-001.20.01" LOG_CI_END="0.11711111668242075" LOG_CI_START="-0.49282303183862053" LOG_EFFECT_SIZE="-0.18785595757809995" MODIFIED="2011-07-08 14:12:26 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0902486712464533" P_Z="0.22731139853191762" STUDIES="2" TAU2="0.1673379650684103" TOTAL_1="292" TOTAL_2="294" WEIGHT="51.69713706772494" Z="1.2073136486197522">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.8251026861368325" CI_START="0.24718646271164663" EFFECT_SIZE="0.45161290322580644" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="31" LOG_CI_END="-0.08349199902894193" LOG_CI_START="-0.6069753172831274" LOG_EFFECT_SIZE="-0.3452336581560347" MODIFIED="2011-07-08 12:01:01 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.30749669242672556" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.09455421585337626" WEIGHT="25.049807225638098"/>
<DICH_DATA CI_END="1.6246355807710464" CI_START="0.5201295009676363" EFFECT_SIZE="0.9192501802451334" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="19" LOG_CI_END="0.21075596038627048" LOG_CI_START="-0.28388851299289214" LOG_EFFECT_SIZE="-0.036566276303310885" MODIFIED="2011-07-08 12:01:08 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.29055661219255274" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.08442314488881349" WEIGHT="26.647329842086844"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.060425155919059" CI_END="1.715431155918101" CI_START="0.5712779434735927" DF="1" EFFECT_SIZE="0.9899434241023175" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="23" I2="5.698200913263805" ID="CMP-001.20.02" LOG_CI_END="0.2343732935348204" LOG_CI_START="-0.24315254333420866" LOG_EFFECT_SIZE="-0.004389624899694112" MODIFIED="2011-07-08 12:01:19 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3031186202208229" P_Z="0.9712555032570431" STUDIES="2" TAU2="0.01125224858620937" TOTAL_1="140" TOTAL_2="132" WEIGHT="36.76737290558036" Z="0.03603368046198671">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="1.5354209632277196" CI_START="0.45228276874936146" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="18" LOG_CI_END="0.18622746576931218" LOG_CI_START="-0.34458995786456176" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="6434" O_E="0.0" SE="0.31180478223116176" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.09722222222222222" WEIGHT="24.660469786637147"/>
<DICH_DATA CI_END="4.361861144664885" CI_START="0.5579269764184505" EFFECT_SIZE="1.56" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.6396718361473874" LOG_CI_START="-0.25342263943846416" LOG_EFFECT_SIZE="0.1931245983544616" MODIFIED="2011-01-27 11:01:19 +0000" MODIFIED_BY="[Empty name]" ORDER="210" O_E="0.0" SE="0.5246081158480825" STUDY_ID="STD-Persson_x002d_Kjerstadius-1999" TOTAL_1="60" TOTAL_2="52" VAR="0.27521367521367524" WEIGHT="12.106903118943215"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.213515687536393E-32" CI_END="1.2754670807557422" CI_START="0.15307386100242595" DF="0" EFFECT_SIZE="0.4418604651162791" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" I2="100.0" ID="CMP-001.20.03" LOG_CI_END="0.10566925414092991" LOG_CI_START="-0.815098963394445" LOG_EFFECT_SIZE="-0.35471485462675756" MODIFIED="2011-07-08 12:01:19 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.13101663649410886" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="57" WEIGHT="11.535490026694678" Z="1.510104989745904">
<NAME>Mixed and other indications</NAME>
<DICH_DATA CI_END="1.2754670807557422" CI_START="0.15307386100242595" EFFECT_SIZE="0.4418604651162791" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="12" LOG_CI_END="0.10566925414092991" LOG_CI_START="-0.815098963394445" LOG_EFFECT_SIZE="-0.35471485462675756" MODIFIED="2011-07-08 12:01:19 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.5408638088564645" STUDY_ID="STD-Owen-1990" TOTAL_1="43" TOTAL_2="57" VAR="0.29253365973072215" WEIGHT="11.535490026694678"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.4050145567763526" CI_END="0.9202154936010734" CI_START="0.30848843773441653" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5328" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="31" I2="16.84042018104158" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="-0.03611045882518415" LOG_CI_START="-0.5107611088503264" LOG_EFFECT_SIZE="-0.2734357838377553" METHOD="MH" MODIFIED="2011-03-09 11:50:15 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.3004400436403416" P_Q="1.0" P_Z="0.023934180726488688" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="349" TOTAL_2="325" WEIGHT="100.00000000000001" Z="2.258184154506443">
<NAME>Meconium below vocal cords</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9745039784147053" CI_START="0.13088814744056723" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="14" LOG_CI_END="-0.011216383534531815" LOG_CI_START="-0.8830996791499065" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2011-01-26 12:34:32 +0000" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="0.5121485637363902" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.26229615133724726" WEIGHT="42.56000000000001"/>
<DICH_DATA CI_END="1.248852331373434" CI_START="0.1654411534954748" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="11" LOG_CI_END="0.09651108892570175" LOG_CI_START="-0.7813564505701143" LOG_EFFECT_SIZE="-0.3424226808222062" ORDER="6436" O_E="0.0" SE="0.5156637382142464" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.2659090909090909" WEIGHT="33.440000000000005"/>
<DICH_DATA CI_END="2.285966030679216" CI_START="0.3975756560889947" EFFECT_SIZE="0.9533333333333334" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.35906977251675115" LOG_CI_START="-0.40058021569799007" LOG_EFFECT_SIZE="-0.02075522159061942" ORDER="6437" O_E="0.0" SE="0.4462221634054265" STUDY_ID="STD-Nageotte-1991" TOTAL_1="50" TOTAL_2="26" VAR="0.19911421911421912" WEIGHT="24.000000000000004"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.71074772859321" CI_END="0.7803151567946931" CI_START="0.25415898261075803" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.44533594775932167" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="152" I2="79.60674701688403" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="-0.10772995729262967" LOG_CI_START="-0.5948945366425791" LOG_EFFECT_SIZE="-0.35131224696760444" METHOD="MH" MODIFIED="2011-07-08 14:13:29 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.002081296361863272" P_Q="0.8109195973289387" P_Z="0.004701511840738165" Q="0.057235711155859764" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.24557559039790777" TOTALS="YES" TOTAL_1="547" TOTAL_2="504" WEIGHT="100.0" Z="2.8268038382557625">
<NAME>Maternal hospital stay &gt; 3 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="11.726774787113072" CI_END="1.402629510492916" CI_START="0.16824125922564437" DF="1" EFFECT_SIZE="0.4857778865617262" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="98" I2="91.47250613954886" ID="CMP-001.22.01" LOG_CI_END="0.14694297195717956" LOG_CI_START="-0.7740674897707235" LOG_EFFECT_SIZE="-0.313562258906772" MODIFIED="2011-07-08 14:13:29 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="6.160805413404358E-4" P_Z="0.18202119817168863" STUDIES="2" TAU2="0.5365726438775699" TOTAL_1="292" TOTAL_2="294" WEIGHT="55.86314616373319" Z="1.3345575537009728">
<NAME>FHR decelerations</NAME>
<DICH_DATA CI_END="0.49650779758712293" CI_START="0.16759063921246195" EFFECT_SIZE="0.28846153846153844" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="52" LOG_CI_END="-0.3040739265795413" LOG_CI_START="-0.7757502425786946" LOG_EFFECT_SIZE="-0.539912084579118" MODIFIED="2011-01-26 12:36:11 +0000" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.27706500285332264" STUDY_ID="STD-Abdel_x002d_Aleem-2005" TOTAL_1="219" TOTAL_2="219" VAR="0.0767650158061117" WEIGHT="25.40455512343232"/>
<DICH_DATA CI_END="1.054190744184388" CI_START="0.5796662740091387" EFFECT_SIZE="0.7817153067301965" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="46" LOG_CI_END="0.022919198781525908" LOG_CI_START="-0.23682196690163443" LOG_EFFECT_SIZE="-0.1069513840600543" MODIFIED="2011-03-09 10:55:48 +0000" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.15257324646179465" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.02327859553589154" WEIGHT="30.458591040300874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.709136991730852" CI_END="0.6431741274063141" CI_START="0.2777361719410475" DF="1" EFFECT_SIZE="0.42264964218292345" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="54" I2="0.0" ID="CMP-001.22.02" LOG_CI_END="-0.1916714340212125" LOG_CI_START="-0.5563675547064363" LOG_EFFECT_SIZE="-0.3740194943638244" MODIFIED="2011-07-08 14:13:29 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.39973092408031563" P_Z="5.816355693044627E-5" STUDIES="2" TAU2="0.0" TOTAL_1="255" TOTAL_2="210" WEIGHT="44.13685383626681" Z="4.020140039283279">
<NAME>Oligohydramnios</NAME>
<DICH_DATA CI_END="0.7587909899126088" CI_START="0.11400397667002032" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="17" LOG_CI_END="-0.11987783468172447" LOG_CI_START="-0.9430799994027858" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2011-07-08 14:13:23 +0100" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.48355302647358617" STUDY_ID="STD-Amin-2003" TOTAL_1="80" TOTAL_2="80" VAR="0.2338235294117647" WEIGHT="17.081632736584307"/>
<DICH_DATA CI_END="0.7376135053496156" CI_START="0.2890906005419988" EFFECT_SIZE="0.4617760617760618" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="37" LOG_CI_END="-0.13217114015789985" LOG_CI_START="-0.5389660286998197" LOG_EFFECT_SIZE="-0.3355685844288598" MODIFIED="2011-07-08 14:13:29 +0100" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.23895333119669798" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.05709869448999884" WEIGHT="27.055221099682505"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.255879661522723" CI_END="1.4215197038918426" CI_START="0.261001119815003" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6091126616274386" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="88" I2="90.24949557713973" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.15275288388730657" LOG_CI_START="-0.5833576293343885" LOG_EFFECT_SIZE="-0.2153023727235409" METHOD="MH" MODIFIED="2011-03-09 12:06:51 +0000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.001362509766433928" P_Q="1.0" P_Z="0.251577622815378" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.3379411235381198" TOTALS="YES" TOTAL_1="248" TOTAL_2="205" WEIGHT="100.0" Z="1.1465259325730337">
<NAME>Neonatal hospital stay &gt; 3 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2185579804692943" CI_START="0.6764892354705762" EFFECT_SIZE="0.9079324625676968" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="43" LOG_CI_END="0.08584619827150344" LOG_CI_START="-0.1697391096545678" LOG_EFFECT_SIZE="-0.0419464556915322" MODIFIED="2011-03-09 11:05:25 +0000" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.1501320750434528" STUDY_ID="STD-Regi-2009" TOTAL_1="73" TOTAL_2="75" VAR="0.022539639956852944" WEIGHT="51.86556946654977"/>
<DICH_DATA CI_END="0.6153954122478583" CI_START="0.25506672669313935" EFFECT_SIZE="0.3961904761904762" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.21084574572727702" LOG_CI_START="-0.5933461911591136" LOG_EFFECT_SIZE="-0.40209596844319534" ORDER="6441" O_E="0.0" SE="0.22468265505440219" STUDY_ID="STD-Schrimmer-1991" TOTAL_1="175" TOTAL_2="130" VAR="0.05048229548229548" WEIGHT="48.13443053345022"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2011-05-18 15:15:21 +0100" MODIFIED_BY="Denise Atherton" NO="2">
<NAME>Transabdominal amnioinfusion for cord compression (potential, or diagnosed by fetal heart rate monitor)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.5194351438265453" CI_START="0.03125338212120451" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.1274131274131274" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-0.28446867031394096" LOG_CI_START="-1.5051029780927876" LOG_EFFECT_SIZE="-0.8947858242033644" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.004059476087024748" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="37" TOTAL_2="33" WEIGHT="100.0" Z="2.8735026996034994">
<NAME>Suspicious/ominous fetal heart rate pattern</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5194351438265453" CI_START="0.03125338212120451" EFFECT_SIZE="0.1274131274131274" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="14" LOG_CI_END="-0.28446867031394096" LOG_CI_START="-1.5051029780927876" LOG_EFFECT_SIZE="-0.8947858242033644" ORDER="6442" O_E="0.0" SE="0.7170066346265661" STUDY_ID="STD-Vergani-1996" TOTAL_1="37" TOTAL_2="33" VAR="0.5140985140985141" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.1506406986892252E-31" CI_END="3.579530691565993" CI_START="0.5224468936762663" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3675213675213673" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" I2="100.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.553826090491975" LOG_CI_START="-0.2819578486724489" LOG_EFFECT_SIZE="0.13593412090976306" METHOD="MH" MODIFIED="2011-05-18 15:15:21 +0100" MODIFIED_BY="Denise Atherton" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.5237682827156964" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="40" WEIGHT="100.0" Z="0.6375475018570194">
<NAME>Meconium-stained liquor</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.579530691565993" CI_START="0.5224468936762664" EFFECT_SIZE="1.3675213675213675" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.553826090491975" LOG_CI_START="-0.2819578486724488" LOG_EFFECT_SIZE="0.13593412090976315" ORDER="6443" O_E="0.0" SE="0.4909436230624052" STUDY_ID="STD-Vergani-1996" TOTAL_1="39" TOTAL_2="40" VAR="0.24102564102564097" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0026122876622948345" CI_END="0.7427681400885754" CI_START="0.05473562574070672" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.20163303034971497" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-0.1291467329350453" LOG_CI_START="-1.2617299126727066" LOG_EFFECT_SIZE="-0.6954383228038761" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9592374529698842" P_Q="1.0" P_Z="0.01608648689795974" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="55" WEIGHT="100.0" Z="2.406947393444877">
<NAME>Caesarean for suspected fetal distress</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.627555752732273" CI_START="0.00976760341308864" EFFECT_SIZE="0.18823529411764706" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5596140959320776" LOG_CI_START="-2.010211982048814" LOG_EFFECT_SIZE="-0.725298943058368" ORDER="6444" O_E="0.0" SE="1.5095285590502205" STUDY_ID="STD-Busowski-1995" TOTAL_1="16" TOTAL_2="15" VAR="2.2786764705882354" WEIGHT="20.690186411955015"/>
<DICH_DATA CI_END="0.876850109690215" CI_START="0.04798719880868202" EFFECT_SIZE="0.20512820512820512" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.05707463935684635" LOG_CI_START="-1.3188746007122651" LOG_EFFECT_SIZE="-0.6879746200345557" ORDER="6445" O_E="0.0" SE="0.7411875433107159" STUDY_ID="STD-Vergani-1996" TOTAL_1="39" TOTAL_2="40" VAR="0.5493589743589743" WEIGHT="79.30981358804499"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0999890687302436" CI_START="0.16602745695228346" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.42735042735042733" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.04138836932756668" LOG_CI_START="-0.7798200841478523" LOG_EFFECT_SIZE="-0.36921585741014284" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.07800137110957334" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="40" WEIGHT="100.0" Z="1.7624021768953135">
<NAME>Caesarean section, overall</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0999890687302434" CI_START="0.16602745695228346" EFFECT_SIZE="0.42735042735042733" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="12" LOG_CI_END="0.04138836932756659" LOG_CI_START="-0.7798200841478523" LOG_EFFECT_SIZE="-0.36921585741014284" ORDER="6446" O_E="0.0" SE="0.48238191061886604" STUDY_ID="STD-Vergani-1996" TOTAL_1="39" TOTAL_2="40" VAR="0.23269230769230767" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="39" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Forceps/vacuum delivery, overall</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="6447" O_E="0.0" SE="0.0" STUDY_ID="STD-Vergani-1996" TOTAL_1="39" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.2629797398259555" CI_END="2.3134780397545986" CI_START="0.17766795659085766" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6411169284467714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="100.0" ID="CMP-002.06" LOG_CI_END="0.36426538139862863" LOG_CI_START="-0.7503908925696873" LOG_EFFECT_SIZE="-0.1930627555855293" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.6080804287119768" P_Q="0.0" P_Z="0.4971716976231503" Q="7.187921650322915E-33" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="55" WEIGHT="100.0" Z="0.6789466072021634">
<NAME>Apgar score &lt; 7 at 5 minutes</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.154313167730004" CI_START="0.013757251170205428" EFFECT_SIZE="0.3137254901960784" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8545679467215713" LOG_CI_START="-1.8614683336055944" LOG_EFFECT_SIZE="-0.5034501934420116" ORDER="6448" O_E="0.0" SE="1.5954131556605964" STUDY_ID="STD-Busowski-1995" TOTAL_1="16" TOTAL_2="15" VAR="2.545343137254902" WEIGHT="28.12565445026178"/>
<DICH_DATA CI_END="3.215975079542482" CI_START="0.1839927119135329" EFFECT_SIZE="0.7692307692307693" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5073126747595234" LOG_CI_START="-0.7351993793731969" LOG_EFFECT_SIZE="-0.11394335230683675" ORDER="6449" O_E="0.0" SE="0.7298577311314224" STUDY_ID="STD-Vergani-1996" TOTAL_1="39" TOTAL_2="40" VAR="0.5326923076923076" WEIGHT="71.87434554973822"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.11702666610298168" CI_END="1.060507170821136" CI_START="0.03593611361716029" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.19521912350597612" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.0255136094273296" LOG_CI_START="-1.4444688923323785" LOG_EFFECT_SIZE="-0.7094776414525245" METHOD="MH" MODIFIED="2011-03-09 14:10:51 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.7322820067600199" P_Q="1.0" P_Z="0.05850055681854783" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="37" WEIGHT="100.0" Z="1.891928133047501">
<NAME>Low cord pH (&lt; 7.20 or as defined by trialists)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4035299648462325" CI_START="0.007521362174569722" EFFECT_SIZE="0.13445378151260504" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3808495408546176" LOG_CI_START="-2.123703498327829" LOG_EFFECT_SIZE="-0.871426978736606" ORDER="6450" O_E="0.0" SE="1.4711868529532615" STUDY_ID="STD-Busowski-1995" TOTAL_1="16" TOTAL_2="15" VAR="2.164390756302521" WEIGHT="47.410358565737056"/>
<DICH_DATA CI_END="2.0623046471083786" CI_START="0.0303059007735027" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.31435282039722706" LOG_CI_START="-1.5184728030531516" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="6451" O_E="0.0" SE="1.07661084384791" STUDY_ID="STD-Vergani-1996" TOTAL_1="22" TOTAL_2="22" VAR="1.1590909090909092" WEIGHT="52.58964143426295"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-11-29 01:48:02 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2011-07-08 14:05:53 +0100" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM), outcome: 1.11 Caesarean section, overall.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADAAMAAwMD/gADAwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID///8AAAALCwsWFhYhISEsLCw3NzdCQkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYAAJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkAmcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwzAP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8zzAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBmMzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNmzGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZM5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZzMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zMM//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP//2b//5n//8z///9BjlLGAAASc0lEQVR42u2db5AT532A3/sjpAP7jlVKOrS0HJmzSYbQxIYcBsb2ZWHsAUK4a5y2M5jOlCTOJJ5JvriettOZJp6MHSDudOx86GQCnYZL8gEKJFebkDjy4TMcZs5J6tad4MHmzrkgkqu157PhVsjmKu2upJW0q11Jrzjp9nlsTitpJa1ePfq9v/e3r3ZbFAEgn1aaABALEAuCTbvfFbX0P8W8MBaEpmhKyTpK7v7sQuY28jjEcvVKsf4o9huKyd6v5RcUzKIrrAJN08wLK0QBVNYVZnvAwoCVuUj/y/xf7nGELMRydSObWhUZVrCC/X63FQGxiqOVPccqs54ZnxSXPAzIsYoGhb4d1IoXALGqzuJpS/DsCrWSLq84x7LyccVcU9EKolMuWbcW6BIRyz7WcxoRKkU3Fd+sZP8qguQdsaqgoISg2bL70uBHwAogLYrPiAUgLWJpRf1ggJjpxI36iaWQeMN8lxsAEAvmpytUNAoFUI8cC6vI3ekKAbEAsQLODE2AWIBYgFgAiAWI1RxQx0IsQCxArIBDHQuxALEAsQAQCxCrSaCOhViAWIBYAYc6FmIBYgFiASAWIFaTQB0LsQCxALECDnUsxALEAsQCQCxArCaBOhZiAWIBYgUc6liIBYgFiAWAWIBYTQJ1LMQCxALECjjUsRALEAsQCwCxALGaBOpYNWI/EWb+vKqcYRXkiZU5X715zvr8EoDErhCnqGPJ7ArBFxrfvxrEMnpCLduONKFDQNdoiWojliLItUBijoVOUB+xAupVKr9IHUueWIqmGXWGzP/pxeC1xcTVCYSQRYtXbApO8Lo8uuZ/7/2Aj1GhQrpQdY4VQCYWr/vw9tNXrGvUsRBLUrwam+4WkZ6XEz5Clglthli+4lV3+mJFcrHnqkoWWo0cyzu/MrwSInFqo7Eww7CQiCWhzrC4xfRKRJctTdAeiCWJ0Ky4YC7Fp8LRzCUBi65QTswaEn1po0bWfoiARcSSGbP6wsMpEZ8M4xURSzL68WXrwx3WFZJ3IpYsIl+eynkFiCUP7X68oiusM3SFRCxArOaBgIVYgFiAWAGH+ViIBYgFiAWAWIBYTQJ1LMQCxALECjjUsRALEAsQCwCxALGaBOpYiAWIBYgVcKhjIda8wg+nEasejLTGaQTEkk588sxwimZwgh+suuRYfuoNI2vDHc/N9EXRiIjlFz9exSfDHWJreJI8C7Gk5lfDD2eO9XDfxSnaopQ2r+Ng6BwowyVevdL/ntGCg1v2/wvNQcTymWN5rZDo6LS+cqEdh+kMEcsXiYPi7Y8fKrtK9LYZ3Vwa1/eQvjMq9MP5fa0Hf518qudvywqTGgrfFxJiYvSubjwiYvmJV/sGjojeu//15GtlVwv1zQ3FxXjXPXhFxHJ1yR6bDv7kiFHHOnTyiMfDnkmGf7lnJRYRsdxGeKfse2aefsSsY6254fW4HXdufhCvEMuN2eFO+56Z0y3m5W2HPB/ZfYN+kK7QNV4N9y3Xn/lkrjd84JG7zOz8r/4DQYhYVTMy3L9cRCKnc8Wo7U+mjDrW4dtpHCli2c/BF5yz8cUnjT0zG+dye2b29nzioEicP/jsI/ghoys0TgidPS2tUALSFc6e6Dcr6PHRO3P5UnTLwTnxzcdC+IFY1dYZTnXusBZ1fUneJI7zXiO2ndCZ3c3WLmdNMRY0XdfT7a0v4B3R+144INqNpYlvTD+dvz0Zxo2aaC93pxKArnDqxrCxZ2a8a9peOSBg1WNUGKj9g9G+5FBcTCwt8MoXTEquuNyQHh4GZ1gY/fM1Z/Wxyr26fPUy/lQmVuYM7UEKWqvX6euKvPL+XeHE4ucHryCQj1FhJkjlBoZaUMoN1uCweIKM56gwc957/dmdVCR8iCUCn2/5F2vCyPWPhTcyx6+SHAu84pWZk/UlX6YtnOHHFM6Ur2NN3PqUkZPtG/zUl76HRHSFkkhdffPPst+74/fTGSKWLOKja1YbC5nfQtMciCUvZg0t2hTNzOTqxytn2mmCakaFob7R4VRopIN4xahQLtEdnUf1SbyiK5QbsTIol/CKiFUHtBt4RcTymZOHKohYQMTyyXh+vgJeIZb/eORx/8TS589xSFHEqhSv+VOXx6YHto++hROIVRFe86cmFq/rFhFxzvx5Icd5r5HAFEgvj0536z2pULn70xd9w4sjWEHEqiBeGfHop4ly96eJ7jz+HFYglu945TF/KtX1Zre5FBqY4sCPEghGHWsi+9uu1NFlWx3XiB9eY/5w1ZqvQB0LsXzUGXzMn0oN9axgvoI8AjGDtE175bFvm/Ho6aP/7LLO4K7XB9tG/nj0PaRALL88Obh1z7f3ZY7NftT17bT94N+PfX/7Ubyi3FABvuZPRT6o5/pBcixGhb7wNX9qC/MVSN4rp6L5U0QsIpZfmD9FxJp/iFhErLqAV4jlC45lhVj1gGNZIVY9qPxYVszHqpFAFEgzxxctNxcLiFhVxavM8UXLzMUCxKoqv+JYVvPAwt8JXd2xrDjOe40s+AIpx7JCrPoQP7zLOpbVJHP4EEtmzOJYVpQb6kFVx7JiXyFieRJNZ1cDHMuKrrAOVHwsKyJWjQRkXyFzsYhYjQERi4hVF/AKseoHOxcRqx7ET3EYNnIs+TnWyGTn5iVMtakSTiDgGq+GH05EfvxJ9i7SFUpldrg/ISKR0+RZtYulaVrJUmA50ZepfG2cm8KRWnMsreC8vdncKpg51sjHQmZF9cr3/qIbS2SKFejkPXGqc4e1qOsk8BJzrIB3hdGvzOjm0oQ+jVfyIpZQzGvZu4IXtRKTv8mcRzxzrnokkRexLJGUNOafwNG+4vpwPHcsZSB5l8RMp7jw6nZ9Gq/k5lggxOo78UpKxMqkVFao0vJpVZCnzSQou0sRy3l8yHwsoCuUBl4hFjQiwTjOe4bE7YtG73r8R3zk5FhSOb+/5fln5w7cNtBLjkVXKDFe7e8/8n+9G77z2g0+cyKWRJJfe8K4PHTyCBGLiCWP3f3m5UeJWIglk1dbzMueQ3zmiCWR8Jx5eetef+vTEyKWL75ywDzS+43b+cxvCkGpY/1o19Vv/d3+b7y3+4n9fOiMCmWibP2uEN98zOd8UEaFiFUXEIscCxBrIcEvWRGrHoy0csQQxKocrxQrPnlmmFPVkbxLj1drP5R4bqaPqctELKnEJ8MJsTV8ljzLFQ5j5EzZcoN1zPiNw6M0FBFLarwydkdEdyZ1WgOxZJHo6LR2c4W2H6AzRCxZRG/LHjHksr6H9J1RobwcKzUUvi8kxPjgnpUYRMSqiLJ1rFDfnwzFxfjSB/GKiCUZ/cQdf8iRHYhY0onchVdELNk5ljk4JG9HrHqIBXSFgFiAWACIVSmkWIgFiAWIFXBmaALE8k0i+ZmPfWaQDx2x5JJSv/bo2KMnPsscKsSSyVufeOqJDaEN37lxko+9/gTn4LaivedzmYt9v/rIi94rJ8O4QcTyxwXroH7v+olY1LEQyy8X7zQvW17gY0csifT8wrycu5ePHbEkMnDgvHF5yzYfK1PHqpEgzcf6p//5Qes7c7fs/qGPg68xH4tRoW9O/+NHZvee/sLn/Rw4mVEhEasuELHIsQCxmgcCVo3YjzaTP2Gv7dS9ADWK5XwWewC6QonJO00gryssHRFm/xC9QIZYipVjKYIuESSKRY4F5FiAWE0EdSx5XaGVWaX7QIU6FtQI+wqBrvAmQh0LsQCxALEAEAsQq0mgjoVYgFiAWAGHOhZiAWIBYgEgFiBWk0AdC7EAsQCxAg51LMQCxALEAkAsQKwmgToWYgFiAWIFHOpYiAWIBYgFgFiAWE0CdSzEAsQCxAo41LEQCxALEAsAsQCxmgTqWDXSThNAFRjn7zJOC5BdQCyQQe7ElrkFukI/UMcixwJyLFhYSZZiX0AskJNjmYmVy7kt6Qqhare04gXE8oQ6Fsk7NGLI4nyFcDMjltao45CbxUzDbIlozi1pbRqvoPkjFt0f1EUsvIJacUnezZgV4B6x7X3cqHCIWHi13WvdxukW2ZKG3hJ/o0KAOuRYAIgFzZS8A9RGu2sqphQuzWeamN+axshWGyNlzo3clcbZjPzWtLuurCn2JW2eN936LBuiANIYVRituG0aYDNsW9PaTN9R4lXzfCI+xWqQTExhI5rlE2FUCJQbALEAsQDk41xuULTsz3oUbf7zxPzWgEvbNMhm2LaGyjvQFQJiAWIBIBYgFiAWAGIBYgFiASAWIBYgVhlSnQ8teuiWePaqqtJyIEOspev/+vqe3r20F/ikrcPfeiu/lfy3SxeFuupS5t8qMT0XudaW6vybNzatuqSu+n37e6Jrrn1JMruCumpahH6/b9lcW1tk6TWamYjlQkisiyyz3/D+kg1/L9o3HE0Z18KnRde6JYvX2w4J+35k45+KmY3vdm24Sisjlhtvj4pNa29J5W8YvyhmxBfFxTeNaxd7xV+K118X120rvCEyq3f+8CgBK4iUTPQr+TWmuULiyFc3iZeuqiIm0v+Mixevhzfnrglj+cXr9hVGUsq1zeLMkoTzE8NCotijds81TKIi8YvHU2LkbpF4wBBN2C+EtdwqzmwWZlxLvZO+piU6lm1+sdzzwsJA845YjgJsSz7TsWztS1e3Jf87uT4TkMbaPz4207n+V29tsSJW17pfijvGZiKbvv6pdcYKbXf8vKVj4yvx+8MnafeFL5ZSXY714/NfXTTw8zfFsbMDYeOG3z0weklcOndNEWfMNS69/NlrYzPiZz33hYzrx66d08Rvd73z8LlDNDs5VmW/hdny8hu33n/OKTk3ghgEOGLVJFZUT7W2vR1yKk+0JmnsQItV02nljOGek1ciRVMHnJLKu95Bo5TlpT9498KGvc+30RJltWn3HD1SJijgHz4cae263HLtP3fTFuVwGxUqWWiiApKvXQiHxNTjQ8cSNEY1YpUM8zLYBn2FS66zaFSPG9TsE+eeRy24QZR7etXlxjrO6TmvP9prLDx4+/GiBlB9bmD5zVS91qrv+5OH7+S9LuUDNVb6xDHzjpha9SvWsdJxLNJrLe160vYeVGmvGvPxZpqiklPpDFIrmqjWku323L3Zi0w0Mr9d+fUdHun9iqLgqW1X7C9lewG1cBNEpa9Yhp/k2qv1uyWhRM3FXNt2F25jQQuKotbKBaSCt1q4Xp3f3zxELNvX04gm5pLt9vxt2busRWG7sfCRZYNSLLeOKuzPV/IMBa8ac7q9cFtr4XRXdqn3nv/KbWf6v9yS/WXtbVa4xbHSjXNoTLW0cev8/uZBLLUoBMfco3Os5MZYmfhtPbFakGUUPp/q2RHE3G+X2n/c+9upbLa1usuzW1Mr6eUcNjX/BDfr/c1fjqWWzUzV8lm14yNj9tTKXHD69qmez6WW/YTlNPy2RV+3lm58+fsuQbbSXkmteT1572/eukIRE0U5q8O9jnfZbox5f9Vj5TNWpy+q46vm15LTVQystupXiYcOd7h89LFqm9RHFlLv9zd/yXtJp+V8r9dQWq3mBVXnqKh6Pqu8zLb318d2v5AS5194aFuHw9cgpvoqwvjdQL9VnUasP7hFLK180M1kkcU5RO5e+125Rs/eaDzS+pa6lhRi+bzfepztqe2h39YJ5F+gpHOQ2FVsSJx4+ppY/fnDRx1jSiz39vKN4Lwt9oZx3LiCJ4jdrPcnjZpmN0ipY1VzHzQaFU30u1L3zYmpeLVAKSPWeGS8/mbVmtJC04k1ce7M0jgNBJLFGu+6Z0fkLGaBXLEmBt/+IxGJjF6hiUCiWONdD65MX+zoOcu0I5An1sS56W5jYYUYzQ3T1Pzu9+IRnMd1UeH9sEDFSudXplci2qfr2eF/LOZ3l0z1Y0FYyGIZ+ZVF9NP6c6ZXIld2sqYI5acFmTOGctORzHXUwklD9vlDtkeqHMNtYeKwSyfVdWZl/lpobCoRLe3MCmZJ2WZe5aYRFc3LErHCFYumbkEAIlZodrOevzY71R/17M+M5XQ8Mx3J/rHPy4q5d4J4FZCIJZbPjq5ZZtk0MtlX/Q8NvXu5Rtx9CnVL3pfvfHU4YXm1Ynn1XqXzfU+zYjGSrOCUG0I7FxlmzU4+fHc+tBRmQ6pD+IkV30Phga6w0KxNoz9NhWZP9Hc4d1qFs6SKOrdcWUJ1n76Qn7VEV7ggcZ+PpR8fON63vGxP530LBIQKjjYT+aDunl85/kITr8BHxBIiEaV9oMqINb9Tk2HBisVJmuAmlhsAEAsQCwJDabmBU5OABFoYBAJdISAWIBYAYgFiAWIBIBYgFiAWAGIBYgFiASAWIBYgFoAU/h/szMnTx5fwSQAAAABJRU5ErkJggg==</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-07-08 14:50:33 +0100" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.02" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM), outcome: 1.2 Caesarean for suspected fetal distress.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2011-11-29 01:47:47 +0000" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.11" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM), outcome: 1.14 Apgar score &lt; 7 at 1 minute.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2011-11-29 01:48:02 +0000" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.12" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transcervical amnioinfusion for intrapartum umbilical cord compression (potential, or diagnosed by EFM)*, outcome: 1.12 Apgar score &lt; 7 at 5 minutes.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2011-11-28 23:08:36 +0000" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2011-11-28 23:08:36 +0000" MODIFIED_BY="[Empty name]" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-07-21 10:33:14 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2011-07-21 10:33:14 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-07-21 10:31:19 +0100" MODIFIED_BY="[Empty name]">Methods used to assess trials included in previous versions of this review</TITLE>
<APPENDIX_BODY MODIFIED="2011-07-21 10:33:14 +0100" MODIFIED_BY="[Empty name]">
<P>The following methods were used to assess <LINK REF="STD-Amin-2003" TYPE="STUDY">Amin 2003</LINK>, <LINK REF="STD-Busowski-1995" TYPE="STUDY">Busowski 1995</LINK>, <LINK REF="STD-Chauhan-1992" TYPE="STUDY">Chauhan 1992</LINK>, <LINK REF="STD-MacGregor-1991" TYPE="STUDY">MacGregor 1991</LINK>, <LINK REF="STD-Miyazaki-1985" TYPE="STUDY">Miyazaki 1985</LINK>, Monahan 1995a, <LINK REF="STD-Nageotte-1985" TYPE="STUDY">Nageotte 1985</LINK>, <LINK REF="STD-Nageotte-1991" TYPE="STUDY">Nageotte 1991</LINK>, <LINK REF="STD-Owen-1990" TYPE="STUDY">Owen 1990</LINK>, <LINK REF="STD-Puertas-2001" TYPE="STUDY">Puertas 2001</LINK>, <LINK REF="STD-Schrimmer-1991" TYPE="STUDY">Schrimmer 1991</LINK>, <LINK REF="STD-Strong-1990" TYPE="STUDY">Strong 1990</LINK>, <LINK REF="STD-Vergani-1996" TYPE="STUDY">Vergani 1996</LINK>, <LINK REF="STD-Wu-1989" TYPE="STUDY">Wu 1989</LINK>, <LINK REF="STD-McEvoy-1991" TYPE="STUDY">McEvoy 1991</LINK>, <LINK REF="STD-Muse-1997" TYPE="STUDY">Muse 1997</LINK>, <LINK REF="STD-Pressman-1996" TYPE="STUDY">Pressman 1996</LINK>, <LINK REF="STD-Washburne-1996" TYPE="STUDY">Washburne 1996</LINK>. Trials under consideration were evaluated for methodological quality and appropriateness for inclusion according to the prespecified selection criteria, without consideration of their results. The risk of bias assessment was based on randomisation, allocation concealment and blinding. Individual outcome data were included in the analysis if they met the prespecified criteria in 'Types of outcome measures'. Included trial data were processed as described in <LINK REF="REF-Alderson-2004" TYPE="REFERENCE">Alderson 2004</LINK>.</P>
<P>Data were extracted from the sources and entered onto the Review Manager computer software (<LINK REF="REF-RevMan-2003" TYPE="REFERENCE">RevMan 2003</LINK>), checked for accuracy, and analysed as above using the RevMan software. For dichotomous data, relative risks and 95% confidence intervals were calculated, and in the absence of heterogeneity, results were pooled using a fixed effects model.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>